{
  "version": "1.0",
  "lastUpdated": "2025-10-23",
  "totalReferences": 748,
  "references": [
    {
      "id": "ref_0519",
      "fullText": "(PDF) Investigating LSA - a ‘legal high’ analogue to LSD, frequently used in the digital realm with relatively unknown effects. (2024). ResearchGate. https://doi.org/10.1192/j.eurpsy.2024.1150",
      "authors": "(PDF) Investigating LSA - a ‘legal high’ analogue to LSD, frequently used in the digital realm with relatively unknown effects.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1192/j.eurpsy.2024.1150",
      "url": "https://doi.org/10.1192/j.eurpsy.2024.1150",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0520",
      "fullText": "(PDF) Using thematic analysis in psychology. (2024). ResearchGate. https://doi.org/10.1191/1478088706qp063oa",
      "authors": "(PDF) Using thematic analysis in psychology.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1191/1478088706qp063oa",
      "url": "https://doi.org/10.1191/1478088706qp063oa",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0001",
      "fullText": "2023 National Survey on Drug Use and Health (NSDUH) Releases. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/release/2023-national-survey-drug-use-and-health-nsduh-releases#detailed-tables",
      "authors": "2023 National Survey on Drug Use and Health (NSDUH) Releases. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/release/2023-national-survey-drug-use-and-health-nsduh-releases#detailed-tables",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/release/2023-national-survey-drug-use-and-health-nsduh-releases#detailed-tables",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0002",
      "fullText": "A retrospective analysis of the “Neverending Trip” after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/357477776_A_retrospective_analysis_of_the_Neverending_Trip_after_administration_of_a_potent_full_agonist_of_5-HT2A_receptor_-_25I-NBOMe",
      "authors": "A retrospective analysis of the “Neverending Trip” after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/357477776_A_retrospective_analysis_of_the_Neverending_Trip_after_administration_of_a_potent_full_agonist_of_5-HT2A_receptor_-_25I-NBOMe",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/357477776_A_retrospective_analysis_of_the_Neverending_Trip_after_administration_of_a_potent_full_agonist_of_5-HT2A_receptor_-_25I-NBOMe",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aakery_2021",
      "fullText": "Aakerøy, R., Brede, W. R., Stølen, S. B., Krabseth, H.-M., Michelsen, L. S., Andreassen, T. N., Ader, T., Frost, J., Slettom, G., Steihaug, O. M., & Slørdal, L. (2021). Severe Neurological Sequelae after a Recreational Dose of LSD. Journal of Analytical Toxicology, 45(7), e1–e3. https://doi.org/10.1093/jat/bkaa145",
      "authors": "Aakerøy, R., Brede, W. R., Stølen, S. B., Krabseth, H.-M., Michelsen, L. S., Andreassen, T. N., Ader, T., Frost, J., Slettom, G., Steihaug, O. M., & Slørdal, L.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1093/jat/bkaa145",
      "url": "https://doi.org/10.1093/jat/bkaa145",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aaronson_2025",
      "fullText": "Aaronson, S. T., Van Der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Suppes, T., & Sackeim, H. A. (2025). Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial. American Journal of Psychiatry, 182(1), 104–113. https://doi.org/10.1176/appi.ajp.20231063",
      "authors": "Aaronson, S. T., Van Der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Suppes, T., & Sackeim, H. A.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20231063",
      "url": "https://doi.org/10.1176/appi.ajp.20231063",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "abdullah_2018",
      "fullText": "Abdullah, M. F. I. L., Singh, D., & Kasinather, B. V. (2018). CASE REPORT OF RECREATIONAL LYSERGIC-ACID-DIETHYLAMIDE (LSD) USE IN MALAYSIA. ASEAN Journal of Psychiatry, 19(1), 1–1.",
      "authors": "Abdullah, M. F. I. L., Singh, D., & Kasinather, B. V.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ables_2024",
      "fullText": "Ables, J. L., Israel, L., Wood, O., Govindarajulu, U., Fremont, R. T., Banerjee, R., Liu, H., Cohen, J., Wang, P., Kumar, K., Lu, G., DeVita, R. J., Garcia-Ocaña, A., Murrough, J. W., & Stewart, A. F. (2024). A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers. Journal of Psychopharmacology (Oxford, England), 38(10), 911–923. https://doi.org/10.1177/02698811241273772",
      "authors": "Ables, J. L., Israel, L., Wood, O., Govindarajulu, U., Fremont, R. T., Banerjee, R., Liu, H., Cohen, J., Wang, P., Kumar, K., Lu, G., DeVita, R. J., Garcia-Ocaña, A., Murrough, J. W., & Stewart, A. F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241273772",
      "url": "https://doi.org/10.1177/02698811241273772",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "abraham_1993",
      "fullText": "Abraham, H. D., & Aldridge, A. M. (1993). Adverse consequences of lysergic acid diethylamide. Addiction, 88(10), 1327–1334. https://doi.org/10.1111/j.1360-0443.1993.tb02018.x",
      "authors": "Abraham, H. D., & Aldridge, A. M.",
      "year": "1993",
      "title": "",
      "journal": "",
      "doi": "10.1111/j.1360-0443.1993.tb02018.x",
      "url": "https://doi.org/10.1111/j.1360-0443.1993.tb02018.x",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "abraham_1996",
      "fullText": "Abraham, H. D., & Duffy, F. H. (1996). Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: Evidence for disinhibition. Psychiatry Research, 67(3), 173–187. https://doi.org/10.1016/0925-4927(96)02833-8",
      "authors": "Abraham, H. D., & Duffy, F. H.",
      "year": "1996",
      "title": "",
      "journal": "",
      "doi": "10.1016/0925-4927(96)02833-8",
      "url": "https://doi.org/10.1016/0925-4927(96)02833-8",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "abrams_2023",
      "fullText": "Abrams, S. K., Rabinovitch, B. S., Zafar, R., Aziz, A. S., Cherup, N. P., McMillan, D. W., Nielson, J. L., & Lewis, E. C. (2023). Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics. Neurotrauma Reports, 4(1), 543–550. https://doi.org/10.1089/neur.2023.0022",
      "authors": "Abrams, S. K., Rabinovitch, B. S., Zafar, R., Aziz, A. S., Cherup, N. P., McMillan, D. W., Nielson, J. L., & Lewis, E. C.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1089/neur.2023.0022",
      "url": "https://doi.org/10.1089/neur.2023.0022",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0010",
      "fullText": "Adams, J. H. (2023a, September 22). Psychedelics and the ethics of suggestibility. Ecstatic Integration. https://www.ecstaticintegration.org/p/psychedelics-and-the-ethics-of-suggestibility",
      "authors": "Adams, J. H. (2023a, September 22). Psychedelics and the ethics of suggestibility. Ecstatic Integration. https://www.ecstaticintegration.org/p/psychedelics-and-the-ethics-of-suggestibility",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.ecstaticintegration.org/p/psychedelics-and-the-ethics-of-suggestibility",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0011",
      "fullText": "Adams, J. H. (2023b, September 29). The power of psychedelic-assisted suggestion: Part two of our analysis of the ethics of suggestibility. Ecstatic Integration. https://www.ecstaticintegration.org/p/the-ethics-of-psychedelic-suggestibility",
      "authors": "Adams, J. H. (2023b, September 29). The power of psychedelic-assisted suggestion: Part two of our analysis of the ethics of suggestibility. Ecstatic Integration. https://www.ecstaticintegration.org/p/the-ethics-of-psychedelic-suggestibility",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.ecstaticintegration.org/p/the-ethics-of-psychedelic-suggestibility",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2020",
      "fullText": "Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2020). Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect? Journal of Cognitive Enhancement, 4(2), 219–227. https://doi.org/10.1007/s41465-019-00151-6",
      "authors": "Aday, J. S., Bloesch, E. K., & Davoli, C. C.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1007/s41465-019-00151-6",
      "url": "https://doi.org/10.1007/s41465-019-00151-6",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2024",
      "fullText": "Aday, J. S., Boehnke, K. F., Herberholz, M., & Kruger, D. J. (2024). Attitudes of psychedelic users regarding cost of treatment and non-hallucinogenic alternatives. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00354",
      "authors": "Aday, J. S., Boehnke, K. F., Herberholz, M., & Kruger, D. J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00354",
      "url": "https://doi.org/10.1556/2054.2024.00354",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2021",
      "fullText": "Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021). Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacology & Translational Science, 4(2), 424–435. https://doi.org/10.1021/acsptsci.1c00014",
      "authors": "Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1021/acsptsci.1c00014",
      "url": "https://doi.org/10.1021/acsptsci.1c00014",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2022",
      "fullText": "Aday, J. S., Heifets, B. D., Pratscher, S. D., Bradley, E., Rosen, R., & Woolley, J. D. (2022). Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology, 239(6), 1989–2010. https://doi.org/10.1007/s00213-022-06123-7",
      "authors": "Aday, J. S., Heifets, B. D., Pratscher, S. D., Bradley, E., Rosen, R., & Woolley, J. D.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06123-7",
      "url": "https://doi.org/10.1007/s00213-022-06123-7",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2024_1",
      "fullText": "Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D. (2024). Psychedelic-assisted psychotherapy: Where is the psychotherapy research? Psychopharmacology, 241(8), 1517–1526. https://doi.org/10.1007/s00213-024-06620-x",
      "authors": "Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-024-06620-x",
      "url": "https://doi.org/10.1007/s00213-024-06620-x",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2020_1",
      "fullText": "Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. (2020). Long-term effects of psychedelic drugs: A systematic review. Neuroscience & Biobehavioral Reviews, 113, 179–189. https://doi.org/10.1016/j.neubiorev.2020.03.017",
      "authors": "Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neubiorev.2020.03.017",
      "url": "https://doi.org/10.1016/j.neubiorev.2020.03.017",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aday_2021_1",
      "fullText": "Aday, J. S., Wood, J. R., Bloesch, E. K., & Davoli, C. C. (2021). Psychedelic drugs and perception: A narrative review of the first era of research. Reviews in the Neurosciences, 32(5), 559–571. https://doi.org/10.1515/revneuro-2020-0094",
      "authors": "Aday, J. S., Wood, J. R., Bloesch, E. K., & Davoli, C. C.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1515/revneuro-2020-0094",
      "url": "https://doi.org/10.1515/revneuro-2020-0094",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aixal_2018",
      "fullText": "Aixalà, M., Dos Santos, R. G., Hallak, J. E. C., & Bouso, J. C. (2018). Psychedelics and Personality. ACS Chemical Neuroscience, 9(10), 2304–2306. https://doi.org/10.1021/acschemneuro.8b00237",
      "authors": "Aixalà, M., Dos Santos, R. G., Hallak, J. E. C., & Bouso, J. C.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1021/acschemneuro.8b00237",
      "url": "https://doi.org/10.1021/acschemneuro.8b00237",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "aixal_2020",
      "fullText": "Aixalá, M., Ona, G., Parés, Ò., & Bouso, J. C. (2020). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs: Education, Prevention and Policy, 27(3), 191–198. https://doi.org/10.1080/09687637.2019.1611739",
      "authors": "Aixalá, M., Ona, G., Parés, Ò., & Bouso, J. C.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/09687637.2019.1611739",
      "url": "https://doi.org/10.1080/09687637.2019.1611739",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ajantaival_2014",
      "fullText": "Ajantaival, T. J. (2014). Psychedelics and indicators of mental distress in adults: National Survey on Drug Use and Health 2008–2014.",
      "authors": "Ajantaival, T. J.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "alimam_2017",
      "fullText": "Al-Imam, A. (2017). The Preferred Terminology Implemented by Psychedelic Users Existing on Online Platforms: A Cross-sectional Analysis. Global Journal of Health Science, 9(11), 140. https://doi.org/10.5539/gjhs.v9n11p140",
      "authors": "Al-Imam, A.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.5539/gjhs.v9n11p140",
      "url": "https://doi.org/10.5539/gjhs.v9n11p140",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "alcntara_1998",
      "fullText": "Alcántara, A. G. (1998). Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone? Journal of Clinical Psychopharmacology, 18(6), 487–488. https://doi.org/10.1097/00004714-199812000-00016",
      "authors": "Alcántara, A. G.",
      "year": "1998",
      "title": "",
      "journal": "",
      "doi": "10.1097/00004714-199812000-00016",
      "url": "https://doi.org/10.1097/00004714-199812000-00016",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "aleman_2012",
      "fullText": "Aleman, J., Crul, M., Voort, P. H. J. van der, & Franssen, E. J. F. (2012). Anticholinergic toxicity after the ingestion of serotonergic “magic mushrooms.” Netherlands Journal of Critical Care, 16(3), 93–96.",
      "authors": "Aleman, J., Crul, M., Voort, P. H. J. van der, & Franssen, E. J. F.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0025",
      "fullText": "Álvarez, C. S., Mazarrasa, J., Faura, R., Bouso, J. C., Domsac, I., Russo, S., & Verdaguer, Á. (n.d.). International Center for Ethnobotanical Education, Research and Service (ICEERS).",
      "authors": "Álvarez, C. S., Mazarrasa, J., Faura, R., Bouso, J. C., Domsac, I., Russo, S., & Verdaguer, Á. (n.d.). International Center for Ethnobotanical Education, Research and Service (ICEERS).",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "alyahya_2024",
      "fullText": "Alyahya, N. M., & Al Saleem, E. A. (2024). Therapeutic Use of Psychedelics for Mental Disorders: A Systematized Review. Journal of Nature and Science of Medicine. https://doi.org/10.4103/jnsm.jnsm_76_24",
      "authors": "Alyahya, N. M., & Al Saleem, E. A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.4103/jnsm.jnsm_76_24",
      "url": "https://doi.org/10.4103/jnsm.jnsm_76_24",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "ambrose_2023",
      "fullText": "Ambrose, J., & Zabinski, J. (2023). Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First. Psychiatric News, 58(03). https://doi.org/10.1176/appi.pn.2023.03.3.43",
      "authors": "Ambrose, J., & Zabinski, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.pn.2023.03.3.43",
      "url": "https://doi.org/10.1176/appi.pn.2023.03.3.43",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "amsterdam_2011",
      "fullText": "Amsterdam, J. van, Opperhuizen, A., & Brink, W. van den. (2011). Harm potential of magic mushroom use: A review. Regulatory Toxicology and Pharmacology, 59(3), 423–429. https://doi.org/10.1016/j.yrtph.2011.01.006",
      "authors": "Amsterdam, J. van, Opperhuizen, A., & Brink, W. van den.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.yrtph.2011.01.006",
      "url": "https://doi.org/10.1016/j.yrtph.2011.01.006",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0029",
      "fullText": "Analysis of Risk Reduction Among Organized Groups That Promote Marijuana and Psychedelic Drugs | Office of Justice Programs. (n.d.). Retrieved January 4, 2025, from https://www.ojp.gov/ncjrs/virtual-library/abstracts/analysis-risk-reduction-among-organized-groups-promote-marijuana",
      "authors": "Analysis of Risk Reduction Among Organized Groups That Promote Marijuana and Psychedelic Drugs | Office of Justice Programs. (n.d.). Retrieved January 4, 2025, from https://www.ojp.gov/ncjrs/virtual-library/abstracts/analysis-risk-reduction-among-organized-groups-promote-marijuana",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.ojp.gov/ncjrs/virtual-library/abstracts/analysis-risk-reduction-among-organized-groups-promote-marijuana",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "andersen_2021",
      "fullText": "Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021). Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies. Acta Psychiatrica Scandinavica, 143(2), 101–118. https://doi.org/10.1111/acps.13249",
      "authors": "Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1111/acps.13249",
      "url": "https://doi.org/10.1111/acps.13249",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "anderson_2018",
      "fullText": "Anderson, L., Lake, H., & Walterfang, M. (2018). The trip of a lifetime: Hallucinogen persisting perceptual disorder. Australasian Psychiatry, 26(1), 11–12. https://doi.org/10.1177/1039856217726694",
      "authors": "Anderson, L., Lake, H., & Walterfang, M.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/1039856217726694",
      "url": "https://doi.org/10.1177/1039856217726694",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "anderson_2019",
      "fullText": "Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L.-A., Hui, K., & Hapke, E. (2019). Psychedelic microdosing benefits and challenges: An empirical codebook. Harm Reduction Journal, 16(1), 43. https://doi.org/10.1186/s12954-019-0308-4",
      "authors": "Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L.-A., Hui, K., & Hapke, E.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1186/s12954-019-0308-4",
      "url": "https://doi.org/10.1186/s12954-019-0308-4",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "anderson_2019_1",
      "fullText": "Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., Hapke, E., & Farb, N. A. S. (2019). Microdosing psychedelics: Personality, mental health, and creativity differences in microdosers. Psychopharmacology, 236(2), 731–740. https://doi.org/10.1007/s00213-018-5106-2",
      "authors": "Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., Hapke, E., & Farb, N. A. S.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-018-5106-2",
      "url": "https://doi.org/10.1007/s00213-018-5106-2",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "argento_2024",
      "fullText": "Argento, E., Petker, T., Vig, J., Robertson, C., Jaeger, A., Necyk, C., Thielking, P., & Walsh, Z. (2024). “This is you teaching you:” Exploring providers’ perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapy. PLOS ONE, 19(8), e0306381. https://doi.org/10.1371/journal.pone.0306381",
      "authors": "Argento, E., Petker, T., Vig, J., Robertson, C., Jaeger, A., Necyk, C., Thielking, P., & Walsh, Z.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0306381",
      "url": "https://doi.org/10.1371/journal.pone.0306381",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "argyri_2024",
      "fullText": "Argyri, E. K., Evans, J., Luke, D., Michael, P., Michelle, K., Rohani-Shukla, C., Suseelan, S., Prideaux, E., McAlpine, R., Murphy-Beiner, A., & Robinson, O. (2024). Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences (SSRN Scholarly Paper No. 4817368). Social Science Research Network. https://doi.org/10.2139/ssrn.4817368",
      "authors": "Argyri, E. K., Evans, J., Luke, D., Michael, P., Michelle, K., Rohani-Shukla, C., Suseelan, S., Prideaux, E., McAlpine, R., Murphy-Beiner, A., & Robinson, O.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.2139/ssrn.4817368",
      "url": "https://doi.org/10.2139/ssrn.4817368",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "arikci_2025",
      "fullText": "Arikci, D., Holze, F., Mueller, L., Vizeli, P., Rudin, D., Luethi, D., ... & Liechti, M. E. (2025). Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double‐Blind, Placebo‐Controlled, Crossover Study. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3726",
      "authors": "Arikci, D., Holze, F., Mueller, L., Vizeli, P., Rudin, D., Luethi, D., ... & Liechti, M. E.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1002/cpt.3726",
      "url": "https://doi.org/10.1002/cpt.3726",
      "categories": [
        "harm_reduction",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "armstrong_2024",
      "fullText": "Armstrong, S. B., & Davis, A. K. (2024). Psychedelic research at a crossroads. Science, 385(6715), 1255–1255. https://doi.org/10.1126/science.adt1024",
      "authors": "Armstrong, S. B., & Davis, A. K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1126/science.adt1024",
      "url": "https://doi.org/10.1126/science.adt1024",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ashraf_2024",
      "fullText": "Ashraf, N. (2024). IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME? Journal of Pakistan Psychiatric Society, 21(02). https://doi.org/10.63050/jpps.21.02.935",
      "authors": "Ashraf, N.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.63050/jpps.21.02.935",
      "url": "https://doi.org/10.63050/jpps.21.02.935",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0039",
      "fullText": "Asselborn, G., Wennig, R., & Yegles, M. (n.d.). Tragic flying attempt under the influence of “magic mushrooms.”",
      "authors": "Asselborn, G., Wennig, R., & Yegles, M. (n.d.). Tragic flying attempt under the influence of “magic mushrooms.”",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "atila_2024a",
      "fullText": "Atila, C., Straumann, I., Vizeli, P., Beck, J., Monnerat, S., Holze, F., Liechti, M. E., & Christ-Crain, M. (2024a). Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials. JAMA Network Open, 7(11), e2445278. https://doi.org/10.1001/jamanetworkopen.2024.45278",
      "authors": "Atila, C., Straumann, I., Vizeli, P., Beck, J., Monnerat, S., Holze, F., Liechti, M. E., & Christ-Crain, M.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamanetworkopen.2024.45278",
      "url": "https://doi.org/10.1001/jamanetworkopen.2024.45278",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "atila_2024b",
      "fullText": "Atila, C., Straumann, I., Vizeli, P., Beck, J., Monnerat, S., Holze, F., Liechti, M. E., & Christ-Crain, M. (2024b). Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials. JAMA Network Open, 7(11), e2445278. https://doi.org/10.1001/jamanetworkopen.2024.45278",
      "authors": "Atila, C., Straumann, I., Vizeli, P., Beck, J., Monnerat, S., Holze, F., Liechti, M. E., & Christ-Crain, M.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamanetworkopen.2024.45278",
      "url": "https://doi.org/10.1001/jamanetworkopen.2024.45278",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "bae_2023",
      "fullText": "Bae, S., Vaysblat, M., Bae, E., Dejanovic, I., & Pierce, M. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. Cureus. https://doi.org/10.7759/cureus.38669",
      "authors": "Bae, S., Vaysblat, M., Bae, E., Dejanovic, I., & Pierce, M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.7759/cureus.38669",
      "url": "https://doi.org/10.7759/cureus.38669",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bagdasarian_2024",
      "fullText": "Bagdasarian, F. A., Hansen, H. D., Chen, J., Yoo, C.-H., Placzek, M. S., Hooker, J. M., & Wey, H.-Y. (2024). Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A. ACS Chemical Neuroscience, 15(14), 2654–2661. https://doi.org/10.1021/acschemneuro.4c00245",
      "authors": "Bagdasarian, F. A., Hansen, H. D., Chen, J., Yoo, C.-H., Placzek, M. S., Hooker, J. M., & Wey, H.-Y.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1021/acschemneuro.4c00245",
      "url": "https://doi.org/10.1021/acschemneuro.4c00245",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0044",
      "fullText": "Baggott, M. J. (n.d.). Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention.",
      "authors": "Baggott, M. J. (n.d.). Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "baggott_2011a",
      "fullText": "Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011a). Abnormal visual experiences in individuals with histories of hallucinogen use: A Web-based questionnaire. Drug and Alcohol Dependence, 114(1), 61–67. https://doi.org/10.1016/j.drugalcdep.2010.09.006",
      "authors": "Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C.",
      "year": "2011a",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugalcdep.2010.09.006",
      "url": "https://doi.org/10.1016/j.drugalcdep.2010.09.006",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "baggott_2011b",
      "fullText": "Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011b). Abnormal visual experiences in individuals with histories of hallucinogen use: A Web-based questionnaire. Drug and Alcohol Dependence, 114(1), 61–67. https://doi.org/10.1016/j.drugalcdep.2010.09.006",
      "authors": "Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C.",
      "year": "2011b",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugalcdep.2010.09.006",
      "url": "https://doi.org/10.1016/j.drugalcdep.2010.09.006",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "baggott_2019",
      "fullText": "Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. (2019). Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. Journal of Psychoactive Drugs, 51(2), 108–117. https://doi.org/10.1080/02791072.2019.1593560",
      "authors": "Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2019.1593560",
      "url": "https://doi.org/10.1080/02791072.2019.1593560",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0048",
      "fullText": "Bakshi, B., Yerraguntla, S., Armon, C., Barkhaus, P., Bertorini, T., Bowser, R., Breevoort, S., Bromberg, M., Brown, A., Carter, G. T., Chang, V., Crayle, J., Fullam, T., Greene, M., Heiman-Patterson, T., Jackson, C., Jhooty, S., Mallon, E., Cadavid, J. M., … Bedlack, R. (n.d.). ALSUntangled #77: Psilocybin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 0(0), 1–4. https://doi.org/10.1080/21678421.2024.2441274",
      "authors": "Bakshi, B., Yerraguntla, S., Armon, C., Barkhaus, P., Bertorini, T., Bowser, R., Breevoort, S., Bromberg, M., Brown, A., Carter, G. T., Chang, V., Crayle, J., Fullam, T., Greene, M., Heiman-Patterson, T., Jackson, C., Jhooty, S., Mallon, E., Cadavid, J. M., … Bedlack, R. (n.d.). ALSUntangled #77: Psilocybin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 0(0), 1–4. https://doi.org/10.1080/21678421.2024.2441274",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/21678421.2024.2441274",
      "url": "https://doi.org/10.1080/21678421.2024.2441274",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ble_2022",
      "fullText": "Bălăeţ, M. (2022). Psychedelic Cognition—The Unreached Frontier of Psychedelic Science. Frontiers in Neuroscience, 16, 832375. https://doi.org/10.3389/fnins.2022.832375",
      "authors": "Bălăeţ, M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fnins.2022.832375",
      "url": "https://doi.org/10.3389/fnins.2022.832375",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "baldo_2024",
      "fullText": "Baldo, B. A. (2024). The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns. Archives of Toxicology, 98(8), 2409–2427. https://doi.org/10.1007/s00204-024-03765-8",
      "authors": "Baldo, B. A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00204-024-03765-8",
      "url": "https://doi.org/10.1007/s00204-024-03765-8",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "ballard_2022",
      "fullText": "Ballard, E. D., Farmer, C. A., Gerner, J., Bloomfield-Clagett, B., Park, L. T., & Zarate, C. A. (2022). Prospective association of psychological pain and hopelessness with suicidal thoughts. Journal of Affective Disorders, 308, 243–248. https://doi.org/10.1016/j.jad.2022.04.033",
      "authors": "Ballard, E. D., Farmer, C. A., Gerner, J., Bloomfield-Clagett, B., Park, L. T., & Zarate, C. A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2022.04.033",
      "url": "https://doi.org/10.1016/j.jad.2022.04.033",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bantagreen_2005",
      "fullText": "Banta-Green, C., Goldbaum, G., Kingston, S., Golden, M., Harruff, R., & Logan, B. K. (2005). Epidemiology of MDMA and Associated Club Drugs in the Seattle Area. Substance Use & Misuse, 40(9–10), 1295–1315. https://doi.org/10.1081/JA-200066793",
      "authors": "Banta-Green, C., Goldbaum, G., Kingston, S., Golden, M., Harruff, R., & Logan, B. K.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1081/JA-200066793",
      "url": "https://doi.org/10.1081/JA-200066793",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barber_2023",
      "fullText": "Barber, G. S., & Dike, C. C. (2023). Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry. Psychiatric Services (Washington, D.C.), 74(8), 838–846. https://doi.org/10.1176/appi.ps.20220525",
      "authors": "Barber, G. S., & Dike, C. C.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ps.20220525",
      "url": "https://doi.org/10.1176/appi.ps.20220525",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barber_2022",
      "fullText": "Barber, G., Nemeroff, C. B., & Siegel, S. (2022). A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability. American Journal of Psychiatry, 179(12), 892–896. https://doi.org/10.1176/appi.ajp.22010073",
      "authors": "Barber, G., Nemeroff, C. B., & Siegel, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.22010073",
      "url": "https://doi.org/10.1176/appi.ajp.22010073",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barber_2024",
      "fullText": "Barber, M., Gardner, J., & Carter, A. (2024). History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers. Journal of Bioethical Inquiry. https://doi.org/10.1007/s11673-024-10386-4",
      "authors": "Barber, M., Gardner, J., & Carter, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s11673-024-10386-4",
      "url": "https://doi.org/10.1007/s11673-024-10386-4",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barker_2022",
      "fullText": "Barker, S. A. (2022). Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology, 239(6), 1749–1763. https://doi.org/10.1007/s00213-022-06065-0",
      "authors": "Barker, S. A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06065-0",
      "url": "https://doi.org/10.1007/s00213-022-06065-0",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "barnett_2022",
      "fullText": "Barnett, B. S. (2022). Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health. Journal of Psychopharmacology, 36(10), 1097–1099. https://doi.org/10.1177/02698811221123051",
      "authors": "Barnett, B. S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221123051",
      "url": "https://doi.org/10.1177/02698811221123051",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "barnett_2021",
      "fullText": "Barnett, B. S., & Greer, G. R. (2021). Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. Journal of the Academy of Consultation-Liaison Psychiatry, 62(4), 460–471. https://doi.org/10.1016/j.jaclp.2020.12.011",
      "authors": "Barnett, B. S., & Greer, G. R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jaclp.2020.12.011",
      "url": "https://doi.org/10.1016/j.jaclp.2020.12.011",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barnett_2024",
      "fullText": "Barnett, B. S., Anand, A., Dewey, E. N., Smith, D., Nayak, S. M., Bruckman, D., & Weleff, J. (2024). Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide’s Risk Profile More Favorably? Psychedelic Medicine, 2(2), 74–86. https://doi.org/10.1089/psymed.2023.0027",
      "authors": "Barnett, B. S., Anand, A., Dewey, E. N., Smith, D., Nayak, S. M., Bruckman, D., & Weleff, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0027",
      "url": "https://doi.org/10.1089/psymed.2023.0027",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "barnett_2022_1",
      "fullText": "Barnett, B. S., Ziegler, K., Doblin, R., & Carlo, A. D. (2022). Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data. Journal of Psychopharmacology (Oxford, England), 36(10), 1118–1128. https://doi.org/10.1177/02698811221117536",
      "authors": "Barnett, B. S., Ziegler, K., Doblin, R., & Carlo, A. D.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221117536",
      "url": "https://doi.org/10.1177/02698811221117536",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "barrett_2016",
      "fullText": "Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016). The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 30(12), 1279–1295. https://doi.org/10.1177/0269881116678781",
      "authors": "Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881116678781",
      "url": "https://doi.org/10.1177/0269881116678781",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "barrett_2018",
      "fullText": "Barrett, F. S., Carbonaro, T. M., Hurwitz, E., Johnson, M. W., & Griffiths, R. R. (2018). Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: Effects on cognition. Psychopharmacology, 235(10), 2915–2927. https://doi.org/10.1007/s00213-018-4981-x",
      "authors": "Barrett, F. S., Carbonaro, T. M., Hurwitz, E., Johnson, M. W., & Griffiths, R. R.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-018-4981-x",
      "url": "https://doi.org/10.1007/s00213-018-4981-x",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "barrett_2020",
      "fullText": "Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020). Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports, 10(1), 2214. https://doi.org/10.1038/s41598-020-59282-y",
      "authors": "Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-020-59282-y",
      "url": "https://doi.org/10.1038/s41598-020-59282-y",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barrett_2017",
      "fullText": "Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017). Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences, 117, 155–160. https://doi.org/10.1016/j.paid.2017.06.004",
      "authors": "Barrett, F. S., Johnson, M. W., & Griffiths, R. R.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.paid.2017.06.004",
      "url": "https://doi.org/10.1016/j.paid.2017.06.004",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "barrios_2024",
      "fullText": "Barrios, K. P., Connolly, D. J., Ferris, J. A., Maier, L. J., Barratt, M. J., Winstock, A. R., Puljević, C., & Gilchrist, G. (2024). Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment. Journal of Psychopharmacology, 02698811241273850. https://doi.org/10.1177/02698811241273850",
      "authors": "Barrios, K. P., Connolly, D. J., Ferris, J. A., Maier, L. J., Barratt, M. J., Winstock, A. R., Puljević, C., & Gilchrist, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241273850",
      "url": "https://doi.org/10.1177/02698811241273850",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "basedow_2022",
      "fullText": "Basedow, L. A., & Kuitunen-Paul, S. (2022). Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review, 41(6), 1391–1403. https://doi.org/10.1111/dar.13480",
      "authors": "Basedow, L. A., & Kuitunen-Paul, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1111/dar.13480",
      "url": "https://doi.org/10.1111/dar.13480",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "basedow_2024",
      "fullText": "Basedow, L. A., Majić, T., Hafiz, N. J., Algharably, E. A. E., Kreutz, R., & Riemer, T. G. (2024). Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis. Scientific Reports, 14(1), 14782. https://doi.org/10.1038/s41598-024-65391-9",
      "authors": "Basedow, L. A., Majić, T., Hafiz, N. J., Algharably, E. A. E., Kreutz, R., & Riemer, T. G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-65391-9",
      "url": "https://doi.org/10.1038/s41598-024-65391-9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bathje_2022",
      "fullText": "Bathje, G. J., Majeski, E., & Kudowor, M. (2022). Psychedelic integration: An analysis of the concept and its practice. Frontiers in Psychology, 13, 824077. https://doi.org/10.3389/fpsyg.2022.824077",
      "authors": "Bathje, G. J., Majeski, E., & Kudowor, M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2022.824077",
      "url": "https://doi.org/10.3389/fpsyg.2022.824077",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "baumann_2022",
      "fullText": "Baumann, S., Carhart-Harris, R., Nutt, D., Erritzoe, D., & Szigeti, B. (2022). Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial. PsyArXiv. https://doi.org/10.31234/osf.io/s4qhf",
      "authors": "Baumann, S., Carhart-Harris, R., Nutt, D., Erritzoe, D., & Szigeti, B.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/s4qhf",
      "url": "https://doi.org/10.31234/osf.io/s4qhf",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "baumeister_2015",
      "fullText": "Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015). Legal highs: Staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology, 5(2), 97–132. https://doi.org/10.1177/2045125314559539",
      "authors": "Baumeister, D., Tojo, L. M., & Tracy, D. K.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/2045125314559539",
      "url": "https://doi.org/10.1177/2045125314559539",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "baxter_2024a",
      "fullText": "Baxter, L., Puljević, C., Piatkowski, T., Ferris, J., Davies, E. L., Barratt, M. J., & Winstock, A. (2024a). Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights. Journal of Psychopharmacology, 38(8), 735–748. https://doi.org/10.1177/02698811241254837",
      "authors": "Baxter, L., Puljević, C., Piatkowski, T., Ferris, J., Davies, E. L., Barratt, M. J., & Winstock, A.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241254837",
      "url": "https://doi.org/10.1177/02698811241254837",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "baxter_2024b",
      "fullText": "Baxter, L., Puljević, C., Piatkowski, T., Ferris, J., Davies, E. L., Barratt, M. J., & Winstock, A. (2024b). Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights. Journal of Psychopharmacology, 38(8), 735–748. https://doi.org/10.1177/02698811241254837",
      "authors": "Baxter, L., Puljević, C., Piatkowski, T., Ferris, J., Davies, E. L., Barratt, M. J., & Winstock, A.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241254837",
      "url": "https://doi.org/10.1177/02698811241254837",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "becker_2023",
      "fullText": "Becker, A. M., Klaiber, A., Holze, F., Istampoulouoglou, I., Duthaler, U., Varghese, N., Eckert, A., & Liechti, M. E. (2023). Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants. The International Journal of Neuropsychopharmacology, 26(2), 97–106. https://doi.org/10.1093/ijnp/pyac075",
      "authors": "Becker, A. M., Klaiber, A., Holze, F., Istampoulouoglou, I., Duthaler, U., Varghese, N., Eckert, A., & Liechti, M. E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyac075",
      "url": "https://doi.org/10.1093/ijnp/pyac075",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bender_2022",
      "fullText": "Bender, D., & Hellerstein, D. J. (2022). Assessing the risk–benefit profile of classical psychedelics: A clinical review of second-wave psychedelic research. Psychopharmacology, 239(6), 1907–1932. https://doi.org/10.1007/s00213-021-06049-6",
      "authors": "Bender, D., & Hellerstein, D. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-06049-6",
      "url": "https://doi.org/10.1007/s00213-021-06049-6",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bennett_2023",
      "fullText": "Bennett, J. N., Blough, M. D., Mitchell, I., Galloway, L., & Bains, R. (2023). A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy. Psychiatry and Clinical Psychology. https://doi.org/10.1101/2023.04.12.23288325",
      "authors": "Bennett, J. N., Blough, M. D., Mitchell, I., Galloway, L., & Bains, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1101/2023.04.12.23288325",
      "url": "https://doi.org/10.1101/2023.04.12.23288325",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "bienemann_2020",
      "fullText": "Bienemann, B., Ruschel, N. S., Campos, M. L., Negreiros, M. A., & Mograbi, D. C. (2020). Self-reported negative outcomes of psilocybin users: A quantitative textual analysis. PLOS ONE, 15(2), e0229067. https://doi.org/10.1371/journal.pone.0229067",
      "authors": "Bienemann, B., Ruschel, N. S., Campos, M. L., Negreiros, M. A., & Mograbi, D. C.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0229067",
      "url": "https://doi.org/10.1371/journal.pone.0229067",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "black_2024",
      "fullText": "Black, J. C., Monte, A. A., Dasgupta, N., Jewell, J. S., Rockhill, K. M., Olson, R. A., & Dart, R. C. (2024). Optimizing real-world benefit and risk of new psychedelic medications: The need for innovative postmarket surveillance. Nature Mental Health, 2(5), 469–477. https://doi.org/10.1038/s44220-024-00233-1",
      "authors": "Black, J. C., Monte, A. A., Dasgupta, N., Jewell, J. S., Rockhill, K. M., Olson, R. A., & Dart, R. C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s44220-024-00233-1",
      "url": "https://doi.org/10.1038/s44220-024-00233-1",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "blaho_1997",
      "fullText": "Blaho, K., Merigian, K., Winbery, S., Geraci, S. A., & Smartt, C. (1997). Clinical pharmacology of lysergic acid diethylamide: Case reports and review of the treatment of intoxication. American Journal of Therapeutics, 4(5–6), 211–221. https://doi.org/10.1097/00045391-199705000-00008",
      "authors": "Blaho, K., Merigian, K., Winbery, S., Geraci, S. A., & Smartt, C.",
      "year": "1997",
      "title": "",
      "journal": "",
      "doi": "10.1097/00045391-199705000-00008",
      "url": "https://doi.org/10.1097/00045391-199705000-00008",
      "categories": [
        "harm_reduction",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "blesthopley_2023",
      "fullText": "Blest-Hopley, G., Amit, B. H., O’Neill, A., & Ruffell, S. G. D. (2023). Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders. Frontiers in Psychiatry, 14, 1191970. https://doi.org/10.3389/fpsyt.2023.1191970",
      "authors": "Blest-Hopley, G., Amit, B. H., O’Neill, A., & Ruffell, S. G. D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1191970",
      "url": "https://doi.org/10.3389/fpsyt.2023.1191970",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "blond_2023",
      "fullText": "Blond, B. N., & Schindler, E. A. D. (2023). Case report: Psychedelic-induced seizures captured by intracranial electrocorticography. Frontiers in Neurology, 14, 1214969. https://doi.org/10.3389/fneur.2023.1214969",
      "authors": "Blond, B. N., & Schindler, E. A. D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fneur.2023.1214969",
      "url": "https://doi.org/10.3389/fneur.2023.1214969",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bodnr_2019",
      "fullText": "Bodnár, K. J., & Kakuk, P. (2019). Research ethics aspects of experimentation with LSD on human subjects: A historical and ethical review. Medicine, Health Care and Philosophy, 22(2), 327–337. https://doi.org/10.1007/s11019-018-9871-9",
      "authors": "Bodnár, K. J., & Kakuk, P.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1007/s11019-018-9871-9",
      "url": "https://doi.org/10.1007/s11019-018-9871-9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bogenschutz_2015",
      "fullText": "Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. https://doi.org/10.1177/0269881114565144",
      "authors": "Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881114565144",
      "url": "https://doi.org/10.1177/0269881114565144",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bhling_2017",
      "fullText": "Bøhling, F. (2017). Psychedelic pleasures: An affective understanding of the joys of tripping. The International Journal on Drug Policy, 49, 133–143. https://doi.org/10.1016/j.drugpo.2017.07.017",
      "authors": "Bøhling, F.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugpo.2017.07.017",
      "url": "https://doi.org/10.1016/j.drugpo.2017.07.017",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bonson_2018",
      "fullText": "Bonson, K. R. (2018). Regulation of human research with LSD in the United States (1949-1987). Psychopharmacology, 235(2), 591–604. https://doi.org/10.1007/s00213-017-4777-4",
      "authors": "Bonson, K. R.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-017-4777-4",
      "url": "https://doi.org/10.1007/s00213-017-4777-4",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bonson_1996",
      "fullText": "Bonson, K. R., Buckholtz, J. W., & Murphy, D. L. (1996). Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 14(6), 425–436. https://doi.org/10.1016/0893-133X(95)00145-4",
      "authors": "Bonson, K. R., Buckholtz, J. W., & Murphy, D. L.",
      "year": "1996",
      "title": "",
      "journal": "",
      "doi": "10.1016/0893-133X(95)00145-4",
      "url": "https://doi.org/10.1016/0893-133X(95)00145-4",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bormann_2023",
      "fullText": "Bormann, N. L., Weber, A. N., Miskle, B., Woodson-DeFauw, N., Arndt, S., & Lynch, A. C. (2023). Perceived risk of LSD varies with age and race: Evidence from 2019 United States cross-sectional data. Social Psychiatry and Psychiatric Epidemiology, 58(10), 1503–1508. https://doi.org/10.1007/s00127-023-02448-6",
      "authors": "Bormann, N. L., Weber, A. N., Miskle, B., Woodson-DeFauw, N., Arndt, S., & Lynch, A. C.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00127-023-02448-6",
      "url": "https://doi.org/10.1007/s00127-023-02448-6",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "bornemann_2020",
      "fullText": "Bornemann, J. (2020). The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being—An Early Review. Journal of Psychoactive Drugs, 52(4), 300–308. https://doi.org/10.1080/02791072.2020.1761573",
      "authors": "Bornemann, J.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2020.1761573",
      "url": "https://doi.org/10.1080/02791072.2020.1761573",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bouchet_2024",
      "fullText": "Bouchet, L., Sager, Z., Yrondi, A., Nigam, K. B., Anderson, B. T., Ross, S., Petridis, P. D., & Beaussant, Y. (2024). Older adults in psychedelic-assisted therapy trials: A systematic review. Journal of Psychopharmacology, 38(1), 33–48. https://doi.org/10.1177/02698811231215420",
      "authors": "Bouchet, L., Sager, Z., Yrondi, A., Nigam, K. B., Anderson, B. T., Ross, S., Petridis, P. D., & Beaussant, Y.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231215420",
      "url": "https://doi.org/10.1177/02698811231215420",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "bouso_2022",
      "fullText": "Bouso, J. C., Andión, Ó., Sarris, J. J., Scheidegger, M., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2022). Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health, 2(11), e0000438. https://doi.org/10.1371/journal.pgph.0000438",
      "authors": "Bouso, J. C., Andión, Ó., Sarris, J. J., Scheidegger, M., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pgph.0000438",
      "url": "https://doi.org/10.1371/journal.pgph.0000438",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "braun_2006",
      "fullText": "Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa",
      "authors": "Braun, V., & Clarke, V.",
      "year": "2006",
      "title": "",
      "journal": "",
      "doi": "10.1191/1478088706qp063oa",
      "url": "https://doi.org/10.1191/1478088706qp063oa",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "breeksema_2022",
      "fullText": "Breeksema, J. J., Kuin, B. W., Kamphuis, J., Van Den Brink, W., Vermetten, E., & Schoevers, R. A. (2022). Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology, 36(10), 1100–1117. https://doi.org/10.1177/02698811221116926",
      "authors": "Breeksema, J. J., Kuin, B. W., Kamphuis, J., Van Den Brink, W., Vermetten, E., & Schoevers, R. A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221116926",
      "url": "https://doi.org/10.1177/02698811221116926",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "breeksema_2024",
      "fullText": "Breeksema, J. J., Niemeijer, A., Krediet, E., Karsten, T., Kamphuis, J., Vermetten, E., Van Den Brink, W., & Schoevers, R. (2024). Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: A qualitative study. Scientific Reports, 14(1), 2929. https://doi.org/10.1038/s41598-024-53188-9",
      "authors": "Breeksema, J. J., Niemeijer, A., Krediet, E., Karsten, T., Kamphuis, J., Vermetten, E., Van Den Brink, W., & Schoevers, R.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-53188-9",
      "url": "https://doi.org/10.1038/s41598-024-53188-9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "breeksema_2022_1",
      "fullText": "Breeksema, J. J., Niemeijer, A., Kuin, B., Veraart, J., Kamphuis, J., Schimmel, N., van den Brink, W., Vermetten, E., & Schoevers, R. (2022). Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Frontiers in Psychiatry, 13, 948115. https://doi.org/10.3389/fpsyt.2022.948115",
      "authors": "Breeksema, J. J., Niemeijer, A., Kuin, B., Veraart, J., Kamphuis, J., Schimmel, N., van den Brink, W., Vermetten, E., & Schoevers, R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.948115",
      "url": "https://doi.org/10.3389/fpsyt.2022.948115",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bremler_2023a",
      "fullText": "Bremler, R., Katati, N., Shergill, P., Erritzoe, D., & Carhart-Harris, R. (2023a). Focusing on the negative: Cases of long-term negative psychological responses to psychedelics. PsyArXiv. https://doi.org/10.31234/osf.io/yzmcj",
      "authors": "Bremler, R., Katati, N., Shergill, P., Erritzoe, D., & Carhart-Harris, R.",
      "year": "2023a",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/yzmcj",
      "url": "https://doi.org/10.31234/osf.io/yzmcj",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "bremler_2023b",
      "fullText": "Bremler, R., Katati, N., Shergill, P., Erritzoe, D., & Carhart-Harris, R. L. (2023b). Case analysis of long-term negative psychological responses to psychedelics. Scientific Reports, 13(1), 15998. https://doi.org/10.1038/s41598-023-41145-x",
      "authors": "Bremler, R., Katati, N., Shergill, P., Erritzoe, D., & Carhart-Harris, R. L.",
      "year": "2023b",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-023-41145-x",
      "url": "https://doi.org/10.1038/s41598-023-41145-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "brodrick_2016",
      "fullText": "Brodrick, J., & Mitchell, B. G. (2016). Hallucinogen Persisting Perception Disorder and Risk of Suicide. Journal of Pharmacy Practice, 29(4), 431–434. https://doi.org/10.1177/0897190014566314",
      "authors": "Brodrick, J., & Mitchell, B. G.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0897190014566314",
      "url": "https://doi.org/10.1177/0897190014566314",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "bruce_2025",
      "fullText": "Bruce, L. (2025). Psychedelics in a Deregulated Policy Climate: What Might 2025 Bring? The American Journal of Bioethics. https://www.tandfonline.com/doi/abs/10.1080/15265161.2024.2433420",
      "authors": "Bruce, L.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.tandfonline.com/doi/abs/10.1080/15265161.2024.2433420",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0098",
      "fullText": "Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A. A., Lees, A., Young, A. H., & Rucker, J. (n.d.). Psychedelic treatment of functional neurological disorder: A systematic review. Therapeutic Advances in Psychopharmacology.",
      "authors": "Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A. A., Lees, A., Young, A. H., & Rucker, J. (n.d.). Psychedelic treatment of functional neurological disorder: A systematic review. Therapeutic Advances in Psychopharmacology.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "byrne_2023",
      "fullText": "Byrne, K. J., Lindsay, S., Baker, N., Schmutz, C., & Lewis, B. (2023). In naturalistic psychedelic use, group use is common and acceptable. Journal of Psychedelic Studies, 7(2), 100–113. https://doi.org/10.1556/2054.2023.00261",
      "authors": "Byrne, K. J., Lindsay, S., Baker, N., Schmutz, C., & Lewis, B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2023.00261",
      "url": "https://doi.org/10.1556/2054.2023.00261",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "calder_2024a",
      "fullText": "Calder, A. E., & Hasler, G. (2024a). Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA. Journal of Affective Disorders, 365, 258–264. https://doi.org/10.1016/j.jad.2024.08.091",
      "authors": "Calder, A. E., & Hasler, G.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2024.08.091",
      "url": "https://doi.org/10.1016/j.jad.2024.08.091",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "calder_2024b",
      "fullText": "Calder, A. E., & Hasler, G. (2024b). Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA. Journal of Affective Disorders, 365, 258–264. https://doi.org/10.1016/j.jad.2024.08.091",
      "authors": "Calder, A. E., & Hasler, G.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2024.08.091",
      "url": "https://doi.org/10.1016/j.jad.2024.08.091",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "calder_2024",
      "fullText": "Calder, A. E., Rausch, B., Liechti, M. E., Holze, F., & Hasler, G. (2024). Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response. Journal of Psychopharmacology, 38(10), 873–886. https://doi.org/10.1177/02698811241278873",
      "authors": "Calder, A. E., Rausch, B., Liechti, M. E., Holze, F., & Hasler, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241278873",
      "url": "https://doi.org/10.1177/02698811241278873",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "calder_2023",
      "fullText": "Calder, A., & Hasler, G. (2023). Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy. JAMA Psychiatry, 80(8), 761. https://doi.org/10.1001/jamapsychiatry.2023.1031",
      "authors": "Calder, A., & Hasler, G.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2023.1031",
      "url": "https://doi.org/10.1001/jamapsychiatry.2023.1031",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "calina_2021",
      "fullText": "Calina, D., Carvalho, F., & Oana Docea, A. (2021). Chapter 43—Toxicity of psychedelic drugs. In A. M. Tsatsakis (Ed.), Toxicological Risk Assessment and Multi-System Health Impacts from Exposure (pp. 545–556). Academic Press. https://doi.org/10.1016/B978-0-323-85215-9.00022-2",
      "authors": "Calina, D., Carvalho, F., & Oana Docea, A.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1016/B978-0-323-85215-9.00022-2",
      "url": "https://doi.org/10.1016/B978-0-323-85215-9.00022-2",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "callon_2021",
      "fullText": "Callon, C., Williams, M., & Lafrance, A. (2021). “Meeting the Medicine Halfway”: Ayahuasca Ceremony Leaders’ Perspectives on Preparation and Integration Practices for Participants. Journal of Humanistic Psychology, 00221678211043300. https://doi.org/10.1177/00221678211043300",
      "authors": "Callon, C., Williams, M., & Lafrance, A.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1177/00221678211043300",
      "url": "https://doi.org/10.1177/00221678211043300",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cameron_2021",
      "fullText": "Cameron, L. P. (2021). Asking questions of psychedelic microdosing. eLife, 10, e66920. https://doi.org/10.7554/eLife.66920",
      "authors": "Cameron, L. P.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.7554/eLife.66920",
      "url": "https://doi.org/10.7554/eLife.66920",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cameron_2020",
      "fullText": "Cameron, L. P., Nazarian, A., & Olson, D. E. (2020). Psychedelic Microdosing: Prevalence and Subjective Effects. Journal of Psychoactive Drugs, 52(2), 113–122. https://doi.org/10.1080/02791072.2020.1718250",
      "authors": "Cameron, L. P., Nazarian, A., & Olson, D. E.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2020.1718250",
      "url": "https://doi.org/10.1080/02791072.2020.1718250",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "campo_2024",
      "fullText": "Campo, W. M., & Yali, A. M. (2024). Psychedelic use and psychological flexibility: The role of meaningful intention and decentering. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00350",
      "authors": "Campo, W. M., & Yali, A. M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00350",
      "url": "https://doi.org/10.1556/2054.2024.00350",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "canady_2023a",
      "fullText": "Canady, V. A. (2023a). FDA issues first draft guidance on psychedelic research. Mental Health Weekly, 33(26), 3–5. https://doi.org/10.1002/mhw.33697",
      "authors": "Canady, V. A.",
      "year": "2023a",
      "title": "",
      "journal": "",
      "doi": "10.1002/mhw.33697",
      "url": "https://doi.org/10.1002/mhw.33697",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "canady_2023b",
      "fullText": "Canady, V. A. (2023b). Report finds psychedelic helpline may avert harmful outcomes. Mental Health Weekly, 33(25), 5–6. https://doi.org/10.1002/mhw.33691",
      "authors": "Canady, V. A.",
      "year": "2023b",
      "title": "",
      "journal": "",
      "doi": "10.1002/mhw.33691",
      "url": "https://doi.org/10.1002/mhw.33691",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "carbonaro_2016",
      "fullText": "Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268–1278. https://doi.org/10.1177/0269881116662634",
      "authors": "Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881116662634",
      "url": "https://doi.org/10.1177/0269881116662634",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carbonaro_2018",
      "fullText": "Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. (2018). Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: Similarities and differences in subjective experiences. Psychopharmacology, 235(2), 521–534. https://doi.org/10.1007/s00213-017-4769-4",
      "authors": "Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-017-4769-4",
      "url": "https://doi.org/10.1007/s00213-017-4769-4",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2017",
      "fullText": "Carhart-Harris, R. L., & Goodwin, G. M. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology, 42(11), 2105–2113. https://doi.org/10.1038/npp.2017.84",
      "authors": "Carhart-Harris, R. L., & Goodwin, G. M.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1038/npp.2017.84",
      "url": "https://doi.org/10.1038/npp.2017.84",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2010",
      "fullText": "Carhart-Harris, R. L., & Nutt, D. J. (2010). User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use, 15(4), 283–300. https://doi.org/10.3109/14659890903271624",
      "authors": "Carhart-Harris, R. L., & Nutt, D. J.",
      "year": "2010",
      "title": "",
      "journal": "",
      "doi": "10.3109/14659890903271624",
      "url": "https://doi.org/10.3109/14659890903271624",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2013",
      "fullText": "Carhart-Harris, R. L., & Nutt, D. J. (2013). Experienced drug users assess the relative harms and benefits of drugs: A web-based survey. Journal of Psychoactive Drugs, 45(4), 322–328. https://doi.org/10.1080/02791072.2013.825034",
      "authors": "Carhart-Harris, R. L., & Nutt, D. J.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2013.825034",
      "url": "https://doi.org/10.1080/02791072.2013.825034",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2018",
      "fullText": "Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J. (2018). Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology, 235(2), 399–408. https://doi.org/10.1007/s00213-017-4771-x",
      "authors": "Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-017-4771-x",
      "url": "https://doi.org/10.1007/s00213-017-4771-x",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2018a",
      "fullText": "Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018a). Psychedelics and the essential importance of context. Journal of Psychopharmacology (Oxford, England), 32(7), 725–731. https://doi.org/10.1177/0269881118754710",
      "authors": "Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M.",
      "year": "2018a",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881118754710",
      "url": "https://doi.org/10.1177/0269881118754710",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2018b",
      "fullText": "Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018b). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32(7), 725–731. https://doi.org/10.1177/0269881118754710",
      "authors": "Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M.",
      "year": "2018b",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881118754710",
      "url": "https://doi.org/10.1177/0269881118754710",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2011",
      "fullText": "Carhart-Harris, R. L., Williams, T. M., Sessa, B., Tyacke, R. J., Rich, A. S., Feilding, A., & Nutt, D. J. (2011). The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: A preliminary investigation of tolerability. Journal of Psychopharmacology (Oxford, England), 25(11), 1562–1567. https://doi.org/10.1177/0269881110367445",
      "authors": "Carhart-Harris, R. L., Williams, T. M., Sessa, B., Tyacke, R. J., Rich, A. S., Feilding, A., & Nutt, D. J.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881110367445",
      "url": "https://doi.org/10.1177/0269881110367445",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "carhartharris_2021",
      "fullText": "Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of Psilocybin versus Escitalopram for Depression. New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994",
      "authors": "Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1056/NEJMoa2032994",
      "url": "https://doi.org/10.1056/NEJMoa2032994",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "carvalho_2014",
      "fullText": "Carvalho, M. C., de Sousa, M. P., Frango, P., Dias, P., Carvalho, J., Rodrigues, M., & Rodrigues, T. (2014). Crisis intervention related to the use of psychoactive substances in recreational settings—Evaluating the Kosmicare Project at Boom Festival. Current Drug Abuse Reviews, 7(2), 81–100. https://doi.org/10.2174/1874473708666150107115515",
      "authors": "Carvalho, M. C., de Sousa, M. P., Frango, P., Dias, P., Carvalho, J., Rodrigues, M., & Rodrigues, T.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.2174/1874473708666150107115515",
      "url": "https://doi.org/10.2174/1874473708666150107115515",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0122",
      "fullText": "Case analysis of long-term negative psychological responses to psychedelics | Scientific Reports. (n.d.). Retrieved January 12, 2025, from https://www.nature.com/articles/s41598-023-41145-x",
      "authors": "Case analysis of long-term negative psychological responses to psychedelics | Scientific Reports. (n.d.). Retrieved January 12, 2025, from https://www.nature.com/articles/s41598-023-41145-x",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.nature.com/articles/s41598-023-41145-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "caudevillaglligo_2012",
      "fullText": "Caudevilla-Gálligo, F., Riba, J., Ventura, M., González, D., Farré, M., Barbanoj, M. J., & Bouso, J. C. (2012). 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): Presence in the recreational drug market in Spain, pattern of use and subjective effects. Journal of Psychopharmacology, 26(7), 1026–1035. https://doi.org/10.1177/0269881111431752",
      "authors": "Caudevilla-Gálligo, F., Riba, J., Ventura, M., González, D., Farré, M., Barbanoj, M. J., & Bouso, J. C.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881111431752",
      "url": "https://doi.org/10.1177/0269881111431752",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "cavanna_2022",
      "fullText": "Cavanna, F., Muller, S., De La Fuente, L. A., Zamberlan, F., Palmucci, M., Janeckova, L., Kuchar, M., Pallavicini, C., & Tagliazucchi, E. (2022). Microdosing with psilocybin mushrooms: A double-blind placebo-controlled study. Translational Psychiatry, 12(1), 307. https://doi.org/10.1038/s41398-022-02039-0",
      "authors": "Cavanna, F., Muller, S., De La Fuente, L. A., Zamberlan, F., Palmucci, M., Janeckova, L., Kuchar, M., Pallavicini, C., & Tagliazucchi, E.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41398-022-02039-0",
      "url": "https://doi.org/10.1038/s41398-022-02039-0",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cavarra_2022",
      "fullText": "Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C. (2022). Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions. Frontiers in Psychology, 13, 887255. https://doi.org/10.3389/fpsyg.2022.887255",
      "authors": "Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2022.887255",
      "url": "https://doi.org/10.3389/fpsyg.2022.887255",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "chadwick_2005",
      "fullText": "Chadwick, B., Waller, D. G., & Edwards, J. G. (2005). Potentially hazardous drug interactions with psychotropics. Advances in Psychiatric Treatment, 11(6), 440–449. https://doi.org/10.1192/apt.11.6.440",
      "authors": "Chadwick, B., Waller, D. G., & Edwards, J. G.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1192/apt.11.6.440",
      "url": "https://doi.org/10.1192/apt.11.6.440",
      "categories": [
        "contraindications"
      ],
      "citedIn": []
    },
    {
      "id": "charilaos_2012",
      "fullText": "Charilaos, L. A., & Sofou, L. (2012). Psychedelic drugs as treatment: A look into the future of psychotherapy.",
      "authors": "Charilaos, L. A., & Sofou, L.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "chary_2018",
      "fullText": "Chary, M., Yi, D., & Manini, A. F. (2018). Candyflipping and Other Combinations: Identifying Drug–Drug Combinations from an Online Forum. Frontiers in Psychiatry, 9, 135. https://doi.org/10.3389/fpsyt.2018.00135",
      "authors": "Chary, M., Yi, D., & Manini, A. F.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2018.00135",
      "url": "https://doi.org/10.3389/fpsyt.2018.00135",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cherian_2024",
      "fullText": "Cherian, K., Shinozuka, K., Tabaac, B. J., Arenas, A., Beutler, B. D., Evans, V. D., Fasano, C., & Muir, O. S. (2024). Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine. American Journal of Therapeutics, 31(2), e133–e140. https://doi.org/10.1097/MJT.0000000000001723",
      "authors": "Cherian, K., Shinozuka, K., Tabaac, B. J., Arenas, A., Beutler, B. D., Evans, V. D., Fasano, C., & Muir, O. S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1097/MJT.0000000000001723",
      "url": "https://doi.org/10.1097/MJT.0000000000001723",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "cherniak_2024",
      "fullText": "Cherniak, A. D., Mikulincer, M., Gruneau Brulin, J., & Granqvist, P. (2024). Perceived attachment history predicts psychedelic experiences: A naturalistic study. Journal of Psychedelic Studies, 8(1), 82–91. https://doi.org/10.1556/2054.2024.00330",
      "authors": "Cherniak, A. D., Mikulincer, M., Gruneau Brulin, J., & Granqvist, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00330",
      "url": "https://doi.org/10.1556/2054.2024.00330",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cheung_2024",
      "fullText": "Cheung, K., Ehrenkranz, R., Hinkle, J. T., & Yaden, D. B. (2024). Commentary: A framework for assessment of adverse events in psychedelic research. Journal of Psychopharmacology, 02698811241309623. https://doi.org/10.1177/02698811241309623",
      "authors": "Cheung, K., Ehrenkranz, R., Hinkle, J. T., & Yaden, D. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241309623",
      "url": "https://doi.org/10.1177/02698811241309623",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0132",
      "fullText": "Cheung, K., Propes, C., Jacobs, E., Earp, B. D., & Yaden, D. B. (n.d.). Psychedelic group-based integration: Ethical assessment and initial recommendations. International Review of Psychiatry, 0(0), 1–11. https://doi.org/10.1080/09540261.2024.2357678",
      "authors": "Cheung, K., Propes, C., Jacobs, E., Earp, B. D., & Yaden, D. B. (n.d.). Psychedelic group-based integration: Ethical assessment and initial recommendations. International Review of Psychiatry, 0(0), 1–11. https://doi.org/10.1080/09540261.2024.2357678",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/09540261.2024.2357678",
      "url": "https://doi.org/10.1080/09540261.2024.2357678",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "chi_2023",
      "fullText": "Chi, Y., & Chen, H. (2023). Investigating Substance Use via Reddit: Systematic Scoping Review. Journal of Medical Internet Research, 25, e48905. https://doi.org/10.2196/48905",
      "authors": "Chi, Y., & Chen, H.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.2196/48905",
      "url": "https://doi.org/10.2196/48905",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ching_2025",
      "fullText": "Ching, T. H. W., & Kelmendi, B. (2025). A primer for culturally attuned psychedelic clinical trials. https://doi.org/10.1556/2054.2025.00394",
      "authors": "Ching, T. H. W., & Kelmendi, B.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2025.00394",
      "url": "https://doi.org/10.1556/2054.2025.00394",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ching_2024",
      "fullText": "Ching, T. H. W., Amoroso, L., Bohner, C., D’Amico, E., Eilbott, J., Entezar, T., Fitzpatrick, M., Fram, G., Grazioplene, R., Hokanson, J., Jankovsky, A., Kichuk, S. A., Martins, B., Patel, P., Schaer, H., Shnayder, S., Witherow, C., Pittenger, C., & Kelmendi, B. (2024). Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: Protocol for a randomized, waitlist-controlled trial with blinded ratings. Frontiers in Psychiatry, 14, 1278823. https://doi.org/10.3389/fpsyt.2023.1278823",
      "authors": "Ching, T. H. W., Amoroso, L., Bohner, C., D’Amico, E., Eilbott, J., Entezar, T., Fitzpatrick, M., Fram, G., Grazioplene, R., Hokanson, J., Jankovsky, A., Kichuk, S. A., Martins, B., Patel, P., Schaer, H., Shnayder, S., Witherow, C., Pittenger, C., & Kelmendi, B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1278823",
      "url": "https://doi.org/10.3389/fpsyt.2023.1278823",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "christensen_2023",
      "fullText": "Christensen, J. A., Fipps, D. C., & Bostwick, J. M. (2023). To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder. Experimental and Clinical Psychopharmacology, 31(2), 300–304. https://doi.org/10.1037/pha0000597",
      "authors": "Christensen, J. A., Fipps, D. C., & Bostwick, J. M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1037/pha0000597",
      "url": "https://doi.org/10.1037/pha0000597",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ciaunica_2022",
      "fullText": "Ciaunica, A., & Safron, A. (2022). Disintegrating and Reintegrating the Self – (In)Flexible Self-Models in Depersonalisation and Psychedelic Experiences. PsyArXiv. https://doi.org/10.31234/osf.io/mah78",
      "authors": "Ciaunica, A., & Safron, A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/mah78",
      "url": "https://doi.org/10.31234/osf.io/mah78",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cohen_1960",
      "fullText": "Cohen, S. (1960). Lysergic acid diethylamide: Side effects and complications. The Journal of Nervous and Mental Disease, 130, 30–40. https://doi.org/10.1097/00005053-196001000-00005",
      "authors": "Cohen, S.",
      "year": "1960",
      "title": "",
      "journal": "",
      "doi": "10.1097/00005053-196001000-00005",
      "url": "https://doi.org/10.1097/00005053-196001000-00005",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "colcott_2024",
      "fullText": "Colcott, J., Guerin, A. A., Carter, O., Meikle, S., & Bedi, G. (2024). Side-effects of mdma-assisted psychotherapy: A systematic review and meta-analysis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 49(8), 1208–1226. https://doi.org/10.1038/s41386-024-01865-8",
      "authors": "Colcott, J., Guerin, A. A., Carter, O., Meikle, S., & Bedi, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41386-024-01865-8",
      "url": "https://doi.org/10.1038/s41386-024-01865-8",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "collins_2024",
      "fullText": "Collins, H. M. (2024). Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms. International Journal of Neuropsychopharmacology, 27(12), pyae057. https://doi.org/10.1093/ijnp/pyae057",
      "authors": "Collins, H. M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyae057",
      "url": "https://doi.org/10.1093/ijnp/pyae057",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "coppola_2017",
      "fullText": "Coppola, M., & Mondola, R. (2017). JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up. Journal of Psychoactive Drugs, 49(3), 262–265. https://doi.org/10.1080/02791072.2017.1316431",
      "authors": "Coppola, M., & Mondola, R.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2017.1316431",
      "url": "https://doi.org/10.1080/02791072.2017.1316431",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "cornfield_2024",
      "fullText": "Cornfield, M., McBride, S., La Torre, J. T., Zalewa, D., Gallo, J., Mahammadli, M., & Williams, M. T. (2024). Exploring effects and experiences of ketamine in group couples therapy. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00302",
      "authors": "Cornfield, M., McBride, S., La Torre, J. T., Zalewa, D., Gallo, J., Mahammadli, M., & Williams, M. T.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00302",
      "url": "https://doi.org/10.1556/2054.2024.00302",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "cowleycourt_2023",
      "fullText": "Cowley-Court, T., Chenhall, R., Sarris, J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2023). Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey. Psychoactives, 2(2), Article 2. https://doi.org/10.3390/psychoactives2020014",
      "authors": "Cowley-Court, T., Chenhall, R., Sarris, J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3390/psychoactives2020014",
      "url": "https://doi.org/10.3390/psychoactives2020014",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0144",
      "fullText": "Coyle, J. R., Presti, D. E., & Baggott, M. J. (n.d.). Quantitative Analysis of Narrative Reports of Psychedelic Drugs.",
      "authors": "Coyle, J. R., Presti, D. E., & Baggott, M. J. (n.d.). Quantitative Analysis of Narrative Reports of Psychedelic Drugs.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "croarkin_2024",
      "fullText": "Croarkin, P. E., Sutherland, I., & Ho, M.-F. (2024). Psychedelic Therapeutics for Adolescents: Safety, Opportunities, and Equipoise. Journal of the American Academy of Child and Adolescent Psychiatry, S0890-8567(24)02061-6. https://doi.org/10.1016/j.jaac.2024.12.003",
      "authors": "Croarkin, P. E., Sutherland, I., & Ho, M.-F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jaac.2024.12.003",
      "url": "https://doi.org/10.1016/j.jaac.2024.12.003",
      "categories": [
        "safety",
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "curry_2018",
      "fullText": "Curry, D. W., Young, M. B., Tran, A. N., Daoud, G. E., & Howell, L. L. (2018). Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice. Neuropharmacology, 128, 196–206. https://doi.org/10.1016/j.neuropharm.2017.10.003",
      "authors": "Curry, D. W., Young, M. B., Tran, A. N., Daoud, G. E., & Howell, L. L.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neuropharm.2017.10.003",
      "url": "https://doi.org/10.1016/j.neuropharm.2017.10.003",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "davis_2022",
      "fullText": "Davis, A. K., Agin-Liebes, G., España, M., Pilecki, B., & Luoma, J. (2022). Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States. Journal of Psychoactive Drugs, 54(4), 309–318. https://doi.org/10.1080/02791072.2021.1971343",
      "authors": "Davis, A. K., Agin-Liebes, G., España, M., Pilecki, B., & Luoma, J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2021.1971343",
      "url": "https://doi.org/10.1080/02791072.2021.1971343",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "davis_2018",
      "fullText": "Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018). The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Journal of Psychopharmacology, 32(7), 779–792. https://doi.org/10.1177/0269881118769063",
      "authors": "Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881118769063",
      "url": "https://doi.org/10.1177/0269881118769063",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0149",
      "fullText": "Davis, A. K., Bates, M., Lund, E. M., Sepeda, N. D., Levin, A. W., Armstrong, S. B., Koffman, R., Hooyer, K., & Yehuda, R. (n.d.). The Epidemiology of Psychedelic Use Among United States Military Veterans. Journal of Psychoactive Drugs, 0(0), 1–14. https://doi.org/10.1080/02791072.2024.2401977",
      "authors": "Davis, A. K., Bates, M., Lund, E. M., Sepeda, N. D., Levin, A. W., Armstrong, S. B., Koffman, R., Hooyer, K., & Yehuda, R. (n.d.). The Epidemiology of Psychedelic Use Among United States Military Veterans. Journal of Psychoactive Drugs, 0(0), 1–14. https://doi.org/10.1080/02791072.2024.2401977",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2401977",
      "url": "https://doi.org/10.1080/02791072.2024.2401977",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "davis_2024",
      "fullText": "Davis, A. K., Timmermann, C., Ortiz Bernal, A. M., Lancelotta, R., Nayak, S., Sepeda, N. D., Nikolaidis, A., & Griffiths, R. R. (2024). Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences. Journal of Psychoactive Drugs, 56(4), 456–466. https://doi.org/10.1080/02791072.2023.2232379",
      "authors": "Davis, A. K., Timmermann, C., Ortiz Bernal, A. M., Lancelotta, R., Nayak, S., Sepeda, N. D., Nikolaidis, A., & Griffiths, R. R.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2023.2232379",
      "url": "https://doi.org/10.1080/02791072.2023.2232379",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "dawson_2024",
      "fullText": "Dawson, K., Carangan, A. M. J. M., Klunder, J., Carreras-Gallo, N., Sehgal, R., Megilligan, S., Askins, B. C., Perkins, N., Mendez, T. L., Smith, R., Dawson, M., Mallin, M., Higgins-Chen, A. T., & Dwaraka, V. B. (2024). Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging (p. 2024.09.10.24313258). medRxiv. https://doi.org/10.1101/2024.09.10.24313258",
      "authors": "Dawson, K., Carangan, A. M. J. M., Klunder, J., Carreras-Gallo, N., Sehgal, R., Megilligan, S., Askins, B. C., Perkins, N., Mendez, T. L., Smith, R., Dawson, M., Mallin, M., Higgins-Chen, A. T., & Dwaraka, V. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1101/2024.09.10.24313258",
      "url": "https://doi.org/10.1101/2024.09.10.24313258",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "deane_2020",
      "fullText": "Deane, G. (2020). Dissolving the self: Active inference, psychedelics, and ego-dissolution. Philosophy and the Mind Sciences, 1(I), 1–27. https://doi.org/10.33735/phimisci.2020.I.39",
      "authors": "Deane, G.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.33735/phimisci.2020.I.39",
      "url": "https://doi.org/10.33735/phimisci.2020.I.39",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "denson_1969",
      "fullText": "Denson, R. (1969). Complications of therapy with lysergide. Canadian Medical Association Journal, 101(11), 53–57.",
      "authors": "Denson, R.",
      "year": "1969",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0154",
      "fullText": "Developing Guidelines and Competencies for the Training of Psychedelic Therapists. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/318022461_Developing_Guidelines_and_Competencies_for_the_Training_of_Psychedelic_Therapists",
      "authors": "Developing Guidelines and Competencies for the Training of Psychedelic Therapists. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/318022461_Developing_Guidelines_and_Competencies_for_the_Training_of_Psychedelic_Therapists",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/318022461_Developing_Guidelines_and_Competencies_for_the_Training_of_Psychedelic_Therapists",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "devenot_2022",
      "fullText": "Devenot, N., Conner, T., & Doyle, R. (2022). Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative: A Manifesto for Psychonauts†. Anthropology of Consciousness, 33(2), 476–505. https://doi.org/10.1111/anoc.12154",
      "authors": "Devenot, N., Conner, T., & Doyle, R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1111/anoc.12154",
      "url": "https://doi.org/10.1111/anoc.12154",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "devenot_2022_1",
      "fullText": "Devenot, N., Seale-Feldman, A., Smith, E., Noorani, T., Garcia-Romeu, A., & Johnson, M. W. (2022). Psychedelic Identity Shift: A Critical Approach to Set And Setting. Kennedy Institute of Ethics Journal, 32(4), 359–399. https://doi.org/10.1353/ken.2022.0022",
      "authors": "Devenot, N., Seale-Feldman, A., Smith, E., Noorani, T., Garcia-Romeu, A., & Johnson, M. W.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1353/ken.2022.0022",
      "url": "https://doi.org/10.1353/ken.2022.0022",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "dollar_2021",
      "fullText": "Dollar, C. B. (2021). Recreation and Realization: Reported Motivations of Use Among Persons Who Consume Psychedelics in Non-Clinical Settings. Journal of Qualitative Criminal Justice & Criminology. https://doi.org/10.21428/88de04a1.cb6fef95",
      "authors": "Dollar, C. B.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.21428/88de04a1.cb6fef95",
      "url": "https://doi.org/10.21428/88de04a1.cb6fef95",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "dossantos_2024",
      "fullText": "Dos Santos, R. G., & Hallak, J. E. C. (2024). Ayahuasca: Pharmacology, safety, and therapeutic effects. CNS Spectrums, 1–9. https://doi.org/10.1017/S109285292400213X",
      "authors": "Dos Santos, R. G., & Hallak, J. E. C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1017/S109285292400213X",
      "url": "https://doi.org/10.1017/S109285292400213X",
      "categories": [
        "safety",
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "dossantos_2018",
      "fullText": "Dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018). Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: A systematic review of systematic reviews. Expert Review of Clinical Pharmacology, 11(9), 889–902. https://doi.org/10.1080/17512433.2018.1511424",
      "authors": "Dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. C.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1080/17512433.2018.1511424",
      "url": "https://doi.org/10.1080/17512433.2018.1511424",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "dourron_2023",
      "fullText": "Dourron, H. M., Nichols, C. D., Simonsson, O., Bradley, M., Carhart-Harris, R., & Hendricks, P. S. (2023). 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? Psychopharmacology. https://doi.org/10.1007/s00213-023-06517-1",
      "authors": "Dourron, H. M., Nichols, C. D., Simonsson, O., Bradley, M., Carhart-Harris, R., & Hendricks, P. S.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-023-06517-1",
      "url": "https://doi.org/10.1007/s00213-023-06517-1",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "dourron_2024",
      "fullText": "Dourron, H., Bradley, M., & Hendricks, P. (2024). Psychedelics’ Uncertain Risks: A Reply to Myran et al. PsyArXiv. https://doi.org/10.31234/osf.io/vujpk",
      "authors": "Dourron, H., Bradley, M., & Hendricks, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/vujpk",
      "url": "https://doi.org/10.31234/osf.io/vujpk",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "doyle_2022a",
      "fullText": "Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., & McIntyre, R. S. (2022a). Hallucinogen persisting perceptual disorder: A scoping review covering frequency, risk factors, prevention, and treatment. Expert Opinion on Drug Safety, 21(6), 733–743. https://doi.org/10.1080/14740338.2022.2063273",
      "authors": "Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., & McIntyre, R. S.",
      "year": "2022a",
      "title": "",
      "journal": "",
      "doi": "10.1080/14740338.2022.2063273",
      "url": "https://doi.org/10.1080/14740338.2022.2063273",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "doyle_2022b",
      "fullText": "Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., & McIntyre, R. S. (2022b). Hallucinogen persisting perceptual disorder: A scoping review covering frequency, risk factors, prevention, and treatment. Expert Opinion on Drug Safety, 21(6), 733–743. https://doi.org/10.1080/14740338.2022.2063273",
      "authors": "Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., & McIntyre, R. S.",
      "year": "2022b",
      "title": "",
      "journal": "",
      "doi": "10.1080/14740338.2022.2063273",
      "url": "https://doi.org/10.1080/14740338.2022.2063273",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "dpsenhppdsignalering_2024",
      "fullText": "DPS en HPPD: Signalering, diagnostiek en behandeling van persistente waarnemingsstoornissen na partydrugs. (2024). ResearchGate. https://doi.org/10.1007/s12501-016-0074-x",
      "authors": "DPS en HPPD: Signalering, diagnostiek en behandeling van persistente waarnemingsstoornissen na partydrugs.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s12501-016-0074-x",
      "url": "https://doi.org/10.1007/s12501-016-0074-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "dupuis_2021",
      "fullText": "Dupuis, D. (2021). Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens. Frontiers in Psychology, 12, 730031. https://doi.org/10.3389/fpsyg.2021.730031",
      "authors": "Dupuis, D.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2021.730031",
      "url": "https://doi.org/10.3389/fpsyg.2021.730031",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "dupuis_2022",
      "fullText": "Dupuis, D., & Veissière, S. (2022). Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos? Transcultural Psychiatry, 59(5), 571–578. https://doi.org/10.1177/13634615221131465",
      "authors": "Dupuis, D., & Veissière, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/13634615221131465",
      "url": "https://doi.org/10.1177/13634615221131465",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "dyck_2018",
      "fullText": "Dyck, E. (2018). Who Is Keeping Tabs? LSD Lessons from the Past for the Future. In B. C. Labate & C. Cavnar (Eds.), Plant Medicines, Healing and Psychedelic Science (pp. 1–17). Springer International Publishing. https://doi.org/10.1007/978-3-319-76720-8_1",
      "authors": "Dyck, E.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/978-3-319-76720-8_1",
      "url": "https://doi.org/10.1007/978-3-319-76720-8_1",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "dyck_2024",
      "fullText": "Dyck, E., & Dixon, J. (2024). Completing the Circle: A History of Psychedelics and Harm Reduction. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2024_511",
      "authors": "Dyck, E., & Dixon, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2024_511",
      "url": "https://doi.org/10.1007/7854_2024_511",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "dyck_2020",
      "fullText": "Dyck, E., & Elcock, C. (2020). Reframing Bummer Trips: Scientific and Cultural Explanations to Adverse Reactions to Psychedelic Drug Use. The Social History of Alcohol and Drugs, 34(2), 271–296. https://doi.org/10.1086/707512",
      "authors": "Dyck, E., & Elcock, C.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1086/707512",
      "url": "https://doi.org/10.1086/707512",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "earleywine_2024_1",
      "fullText": "Earleywine, M., & Gomez, S. G. (2024). Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects. Psychedelic Medicine, 2(3), 138–145. https://doi.org/10.1089/psymed.2023.0054",
      "authors": "Earleywine, M., & Gomez, S. G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0054",
      "url": "https://doi.org/10.1089/psymed.2023.0054",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "earleywine_2022",
      "fullText": "Earleywine, M., & Herrmann, Z. M. (2022). Psychedelics for Psychiatric Disorders: Promise, Not Panacea. Psychiatric Annals, 52(9), 354–358. https://doi.org/10.3928/00485713-20220810-01",
      "authors": "Earleywine, M., & Herrmann, Z. M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3928/00485713-20220810-01",
      "url": "https://doi.org/10.3928/00485713-20220810-01",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "earleywine_2024",
      "fullText": "Earleywine, M., Falabella, G. S., Oliva, A. B., & Low, F. (2024). Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing. Journal of Psychoactive Drugs, 1–10. https://doi.org/10.1080/02791072.2024.2421892",
      "authors": "Earleywine, M., Falabella, G. S., Oliva, A. B., & Low, F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2421892",
      "url": "https://doi.org/10.1080/02791072.2024.2421892",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "eckerns_2022",
      "fullText": "Eckernäs, E., Timmermann, C., Carhart-Harris, R., Röshammar, D., & Ashton, M. (2022). Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine—Implications for dose considerations. Clinical and Translational Science, 15(12), 2928–2937. https://doi.org/10.1111/cts.13410",
      "authors": "Eckernäs, E., Timmermann, C., Carhart-Harris, R., Röshammar, D., & Ashton, M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1111/cts.13410",
      "url": "https://doi.org/10.1111/cts.13410",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "edelsohn_2023",
      "fullText": "Edelsohn, G. A., & Sisti, D. (2023). Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment. Perspectives in Biology and Medicine, 66(1), 129–144. https://doi.org/10.1353/pbm.2023.0007",
      "authors": "Edelsohn, G. A., & Sisti, D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1353/pbm.2023.0007",
      "url": "https://doi.org/10.1353/pbm.2023.0007",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "edwards_2023",
      "fullText": "Edwards, D., Csontos, J., Pascoe, M. J., Westwell, A., Gillen, E., Bennett, C., Hannigan, B., Carrier, J., & Harden, J. (2023). A rapid scoping review of self-initiated harm reduction strategies for ecstasy (MDMA) users in recreational settings. In Review. https://doi.org/10.21203/rs.3.rs-2178425/v2",
      "authors": "Edwards, D., Csontos, J., Pascoe, M. J., Westwell, A., Gillen, E., Bennett, C., Hannigan, B., Carrier, J., & Harden, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.21203/rs.3.rs-2178425/v2",
      "url": "https://doi.org/10.21203/rs.3.rs-2178425/v2",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "ehrenkranz_2024",
      "fullText": "Ehrenkranz, R., Agrawal, M., Nayak, S. M., & Yaden, D. B. (2024). Adverse Events Should Not Be Surprising in Psychedelic Research. Psychedelic Medicine. https://doi.org/10.1089/psymed.2024.0006",
      "authors": "Ehrenkranz, R., Agrawal, M., Nayak, S. M., & Yaden, D. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2024.0006",
      "url": "https://doi.org/10.1089/psymed.2024.0006",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "eisner_1997",
      "fullText": "Eisner, B. (1997). Set, setting, and matrix. Journal of Psychoactive Drugs, 29(2), 213–216. https://doi.org/10.1080/02791072.1997.10400190",
      "authors": "Eisner, B.",
      "year": "1997",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.1997.10400190",
      "url": "https://doi.org/10.1080/02791072.1997.10400190",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ellisonwright_2015",
      "fullText": "Ellison‐Wright, Z., & Sessa, B. (2015). A persisting perception disorder after cannabis use. Progress in Neurology and Psychiatry, 19(1), 10–13. https://doi.org/10.1002/pnp.363",
      "authors": "Ellison‐Wright, Z., & Sessa, B.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1002/pnp.363",
      "url": "https://doi.org/10.1002/pnp.363",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "elsey_2017",
      "fullText": "Elsey, J. W. B. (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law, 3, 2050324517723232. https://doi.org/10.1177/2050324517723232",
      "authors": "Elsey, J. W. B.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1177/2050324517723232",
      "url": "https://doi.org/10.1177/2050324517723232",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0180",
      "fullText": "Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network. (n.d.). Retrieved January 12, 2025, from https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2825649",
      "authors": "Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network. (n.d.). Retrieved January 12, 2025, from https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2825649",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2825649",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "engel_2022",
      "fullText": "Engel, L. B., Thal, S. B., & Bright, S. J. (2022). Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services? Contemporary Drug Problems, 49(4), 356–368. https://doi.org/10.1177/00914509221121420",
      "authors": "Engel, L. B., Thal, S. B., & Bright, S. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/00914509221121420",
      "url": "https://doi.org/10.1177/00914509221121420",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "engel_2024",
      "fullText": "Engel, L. B., Thal, S., Bright, S. J., & Low, M. (2024). Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00377",
      "authors": "Engel, L. B., Thal, S., Bright, S. J., & Low, M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00377",
      "url": "https://doi.org/10.1556/2054.2024.00377",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "erritzoe_2017",
      "fullText": "Erritzoe, D., & Richards, W. A. (2017). Lessons to be learned from early psychedelic therapy in Denmark. Nordic Journal of Psychiatry, 71(7), 487–488. https://doi.org/10.1080/08039488.2017.1336252",
      "authors": "Erritzoe, D., & Richards, W. A.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1080/08039488.2017.1336252",
      "url": "https://doi.org/10.1080/08039488.2017.1336252",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0184",
      "fullText": "Evans, J., & Joseph Holcomb, A. (n.d.). Guruism and Cultic Social Dynamics in Psychedelic Organisations.pdf. Dropbox. Retrieved January 9, 2025, from https://www.dropbox.com/scl/fi/qyi2rmw2gxlirpzpuuyde/Guruism-and-Cultic-Social-Dynamics-in-Psychedelic-Organisations.pdf?dl=0&rlkey=czgo0yl96tulii9xjbbqoveb2",
      "authors": "Evans, J., & Joseph Holcomb, A. (n.d.). Guruism and Cultic Social Dynamics in Psychedelic Organisations.pdf. Dropbox. Retrieved January 9, 2025, from https://www.dropbox.com/scl/fi/qyi2rmw2gxlirpzpuuyde/Guruism-and-Cultic-Social-Dynamics-in-Psychedelic-Organisations.pdf?dl=0&rlkey=czgo0yl96tulii9xjbbqoveb2",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.dropbox.com/scl/fi/qyi2rmw2gxlirpzpuuyde/Guruism-and-Cultic-Social-Dynamics-in-Psychedelic-Organisations.pdf?dl=0&rlkey=czgo0yl96tulii9xjbbqoveb2",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "evans_2023",
      "fullText": "Evans, J., Robinson, O. C., Argyri, E. K., Suseelan, S., Murphy-Beiner, A., McAlpine, R., Luke, D., Michelle, K., & Prideaux, E. (2023). Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLOS ONE, 18(10), e0293349. https://doi.org/10.1371/journal.pone.0293349",
      "authors": "Evans, J., Robinson, O. C., Argyri, E. K., Suseelan, S., Murphy-Beiner, A., McAlpine, R., Luke, D., Michelle, K., & Prideaux, E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0293349",
      "url": "https://doi.org/10.1371/journal.pone.0293349",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "evans_2024",
      "fullText": "Evans, V. D., Arenas, A., Shinozuka, K., Tabaac, B. J., Beutler, B. D., Cherian, K., Fasano, C., & Muir, O. S. (2024). Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine. American Journal of Therapeutics, 31(2), e155. https://doi.org/10.1097/MJT.0000000000001721",
      "authors": "Evans, V. D., Arenas, A., Shinozuka, K., Tabaac, B. J., Beutler, B. D., Cherian, K., Fasano, C., & Muir, O. S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1097/MJT.0000000000001721",
      "url": "https://doi.org/10.1097/MJT.0000000000001721",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "eveloff_1968",
      "fullText": "Eveloff, H. H. (1968). The LSD syndrome. A review. California Medicine, 109(5), 368–373.",
      "authors": "Eveloff, H. H.",
      "year": "1968",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "evens_2023",
      "fullText": "Evens, R., Schmidt, M. E., Majić, T., & Schmidt, T. T. (2023). The psychedelic afterglow phenomenon: A systematic review of subacute effects of classic serotonergic psychedelics. Therapeutic Advances in Psychopharmacology, 13, 20451253231172254. https://doi.org/10.1177/20451253231172254",
      "authors": "Evens, R., Schmidt, M. E., Majić, T., & Schmidt, T. T.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/20451253231172254",
      "url": "https://doi.org/10.1177/20451253231172254",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0189",
      "fullText": "Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychotic Symptoms. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/358112937_Expert_Opinion_on_Psychedelic-Assisted_Psychotherapy_for_People_with_Psychotic_Symptoms",
      "authors": "Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychotic Symptoms. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/358112937_Expert_Opinion_on_Psychedelic-Assisted_Psychotherapy_for_People_with_Psychotic_Symptoms",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/358112937_Expert_Opinion_on_Psychedelic-Assisted_Psychotherapy_for_People_with_Psychotic_Symptoms",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "fadiman_2019",
      "fullText": "Fadiman, J., & Korb, S. (2019). Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. Journal of Psychoactive Drugs, 51(2), 118–122. https://doi.org/10.1080/02791072.2019.1593561",
      "authors": "Fadiman, J., & Korb, S.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2019.1593561",
      "url": "https://doi.org/10.1080/02791072.2019.1593561",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "falchicarvalho_2024",
      "fullText": "Falchi-Carvalho, M., Wießner, I., Silva, S. R. B., O Maia, L., Barros, H., Laborde, S., Arichelle, F., Tullman, S., Silva-Costa, N., Assunção, A., Almeida, R., Pantrigo, É. J., Bolcont, R., Costa-Macedo, J. V., Arcoverde, E., Galvão-Coelho, N., Araujo, D. B., & Palhano-Fontes, F. (2024). Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 80, 27–35. https://doi.org/10.1016/j.euroneuro.2023.12.006",
      "authors": "Falchi-Carvalho, M., Wießner, I., Silva, S. R. B., O Maia, L., Barros, H., Laborde, S., Arichelle, F., Tullman, S., Silva-Costa, N., Assunção, A., Almeida, R., Pantrigo, É. J., Bolcont, R., Costa-Macedo, J. V., Arcoverde, E., Galvão-Coelho, N., Araujo, D. B., & Palhano-Fontes, F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.euroneuro.2023.12.006",
      "url": "https://doi.org/10.1016/j.euroneuro.2023.12.006",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "family_2022",
      "fullText": "Family, N., Hendricks, P. S., Williams, L. T., Luke, D., Krediet, E., Maillet, E. L., & Raz, S. (2022). Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology (Oxford, England), 36(3), 321–336. https://doi.org/10.1177/02698811211069103",
      "authors": "Family, N., Hendricks, P. S., Williams, L. T., Luke, D., Krediet, E., Maillet, E. L., & Raz, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211069103",
      "url": "https://doi.org/10.1177/02698811211069103",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "family_2020",
      "fullText": "Family, N., Maillet, E. L., Williams, L. T. J., Krediet, E., Carhart-Harris, R. L., Williams, T. M., Nichols, C. D., Goble, D. J., & Raz, S. (2020). Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacology, 237(3), 841–853. https://doi.org/10.1007/s00213-019-05417-7",
      "authors": "Family, N., Maillet, E. L., Williams, L. T. J., Krediet, E., Carhart-Harris, R. L., Williams, T. M., Nichols, C. D., Goble, D. J., & Raz, S.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-019-05417-7",
      "url": "https://doi.org/10.1007/s00213-019-05417-7",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "fang_2024",
      "fullText": "Fang, S., Yang, X., & Zhang, W. (2024). Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Psychiatry, 15, 1359088. https://doi.org/10.3389/fpsyt.2024.1359088",
      "authors": "Fang, S., Yang, X., & Zhang, W.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2024.1359088",
      "url": "https://doi.org/10.3389/fpsyt.2024.1359088",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "feduccia_2021",
      "fullText": "Feduccia, A. A., Jerome, L., Mithoefer, M. C., & Holland, J. (2021). Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Psychopharmacology, 238(2), 581–588. https://doi.org/10.1007/s00213-020-05710-w",
      "authors": "Feduccia, A. A., Jerome, L., Mithoefer, M. C., & Holland, J.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-020-05710-w",
      "url": "https://doi.org/10.1007/s00213-020-05710-w",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "fernndezcaldern_2020",
      "fullText": "Fernández-Calderón, F., Vidal-Giné, C., Rojas-Tejada, A. J., & Lozano-Rojas, Ó. M. (2020). Patterns of Simultaneous Polysubstance Use among Partygoers: Correlates and Differences in Adverse Acute Effects Experienced. Journal of Psychoactive Drugs, 52(4), 344–356. https://doi.org/10.1080/02791072.2020.1752959",
      "authors": "Fernández-Calderón, F., Vidal-Giné, C., Rojas-Tejada, A. J., & Lozano-Rojas, Ó. M.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2020.1752959",
      "url": "https://doi.org/10.1080/02791072.2020.1752959",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "fogg_2021",
      "fullText": "Fogg, C., Michaels, T. I., de la Salle, S., Jahn, Z. W., & Williams, M. T. (2021). Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies. Experimental and Clinical Psychopharmacology, 29(5), 539–554. https://doi.org/10.1037/pha0000490",
      "authors": "Fogg, C., Michaels, T. I., de la Salle, S., Jahn, Z. W., & Williams, M. T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1037/pha0000490",
      "url": "https://doi.org/10.1037/pha0000490",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "fonzo_2025",
      "fullText": "Fonzo, G. A., Nemeroff, C. B., & Kalin, N. (2025). Psychedelics in Psychiatry: Oh, What A Trip! American Journal of Psychiatry, 182(1), 1–5. https://doi.org/10.1176/appi.ajp.20241025",
      "authors": "Fonzo, G. A., Nemeroff, C. B., & Kalin, N.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20241025",
      "url": "https://doi.org/10.1176/appi.ajp.20241025",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "fonzo_2025_1",
      "fullText": "Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A., McDonald, W. M., Widge, A. S., Rodriguez, C. I., & Nemeroff, C. B. (2025). Psilocybin: From Psychiatric Pariah to Perceived Panacea. American Journal of Psychiatry, 182(1), 54–78. https://doi.org/10.1176/appi.ajp.20230682",
      "authors": "Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A., McDonald, W. M., Widge, A. S., Rodriguez, C. I., & Nemeroff, C. B.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230682",
      "url": "https://doi.org/10.1176/appi.ajp.20230682",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0201",
      "fullText": "Ford, H. H., Fraser, C. C., Solly, E. E., Fielding, J. J., White, O., Rudaks, L. I., Watson, E., Lubomski, M., Edema-Hildebrand, F., Ahmad, K., Liang, C., Davis, R., Sue, C., & Leonards, S. (n.d.). 079 HALLUCINOGENIC PERSISTING PERCEPTION DISORDER: A CASE SERIES AND REVIEW OF THE LITERATURE.",
      "authors": "Ford, H. H., Fraser, C. C., Solly, E. E., Fielding, J. J., White, O., Rudaks, L. I., Watson, E., Lubomski, M., Edema-Hildebrand, F., Ahmad, K., Liang, C., Davis, R., Sue, C., & Leonards, S. (n.d.). 079 HALLUCINOGENIC PERSISTING PERCEPTION DISORDER: A CASE SERIES AND REVIEW OF THE LITERATURE.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ford_2022",
      "fullText": "Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O., & Van Der Walt, A. (2022). Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature. Frontiers in Neurology, 13, 878609. https://doi.org/10.3389/fneur.2022.878609",
      "authors": "Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O., & Van Der Walt, A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fneur.2022.878609",
      "url": "https://doi.org/10.3389/fneur.2022.878609",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "forstmann_2021",
      "fullText": "Forstmann, M., & Sagioglou, C. (2021). New insights into the clinical and nonclinical effects of psychedelic substances: An integrative review. PsyArXiv. https://doi.org/10.31234/osf.io/2489x",
      "authors": "Forstmann, M., & Sagioglou, C.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/2489x",
      "url": "https://doi.org/10.31234/osf.io/2489x",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "fradkin_2024",
      "fullText": "Fradkin, D. (2024). Breaking through the doors of perception, consciousness, and existence: To what extent does psychedelic phenomenology ontologically depend on external factors? Journal of Psychedelic Studies, 8(1), 122–141. https://doi.org/10.1556/2054.2022.00168",
      "authors": "Fradkin, D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2022.00168",
      "url": "https://doi.org/10.1556/2054.2022.00168",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "freitas_2024",
      "fullText": "Freitas, R. R., Gotsis, E. S., Gallo, A. T., Fitzgibbon, B. M., Bailey, N. W., & Fitzgerald, P. B. (2024). The safety of psilocybin-assisted psychotherapy: A systematic review. The Australian and New Zealand Journal of Psychiatry, 48674241289024. https://doi.org/10.1177/00048674241289024",
      "authors": "Freitas, R. R., Gotsis, E. S., Gallo, A. T., Fitzgibbon, B. M., Bailey, N. W., & Fitzgerald, P. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/00048674241289024",
      "url": "https://doi.org/10.1177/00048674241289024",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "friedman_2015",
      "fullText": "Friedman, M. L., Malakooti, M., Smith, C., Harris, Z. L., & Wainwright, M. (2015). Ingestion of Synthetic Street Drug “25-I” (25I-NBOMe) Causing Type B Lactic Acidosis and Multi-Organ Dysfunction. Journal of Medical Cases, 6(3), 125–127. https://doi.org/10.14740/jmc2023w",
      "authors": "Friedman, M. L., Malakooti, M., Smith, C., Harris, Z. L., & Wainwright, M.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.14740/jmc2023w",
      "url": "https://doi.org/10.14740/jmc2023w",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "fuentes_2020",
      "fullText": "Fuentes, J. J., Fonseca, F., Elices, M., Farré, M., & Torrens, M. (2020). Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Frontiers in Psychiatry, 10. https://doi.org/10.3389/fpsyt.2019.00943",
      "authors": "Fuentes, J. J., Fonseca, F., Elices, M., Farré, M., & Torrens, M.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2019.00943",
      "url": "https://doi.org/10.3389/fpsyt.2019.00943",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "glerner_2015",
      "fullText": "G Lerner, A., & Lev-Ran, S. (2015). LSD-associated “Alice in Wonderland Syndrome”(AIWS): A Hallucinogen Persisting Perception Disorder (HPPD) Case Report. The Israel Journal of Psychiatry and Related Sciences, 52(1), 67–68.",
      "authors": "G Lerner, A., & Lev-Ran, S.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "glerner_2014",
      "fullText": "G Lerner, A., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: A Clinical-oriented Concise Review. The Israel Journal of Psychiatry and Related Sciences, 51(4), 296–301.",
      "authors": "G Lerner, A., Rudinski, D., Bor, O., & Goodman, C.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "gandy_2020",
      "fullText": "Gandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D., & Watts, R. (2020). The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychology Open, 7(2), 2055102920978123. https://doi.org/10.1177/2055102920978123",
      "authors": "Gandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D., & Watts, R.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1177/2055102920978123",
      "url": "https://doi.org/10.1177/2055102920978123",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "garciaromeu_2018",
      "fullText": "Garcia-Romeu, A., & Richards, W. A. (2018). Current perspectives on psychedelic therapy: Use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry, 30(4), 291–316. https://doi.org/10.1080/09540261.2018.1486289",
      "authors": "Garcia-Romeu, A., & Richards, W. A.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1080/09540261.2018.1486289",
      "url": "https://doi.org/10.1080/09540261.2018.1486289",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "garciaromeu_2020",
      "fullText": "Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020). Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Frontiers in Psychiatry, 10, 955. https://doi.org/10.3389/fpsyt.2019.00955",
      "authors": "Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2019.00955",
      "url": "https://doi.org/10.3389/fpsyt.2019.00955",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "garel_2023",
      "fullText": "Garel, N., Thibault Lévesque, J., Sandra, D. A., Lessard-Wajcer, J., Solomonova, E., Lifshitz, M., Richard-Devantoy, S., & Greenway, K. T. (2023). Imprinting: Expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings. Frontiers in Human Neuroscience, 17, 1200393. https://doi.org/10.3389/fnhum.2023.1200393",
      "authors": "Garel, N., Thibault Lévesque, J., Sandra, D. A., Lessard-Wajcer, J., Solomonova, E., Lifshitz, M., Richard-Devantoy, S., & Greenway, K. T.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fnhum.2023.1200393",
      "url": "https://doi.org/10.3389/fnhum.2023.1200393",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gashi_2021",
      "fullText": "Gashi, L., Sandberg, S., & Pedersen, W. (2021). Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy, 87, 102997. https://doi.org/10.1016/j.drugpo.2020.102997",
      "authors": "Gashi, L., Sandberg, S., & Pedersen, W.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugpo.2020.102997",
      "url": "https://doi.org/10.1016/j.drugpo.2020.102997",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gasser_2014",
      "fullText": "Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases. Journal of Nervous & Mental Disease, 202(7), 513–520. https://doi.org/10.1097/NMD.0000000000000113",
      "authors": "Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1097/NMD.0000000000000113",
      "url": "https://doi.org/10.1097/NMD.0000000000000113",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "gatch_2021",
      "fullText": "Gatch, M. B., Hoch, A., & Carbonaro, T. M. (2021). Discriminative Stimulus Effects of Substituted Tryptamines in Rats. ACS Pharmacology & Translational Science, 4(2), 467–471. https://doi.org/10.1021/acsptsci.0c00173",
      "authors": "Gatch, M. B., Hoch, A., & Carbonaro, T. M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1021/acsptsci.0c00173",
      "url": "https://doi.org/10.1021/acsptsci.0c00173",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "gcu_2024",
      "fullText": "GCU, Lahore, Pakistan, & Shabir, K. (2024). Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence. Premier Journal of Science. https://doi.org/10.70389/PJS.100036",
      "authors": "GCU, Lahore, Pakistan, & Shabir, K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.70389/PJS.100036",
      "url": "https://doi.org/10.70389/PJS.100036",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "geller_2024",
      "fullText": "Geller, J., & Whitney, E. (2024). Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma. Current Psychiatry Reports. https://doi.org/10.1007/s11920-024-01577-2",
      "authors": "Geller, J., & Whitney, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s11920-024-01577-2",
      "url": "https://doi.org/10.1007/s11920-024-01577-2",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "george_2022",
      "fullText": "George, D. R., Hanson, R., Wilkinson, D., & Garcia-Romeu, A. (2022). Ancient Roots of Today’s Emerging Renaissance in Psychedelic Medicine. Culture, Medicine, and Psychiatry, 46(4), 890–903. https://doi.org/10.1007/s11013-021-09749-y",
      "authors": "George, D. R., Hanson, R., Wilkinson, D., & Garcia-Romeu, A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s11013-021-09749-y",
      "url": "https://doi.org/10.1007/s11013-021-09749-y",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "geppert_2022",
      "fullText": "Geppert, C. (2022). Psychedelics and the Military: What a Long, Strange Trip It’s Been. Federal Practitioner, 39(10). https://doi.org/10.12788/fp.0332",
      "authors": "Geppert, C.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.12788/fp.0332",
      "url": "https://doi.org/10.12788/fp.0332",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gezon_2024",
      "fullText": "Gezon, L. L. (2024). Community-based psychedelic integration and social efficacy: An ethnographic study in the Southeastern United States. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00381",
      "authors": "Gezon, L. L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00381",
      "url": "https://doi.org/10.1556/2054.2024.00381",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ghaznavi_2025",
      "fullText": "Ghaznavi, S., Ruskin, J. N., Haggerty, S. J., King, F., & Rosenbaum, J. F. (2025). Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment. American Journal of Psychiatry, 182(1), 47–53. https://doi.org/10.1176/appi.ajp.20230914",
      "authors": "Ghaznavi, S., Ruskin, J. N., Haggerty, S. J., King, F., & Rosenbaum, J. F.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230914",
      "url": "https://doi.org/10.1176/appi.ajp.20230914",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "girn_2020",
      "fullText": "Girn, M., Roseman, L., Bernhardt, B., Smallwood, J., Carhart-Harris, R., & Spreng, R. N. (2020). Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroscience. https://doi.org/10.1101/2020.05.01.072314",
      "authors": "Girn, M., Roseman, L., Bernhardt, B., Smallwood, J., Carhart-Harris, R., & Spreng, R. N.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1101/2020.05.01.072314",
      "url": "https://doi.org/10.1101/2020.05.01.072314",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "glue_2016",
      "fullText": "Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., Hung, C. T., Harland, S., Devane, J., Crockett, R. S., Howes, J., Darpo, B., Zhou, M., Weis, H., & Friedhoff, L. (2016). Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients. Clinical Pharmacology in Drug Development, 5(6), 460–468. https://doi.org/10.1002/cpdd.254",
      "authors": "Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., Hung, C. T., Harland, S., Devane, J., Crockett, R. S., Howes, J., Darpo, B., Zhou, M., Weis, H., & Friedhoff, L.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1002/cpdd.254",
      "url": "https://doi.org/10.1002/cpdd.254",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "glue_2015",
      "fullText": "Glue, P., Lockhart, M., Lam, F., Hung, N., Hung, C.-T., & Friedhoff, L. (2015). Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability. Journal of Clinical Pharmacology, 55(2), 189–194. https://doi.org/10.1002/jcph.404",
      "authors": "Glue, P., Lockhart, M., Lam, F., Hung, N., Hung, C.-T., & Friedhoff, L.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1002/jcph.404",
      "url": "https://doi.org/10.1002/jcph.404",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "glue_2015_1",
      "fullText": "Glue, P., Winter, H., Garbe, K., Jakobi, H., Lyudin, A., Lenagh-Glue, Z., & Hung, C. T. (2015). Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers. Journal of Clinical Pharmacology, 55(6), 680–687. https://doi.org/10.1002/jcph.471",
      "authors": "Glue, P., Winter, H., Garbe, K., Jakobi, H., Lyudin, A., Lenagh-Glue, Z., & Hung, C. T.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1002/jcph.471",
      "url": "https://doi.org/10.1002/jcph.471",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "glynos_2024",
      "fullText": "Glynos, N. G., Aday, J. S., Kruger, D., Boehnke, K. F., Lake, S., & Lucas, P. (2024). Psychedelic substitution: Altered substance use patterns following psychedelic use in a global survey. Frontiers in Psychiatry, 15, 1349565. https://doi.org/10.3389/fpsyt.2024.1349565",
      "authors": "Glynos, N. G., Aday, J. S., Kruger, D., Boehnke, K. F., Lake, S., & Lucas, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2024.1349565",
      "url": "https://doi.org/10.3389/fpsyt.2024.1349565",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "glynos_2023",
      "fullText": "Glynos, N. G., Fields, C. W., Barron, J., Herberholz, M., Kruger, D. J., & Boehnke, K. F. (2023). Naturalistic Psychedelic Use: A World Apart from Clinical Care. Journal of Psychoactive Drugs, 55(4), 379–388. https://doi.org/10.1080/02791072.2022.2108356",
      "authors": "Glynos, N. G., Fields, C. W., Barron, J., Herberholz, M., Kruger, D. J., & Boehnke, K. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2108356",
      "url": "https://doi.org/10.1080/02791072.2022.2108356",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "goldberg_2020",
      "fullText": "Goldberg, S. B., Shechet, B., Nicholas, C. R., Ng, C. W., Deole, G., Chen, Z., & Raison, C. L. (2020). Post-acute psychological effects of classical serotonergic psychedelics: A systematic review and meta-analysis. Psychological Medicine, 50(16), 2655–2666. https://doi.org/10.1017/S003329172000389X",
      "authors": "Goldberg, S. B., Shechet, B., Nicholas, C. R., Ng, C. W., Deole, G., Chen, Z., & Raison, C. L.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1017/S003329172000389X",
      "url": "https://doi.org/10.1017/S003329172000389X",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "golden_2022a",
      "fullText": "Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S. (2022a). Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature. Current Topics in Behavioral Neurosciences, 56, 35–70. https://doi.org/10.1007/7854_2021_298",
      "authors": "Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S.",
      "year": "2022a",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2021_298",
      "url": "https://doi.org/10.1007/7854_2021_298",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "golden_2022b",
      "fullText": "Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S. (2022b). Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature. In F. S. Barrett & K. H. Preller (Eds.), Disruptive Psychopharmacology (Vol. 56, pp. 35–70). Springer International Publishing. https://doi.org/10.1007/7854_2021_298",
      "authors": "Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S.",
      "year": "2022b",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2021_298",
      "url": "https://doi.org/10.1007/7854_2021_298",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "goldy_2024",
      "fullText": "Goldy, S. P., Du, B. A., Rohde, J. S., Nayak, S. M., Strickland, J. C., Ehrenkranz, R., Levine, M., Barrett, F. S., & Yaden, D. B. (2024). Psychedelic risks and benefits: A cross-sectional survey study. Journal of Psychopharmacology, 02698811241292951. https://doi.org/10.1177/02698811241292951",
      "authors": "Goldy, S. P., Du, B. A., Rohde, J. S., Nayak, S. M., Strickland, J. C., Ehrenkranz, R., Levine, M., Barrett, F. S., & Yaden, D. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241292951",
      "url": "https://doi.org/10.1177/02698811241292951",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "gomezescolar_2024",
      "fullText": "Gomez-Escolar, A., Folch-Sanchez, D., Stefaniuk, J., Swithenbank, Z., Nisa, A., Braddick, F., Idrees Chaudhary, N., Van Der Meer, P. B., & Batalla, A. (2024). Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges. CNS Drugs, 38(10), 771–789. https://doi.org/10.1007/s40263-024-01101-3",
      "authors": "Gomez-Escolar, A., Folch-Sanchez, D., Stefaniuk, J., Swithenbank, Z., Nisa, A., Braddick, F., Idrees Chaudhary, N., Van Der Meer, P. B., & Batalla, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s40263-024-01101-3",
      "url": "https://doi.org/10.1007/s40263-024-01101-3",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "gorman_2021",
      "fullText": "Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021). Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Frontiers in Psychology, 12, 645246. https://doi.org/10.3389/fpsyg.2021.645246",
      "authors": "Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2021.645246",
      "url": "https://doi.org/10.3389/fpsyg.2021.645246",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "gotvaldov_2021",
      "fullText": "Gotvaldová, K., Hájková, K., Borovička, J., Jurok, R., Cihlářová, P., & Kuchař, M. (2021). Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. Drug Testing and Analysis, 13(2), 439–446. https://doi.org/10.1002/dta.2950",
      "authors": "Gotvaldová, K., Hájková, K., Borovička, J., Jurok, R., Cihlářová, P., & Kuchař, M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1002/dta.2950",
      "url": "https://doi.org/10.1002/dta.2950",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "griffin_2024",
      "fullText": "Griffin, C., & Knight, A. (2024). Treatment and therapy of mental health conditions in the Global South using psychedelics: A scoping review and narrative synthesis. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00333",
      "authors": "Griffin, C., & Knight, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00333",
      "url": "https://doi.org/10.1556/2054.2024.00333",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "griffiths_2019",
      "fullText": "Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. (2019). Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLOS ONE, 14(4), e0214377. https://doi.org/10.1371/journal.pone.0214377",
      "authors": "Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0214377",
      "url": "https://doi.org/10.1371/journal.pone.0214377",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "griffiths_2016",
      "fullText": "Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513",
      "authors": "Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881116675513",
      "url": "https://doi.org/10.1177/0269881116675513",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "griffiths_2006",
      "fullText": "Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5",
      "authors": "Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R.",
      "year": "2006",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-006-0457-5",
      "url": "https://doi.org/10.1007/s00213-006-0457-5",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "grob_2022",
      "fullText": "Grob, C. S., Bossis, A. P., & Griffiths, R. R. (2022). Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer. In J. L. Steel & B. I. Carr (Eds.), Psychological Aspects of Cancer (pp. 69–89). Springer International Publishing. https://doi.org/10.1007/978-3-030-85702-8_5",
      "authors": "Grob, C. S., Bossis, A. P., & Griffiths, R. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/978-3-030-85702-8_5",
      "url": "https://doi.org/10.1007/978-3-030-85702-8_5",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gross_2002",
      "fullText": "Gross, S. R., Barrett, S. P., Shestowsky, J. S., & Pihl, R. O. (2002). Ecstasy and Drug Consumption Patterns: A Canadian Rave Population Study. The Canadian Journal of Psychiatry, 47(6), 546–551. https://doi.org/10.1177/070674370204700606",
      "authors": "Gross, S. R., Barrett, S. P., Shestowsky, J. S., & Pihl, R. O.",
      "year": "2002",
      "title": "",
      "journal": "",
      "doi": "10.1177/070674370204700606",
      "url": "https://doi.org/10.1177/070674370204700606",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "grnder_2021",
      "fullText": "Gründer, G., & Jungaberle, H. (2021). The Potential Role of Psychedelic Drugs in Mental Health Care of the Future. Pharmacopsychiatry, 54(4), 191–199. https://doi.org/10.1055/a-1486-7386",
      "authors": "Gründer, G., & Jungaberle, H.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1055/a-1486-7386",
      "url": "https://doi.org/10.1055/a-1486-7386",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gukasyan_2022_1",
      "fullText": "Gukasyan, N., & Nayak, S. M. (2022). Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Transcultural Psychiatry, 59(5), 652–664. https://doi.org/10.1177/1363461520983684",
      "authors": "Gukasyan, N., & Nayak, S. M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/1363461520983684",
      "url": "https://doi.org/10.1177/1363461520983684",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "gukasyan_2022",
      "fullText": "Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022). Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology (Oxford, England), 36(2), 151–158. https://doi.org/10.1177/02698811211073759",
      "authors": "Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211073759",
      "url": "https://doi.org/10.1177/02698811211073759",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "gukasyan_2023",
      "fullText": "Gukasyan, N., Griffiths, R. R., Yaden, D. B., Antoine, D. G., & Nayak, S. M. (2023). Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. Journal of Psychopharmacology (Oxford, England), 37(7), 707–716. https://doi.org/10.1177/02698811231179910",
      "authors": "Gukasyan, N., Griffiths, R. R., Yaden, D. B., Antoine, D. G., & Nayak, S. M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231179910",
      "url": "https://doi.org/10.1177/02698811231179910",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "guo_2022",
      "fullText": "Guo, H., Wang, B., Yuan, S., Wu, S., Liu, J., He, M., & Wang, J. (2022). Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System. Frontiers in Pharmacology, 13, 849758. https://doi.org/10.3389/fphar.2022.849758",
      "authors": "Guo, H., Wang, B., Yuan, S., Wu, S., Liu, J., He, M., & Wang, J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2022.849758",
      "url": "https://doi.org/10.3389/fphar.2022.849758",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hackl_2022",
      "fullText": "Hackl, B., Todt, H., Kubista, H., Hilber, K., & Koenig, X. (2022). Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. The International Journal of Neuropsychopharmacology, 25(4), 280–282. https://doi.org/10.1093/ijnp/pyab085",
      "authors": "Hackl, B., Todt, H., Kubista, H., Hilber, K., & Koenig, X.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyab085",
      "url": "https://doi.org/10.1093/ijnp/pyab085",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "haden_2020",
      "fullText": "Haden, M., & Woods, B. (2020). LSD Overdoses: Three Case Reports. Journal of Studies on Alcohol and Drugs, 81(1), 115–118. https://doi.org/10.15288/jsad.2020.81.115",
      "authors": "Haden, M., & Woods, B.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.15288/jsad.2020.81.115",
      "url": "https://doi.org/10.15288/jsad.2020.81.115",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "haden_2016",
      "fullText": "Haden, M., Emerson, B., & Tupper, K. W. (2016). A Public-Health-Based Vision for the Management and Regulation of Psychedelics. Journal of Psychoactive Drugs, 48(4), 243–252. https://doi.org/10.1080/02791072.2016.1202459",
      "authors": "Haden, M., Emerson, B., & Tupper, K. W.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2016.1202459",
      "url": "https://doi.org/10.1080/02791072.2016.1202459",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "haft_2025",
      "fullText": "Haft, S. L., Downey, A. E., Raymond-Flesch, M., Fernandes-Osterhold, G., Bradley, E. R., O’Donovan, A., & Woolley, J. (2025). A systematic review of participant diversity in psychedelic-assisted psychotherapy trials. Psychiatry Research, 345, 116359. https://doi.org/10.1016/j.psychres.2025.116359",
      "authors": "Haft, S. L., Downey, A. E., Raymond-Flesch, M., Fernandes-Osterhold, G., Bradley, E. R., O’Donovan, A., & Woolley, J.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psychres.2025.116359",
      "url": "https://doi.org/10.1016/j.psychres.2025.116359",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "haijen_2018",
      "fullText": "Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., & Carhart-Harris, R. L. (2018). Predicting Responses to Psychedelics: A Prospective Study. Frontiers in Pharmacology, 9, 897. https://doi.org/10.3389/fphar.2018.00897",
      "authors": "Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., & Carhart-Harris, R. L.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2018.00897",
      "url": "https://doi.org/10.3389/fphar.2018.00897",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_1999",
      "fullText": "Halpern, J. H., & Pope, H. G. (1999). Do hallucinogens cause residual neuropsychological toxicity? Drug and Alcohol Dependence, 53(3), 247–256. https://doi.org/10.1016/s0376-8716(98)00129-x",
      "authors": "Halpern, J. H., & Pope, H. G.",
      "year": "1999",
      "title": "",
      "journal": "",
      "doi": "10.1016/s0376-8716(98)00129-x",
      "url": "https://doi.org/10.1016/s0376-8716(98)00129-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_2003a",
      "fullText": "Halpern, J. H., & Pope, H. G. (2003a). Hallucinogen persisting perception disorder: What do we know after 50 years? Drug and Alcohol Dependence, 69(2), 109–119. https://doi.org/10.1016/s0376-8716(02)00306-x",
      "authors": "Halpern, J. H., & Pope, H. G.",
      "year": "2003a",
      "title": "",
      "journal": "",
      "doi": "10.1016/s0376-8716(02)00306-x",
      "url": "https://doi.org/10.1016/s0376-8716(02)00306-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_2003b",
      "fullText": "Halpern, J. H., & Pope, H. G. (2003b). Hallucinogen persisting perception disorder: What do we know after 50 years? Drug and Alcohol Dependence, 69(2), 109–119. https://doi.org/10.1016/S0376-8716(02)00306-X",
      "authors": "Halpern, J. H., & Pope, H. G.",
      "year": "2003b",
      "title": "",
      "journal": "",
      "doi": "10.1016/S0376-8716(02)00306-X",
      "url": "https://doi.org/10.1016/S0376-8716(02)00306-X",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_2018",
      "fullText": "Halpern, J. H., Lerner, A. G., & Passie, T. (2018). A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Current Topics in Behavioral Neurosciences, 36, 333–360. https://doi.org/10.1007/7854_2016_457",
      "authors": "Halpern, J. H., Lerner, A. G., & Passie, T.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2016_457",
      "url": "https://doi.org/10.1007/7854_2016_457",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_2011",
      "fullText": "Halpern, J. H., Sherwood, A. R., Hudson, J. I., Gruber, S., Kozin, D., & Pope, H. G. (2011). Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction (Abingdon, England), 106(4), 777–786. https://doi.org/10.1111/j.1360-0443.2010.03252.x",
      "authors": "Halpern, J. H., Sherwood, A. R., Hudson, J. I., Gruber, S., Kozin, D., & Pope, H. G.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1111/j.1360-0443.2010.03252.x",
      "url": "https://doi.org/10.1111/j.1360-0443.2010.03252.x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "halpern_2008",
      "fullText": "Halpern, J. H., Sherwood, A. R., Passie, T., Blackwell, K. C., & Ruttenber, A. J. (2008). Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 14(8), SR15-22.",
      "authors": "Halpern, J. H., Sherwood, A. R., Passie, T., Blackwell, K. C., & Ruttenber, A. J.",
      "year": "2008",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2016",
      "fullText": "Hartogsohn, I. (2016). Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology (Oxford, England), 30(12), 1259–1267. https://doi.org/10.1177/0269881116677852",
      "authors": "Hartogsohn, I.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881116677852",
      "url": "https://doi.org/10.1177/0269881116677852",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2017",
      "fullText": "Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3, 2050324516683325. https://doi.org/10.1177/2050324516683325",
      "authors": "Hartogsohn, I.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1177/2050324516683325",
      "url": "https://doi.org/10.1177/2050324516683325",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2021",
      "fullText": "Hartogsohn, I. (2021). Set and Setting in the Santo Daime. Frontiers in Pharmacology, 12, 651037. https://doi.org/10.3389/fphar.2021.651037",
      "authors": "Hartogsohn, I.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2021.651037",
      "url": "https://doi.org/10.3389/fphar.2021.651037",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2022",
      "fullText": "Hartogsohn, I. (2022). Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture. Transcultural Psychiatry, 59(5), 579–591. https://doi.org/10.1177/13634615221100385",
      "authors": "Hartogsohn, I.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/13634615221100385",
      "url": "https://doi.org/10.1177/13634615221100385",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2024",
      "fullText": "Hartogsohn, I. (2024). Set and Setting for Psychedelic Harm Reduction. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2024_509",
      "authors": "Hartogsohn, I.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2024_509",
      "url": "https://doi.org/10.1007/7854_2024_509",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "hartogsohn_2022_1",
      "fullText": "Hartogsohn, I., & Petranker, R. (2022). Set and setting in microdosing: An oft-overlooked principle. Psychopharmacology, 239(12), 3771–3777. https://doi.org/10.1007/s00213-022-06249-8",
      "authors": "Hartogsohn, I., & Petranker, R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06249-8",
      "url": "https://doi.org/10.1007/s00213-022-06249-8",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hase_2022",
      "fullText": "Hase, A., Erdmann, M., Limbach, V., & Hasler, G. (2022). Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology, 239(2), 643–659. https://doi.org/10.1007/s00213-022-06062-3",
      "authors": "Hase, A., Erdmann, M., Limbach, V., & Hasler, G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06062-3",
      "url": "https://doi.org/10.1007/s00213-022-06062-3",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "haslacher_2022",
      "fullText": "Haslacher, D., Novkovic, N., Buthut, M., Heinz, A., & Soekadar, S. R. (2022). Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report. Frontiers in Psychiatry, 13, 867314. https://doi.org/10.3389/fpsyt.2022.867314",
      "authors": "Haslacher, D., Novkovic, N., Buthut, M., Heinz, A., & Soekadar, S. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.867314",
      "url": "https://doi.org/10.3389/fpsyt.2022.867314",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hasler_2004",
      "fullText": "Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004). Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study. Psychopharmacology, 172(2), 145–156. https://doi.org/10.1007/s00213-003-1640-6",
      "authors": "Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X.",
      "year": "2004",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-003-1640-6",
      "url": "https://doi.org/10.1007/s00213-003-1640-6",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "healy_2021",
      "fullText": "Healy, C. J. (2021). The acute effects of classic psychedelics on memory in humans. Psychopharmacology, 238(3), 639–653. https://doi.org/10.1007/s00213-020-05756-w",
      "authors": "Healy, C. J.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-020-05756-w",
      "url": "https://doi.org/10.1007/s00213-020-05756-w",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hendin_2021",
      "fullText": "Hendin, H. M., & Penn, A. D. (2021). An episode of mania following self‐reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report. Bipolar Disorders, 23(7), 733–735. https://doi.org/10.1111/bdi.13095",
      "authors": "Hendin, H. M., & Penn, A. D.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1111/bdi.13095",
      "url": "https://doi.org/10.1111/bdi.13095",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hendricks_2022",
      "fullText": "Hendricks, P. S., Copes, H., Family, N., Williams, L. T., Luke, D., & Raz, S. (2022). Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology (Oxford, England), 36(3), 337–347. https://doi.org/10.1177/02698811211055855",
      "authors": "Hendricks, P. S., Copes, H., Family, N., Williams, L. T., Luke, D., & Raz, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211055855",
      "url": "https://doi.org/10.1177/02698811211055855",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hendricks_2018",
      "fullText": "Hendricks, P. S., Crawford, M. S., Cropsey, K. L., Copes, H., Sweat, N. W., Walsh, Z., & Pavela, G. (2018). The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology (Oxford, England), 32(1), 37–48. https://doi.org/10.1177/0269881117735685",
      "authors": "Hendricks, P. S., Crawford, M. S., Cropsey, K. L., Copes, H., Sweat, N. W., Walsh, Z., & Pavela, G.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881117735685",
      "url": "https://doi.org/10.1177/0269881117735685",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hendricks_2015",
      "fullText": "Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29(3), 280–288. https://doi.org/10.1177/0269881114565653",
      "authors": "Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881114565653",
      "url": "https://doi.org/10.1177/0269881114565653",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hendy_2018",
      "fullText": "Hendy, K. (2018). Placebo Problems: Boundary Work in the Psychedelic Science Renaissance. In B. C. Labate & C. Cavnar (Eds.), Plant Medicines, Healing and Psychedelic Science (pp. 151–166). Springer International Publishing. https://doi.org/10.1007/978-3-319-76720-8_9",
      "authors": "Hendy, K.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/978-3-319-76720-8_9",
      "url": "https://doi.org/10.1007/978-3-319-76720-8_9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "henningfield_2023",
      "fullText": "Henningfield, J. E., Ashworth, J., Heal, D. J., & Smith, S. L. (2023). Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of Psychopharmacology (Oxford, England), 37(1), 33–44. https://doi.org/10.1177/02698811221140004",
      "authors": "Henningfield, J. E., Ashworth, J., Heal, D. J., & Smith, S. L.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221140004",
      "url": "https://doi.org/10.1177/02698811221140004",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "henningfield_2021",
      "fullText": "Henningfield, J. E., Wang, D. W., & Huestis, M. A. (2021). Kratom Abuse Potential 2021: An Updated Eight Factor Analysis. Frontiers in Pharmacology, 12, 775073. https://doi.org/10.3389/fphar.2021.775073",
      "authors": "Henningfield, J. E., Wang, D. W., & Huestis, M. A.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2021.775073",
      "url": "https://doi.org/10.3389/fphar.2021.775073",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "henrquezhernndez_2023",
      "fullText": "Henríquez-Hernández, L. A., Rojas-Hernández, J., Quintana-Hernández, D. J., & Borkel, L. F. (2023). Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. Toxics, 11(2), 148. https://doi.org/10.3390/toxics11020148",
      "authors": "Henríquez-Hernández, L. A., Rojas-Hernández, J., Quintana-Hernández, D. J., & Borkel, L. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3390/toxics11020148",
      "url": "https://doi.org/10.3390/toxics11020148",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hermle_2008",
      "fullText": "Hermle, L., Kovar, K.-A., Hewer, W., & Ruchsow, M. (2008). [Hallucinogen-induced psychological disorders]. Fortschritte Der Neurologie-Psychiatrie, 76(6), 334–342. https://doi.org/10.1055/s-2008-1038191",
      "authors": "Hermle, L., Kovar, K.-A., Hewer, W., & Ruchsow, M.",
      "year": "2008",
      "title": "",
      "journal": "",
      "doi": "10.1055/s-2008-1038191",
      "url": "https://doi.org/10.1055/s-2008-1038191",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hermle_2015",
      "fullText": "Hermle, L., Ruchsow, M., & Täschner, K. (2015). Halluzinogen-induzierte Persistierende Wahrnehmungsstörung (HPPD) und Flashback-Phänomene – Differenzialdiagnose und Erklärungsmodelle. Fortschritte der Neurologie · Psychiatrie, 83(09), 506–515. https://doi.org/10.1055/s-0035-1553717",
      "authors": "Hermle, L., Ruchsow, M., & Täschner, K.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1055/s-0035-1553717",
      "url": "https://doi.org/10.1055/s-0035-1553717",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0277",
      "fullText": "Hermle, L., Simon, M., Ruchsow, M., & Geppert, M. (n.d.). Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology.",
      "authors": "Hermle, L., Simon, M., Ruchsow, M., & Geppert, M. (n.d.). Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "herrmann_2023",
      "fullText": "Herrmann, Z., Levin, A. W., Cole, S. P., Slabaugh, S., Barnett, B., Penn, A., Jain, R., Raison, C., Rajanna, B., & Jain, S. (2023). Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States. Psychedelic Medicine, 1(3), 139–149. https://doi.org/10.1089/psymed.2023.0030",
      "authors": "Herrmann, Z., Levin, A. W., Cole, S. P., Slabaugh, S., Barnett, B., Penn, A., Jain, R., Raison, C., Rajanna, B., & Jain, S.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0030",
      "url": "https://doi.org/10.1089/psymed.2023.0030",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hibicke_2024",
      "fullText": "Hibicke, M., Billac, G., & Nichols, C. D. (2024). Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic. Psychedelic Medicine, 2(1), 10–14. https://doi.org/10.1089/psymed.2023.0037",
      "authors": "Hibicke, M., Billac, G., & Nichols, C. D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0037",
      "url": "https://doi.org/10.1089/psymed.2023.0037",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hinkle_2024",
      "fullText": "Hinkle, J. T., Graziosi, M., Nayak, S. M., & Yaden, D. B. (2024). Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. JAMA Psychiatry, 81(12), 1225–1235. https://doi.org/10.1001/jamapsychiatry.2024.2546",
      "authors": "Hinkle, J. T., Graziosi, M., Nayak, S. M., & Yaden, D. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2024.2546",
      "url": "https://doi.org/10.1001/jamapsychiatry.2024.2546",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "hiplito_2023",
      "fullText": "Hipólito, I., Mago, J., Rosas, F. E., & Carhart-Harris, R. (2023). Pattern breaking: A complex systems approach to psychedelic medicine. Neuroscience of Consciousness, 2023(1), niad017. https://doi.org/10.1093/nc/niad017",
      "authors": "Hipólito, I., Mago, J., Rosas, F. E., & Carhart-Harris, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1093/nc/niad017",
      "url": "https://doi.org/10.1093/nc/niad017",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hirschfeld_2021",
      "fullText": "Hirschfeld, T., Smit-Rigter, L., Van Der Gouwe, D., Reiche, S., Stöver, H., & Majić, T. (2021). Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis. Current Addiction Reports, 8(3), 389–398. https://doi.org/10.1007/s40429-021-00385-5",
      "authors": "Hirschfeld, T., Smit-Rigter, L., Van Der Gouwe, D., Reiche, S., Stöver, H., & Majić, T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1007/s40429-021-00385-5",
      "url": "https://doi.org/10.1007/s40429-021-00385-5",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hochstetler_2023",
      "fullText": "Hochstetler, A., & Peters, D. J. (2023). Geography of poly-substance drug mortality. Journal of Criminal Justice, 86, 102044. https://doi.org/10.1016/j.jcrimjus.2023.102044",
      "authors": "Hochstetler, A., & Peters, D. J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jcrimjus.2023.102044",
      "url": "https://doi.org/10.1016/j.jcrimjus.2023.102044",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hoener_2024",
      "fullText": "Hoener, S., Wolfgang, A., Nissan, D., & Howe, E. (2024). Ethical considerations for psychedelic-assisted therapy in military clinical settings. Journal of Medical Ethics, 50(4), 258–262. https://doi.org/10.1136/jme-2023-108943",
      "authors": "Hoener, S., Wolfgang, A., Nissan, D., & Howe, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1136/jme-2023-108943",
      "url": "https://doi.org/10.1136/jme-2023-108943",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "holoyda_2023",
      "fullText": "Holoyda, B. J. (2023). Malpractice and Other Civil Liability in Psychedelic Psychiatry. Psychiatric Services (Washington, D.C.), 74(1), 92–95. https://doi.org/10.1176/appi.ps.20220528",
      "authors": "Holoyda, B. J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ps.20220528",
      "url": "https://doi.org/10.1176/appi.ps.20220528",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "holze_2023",
      "fullText": "Holze, F., Becker, A. M., Kolaczynska, K. E., Duthaler, U., & Liechti, M. E. (2023). Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. Clinical Pharmacology and Therapeutics, 113(4), 822–831. https://doi.org/10.1002/cpt.2821",
      "authors": "Holze, F., Becker, A. M., Kolaczynska, K. E., Duthaler, U., & Liechti, M. E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1002/cpt.2821",
      "url": "https://doi.org/10.1002/cpt.2821",
      "categories": [
        "harm_reduction",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "holze_2022",
      "fullText": "Holze, F., Caluori, T. V., Vizeli, P., & Liechti, M. E. (2022). Safety pharmacology of acute LSD administration in healthy subjects. Psychopharmacology, 239(6), 1893–1905. https://doi.org/10.1007/s00213-021-05978-6",
      "authors": "Holze, F., Caluori, T. V., Vizeli, P., & Liechti, M. E.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-05978-6",
      "url": "https://doi.org/10.1007/s00213-021-05978-6",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "holze_2021",
      "fullText": "Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2021). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 46(3), 537–544. https://doi.org/10.1038/s41386-020-00883-6",
      "authors": "Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41386-020-00883-6",
      "url": "https://doi.org/10.1038/s41386-020-00883-6",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "honk_2024",
      "fullText": "Honk, L., Stenfors, C. U. D., Goldberg, S. B., Hendricks, P. S., Osika, W., Dourron, H. M., Lebedev, A., Petrovic, P., & Simonsson, O. (2024). Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom. Journal of Affective Disorders, 351, 194–201. https://doi.org/10.1016/j.jad.2024.01.197",
      "authors": "Honk, L., Stenfors, C. U. D., Goldberg, S. B., Hendricks, P. S., Osika, W., Dourron, H. M., Lebedev, A., Petrovic, P., & Simonsson, O.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2024.01.197",
      "url": "https://doi.org/10.1016/j.jad.2024.01.197",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "honyiglo_2019",
      "fullText": "Honyiglo, E., Franchi, A., Cartiser, N., Bottinelli, C., Advenier, A.-S., Bévalot, F., & Fanton, L. (2019). Unpredictable Behavior Under the Influence of “Magic Mushrooms”: A Case Report and Review of the Literature. Journal of Forensic Sciences, 64(4), 1266–1270. https://doi.org/10.1111/1556-4029.13982",
      "authors": "Honyiglo, E., Franchi, A., Cartiser, N., Bottinelli, C., Advenier, A.-S., Bévalot, F., & Fanton, L.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1111/1556-4029.13982",
      "url": "https://doi.org/10.1111/1556-4029.13982",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hooyer_2023",
      "fullText": "Hooyer, K., Applbaum, K., & Kasza, D. (2023). Altered States of Combat: Veteran Trauma and the Quest for Novel Therapeutics in Psychedelic Substances. Journal of Humanistic Psychology, 63(6), 744–763. https://doi.org/10.1177/0022167820904523",
      "authors": "Hooyer, K., Applbaum, K., & Kasza, D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/0022167820904523",
      "url": "https://doi.org/10.1177/0022167820904523",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "horita_1954",
      "fullText": "Horita, A., & Dille, J. M. (1954). Pyretogenic effect of lysergic acid diethylamide. Science (New York, N.Y.), 120(3131), 1100–1101. https://doi.org/10.1126/science.120.3131.1100",
      "authors": "Horita, A., & Dille, J. M.",
      "year": "1954",
      "title": "",
      "journal": "",
      "doi": "10.1126/science.120.3131.1100",
      "url": "https://doi.org/10.1126/science.120.3131.1100",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hovmand_2023",
      "fullText": "Hovmand, O. R., Poulsen, E. D., Arnfred, S., & Storebø, O. J. (2023). Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. Journal of Psychopharmacology, 37(7), 649–659. https://doi.org/10.1177/02698811231180276",
      "authors": "Hovmand, O. R., Poulsen, E. D., Arnfred, S., & Storebø, O. J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231180276",
      "url": "https://doi.org/10.1177/02698811231180276",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "howshouldclinicianssharedecisionmakingwithpatientsinterestedinusingpsychedelicstofeelpsychologicallysafe_2024",
      "fullText": "How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe? (2024). AMA Journal of Ethics, 26(11), E842-849. https://doi.org/10.1001/amajethics.2024.842",
      "authors": "How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe?",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/amajethics.2024.842",
      "url": "https://doi.org/10.1001/amajethics.2024.842",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hu_2024",
      "fullText": "Hu, X., Gorman, I., & Nielson, E. (2024). Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2024_529",
      "authors": "Hu, X., Gorman, I., & Nielson, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2024_529",
      "url": "https://doi.org/10.1007/7854_2024_529",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "husain_2022",
      "fullText": "Husain, M. I., Umer, M., & Mulsant, B. H. (2022). Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits? Expert Opinion on Drug Safety, 21(6), 721–724. https://doi.org/10.1080/14740338.2022.2063274",
      "authors": "Husain, M. I., Umer, M., & Mulsant, B. H.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1080/14740338.2022.2063274",
      "url": "https://doi.org/10.1080/14740338.2022.2063274",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "hutten_2019",
      "fullText": "Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C. (2019). Motives and Side-Effects of Microdosing With Psychedelics Among Users. International Journal of Neuropsychopharmacology, 22(7), 426–434. https://doi.org/10.1093/ijnp/pyz029",
      "authors": "Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., & Kuypers, K. P. C.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyz029",
      "url": "https://doi.org/10.1093/ijnp/pyz029",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "hyde_1978",
      "fullText": "Hyde, C., Glancy, G., Omerod, P., Hall, D., & Taylor, G. S. (1978). Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications. British Journal of Psychiatry, 132(6), 602–604. https://doi.org/10.1192/bjp.132.6.602",
      "authors": "Hyde, C., Glancy, G., Omerod, P., Hall, D., & Taylor, G. S.",
      "year": "1978",
      "title": "",
      "journal": "",
      "doi": "10.1192/bjp.132.6.602",
      "url": "https://doi.org/10.1192/bjp.132.6.602",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "hysek_2010",
      "fullText": "Hysek, C. M., Vollenweider, F. X., & Liechti, M. E. (2010). Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy). Emergency Medicine Journal: EMJ, 27(8), 586–589. https://doi.org/10.1136/emj.2009.079905",
      "authors": "Hysek, C. M., Vollenweider, F. X., & Liechti, M. E.",
      "year": "2010",
      "title": "",
      "journal": "",
      "doi": "10.1136/emj.2009.079905",
      "url": "https://doi.org/10.1136/emj.2009.079905",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "iaria_2010",
      "fullText": "Iaria, G., Fox, C. J., Scheel, M., Stowe, R. M., & Barton, J. J. S. (2010). A case of persistent visual hallucinations of faces following LSD abuse: A functional Magnetic Resonance Imaging study. Neurocase, 16(2), 106–118. https://doi.org/10.1080/13554790903329141",
      "authors": "Iaria, G., Fox, C. J., Scheel, M., Stowe, R. M., & Barton, J. J. S.",
      "year": "2010",
      "title": "",
      "journal": "",
      "doi": "10.1080/13554790903329141",
      "url": "https://doi.org/10.1080/13554790903329141",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0301",
      "fullText": "Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature | BMC Psychiatry. (n.d.). Retrieved February 27, 2025, from https://link.springer.com/article/10.1186/s12888-018-1824-6?fbclid=IwAR1al6a0H9j2rjbeZOs_CN_7pSk6Xf78c9zw1ujjIQ8BNOsi2IZI2g7KhEM",
      "authors": "Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature | BMC Psychiatry. (n.d.). Retrieved February 27, 2025, from https://link.springer.com/article/10.1186/s12888-018-1824-6?fbclid=IwAR1al6a0H9j2rjbeZOs_CN_7pSk6Xf78c9zw1ujjIQ8BNOsi2IZI2g7KhEM",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://link.springer.com/article/10.1186/s12888-018-1824-6?fbclid=IwAR1al6a0H9j2rjbeZOs_CN_7pSk6Xf78c9zw1ujjIQ8BNOsi2IZI2g7KhEM",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0303",
      "fullText": "Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns—Mitch Earleywine, Fiona Low, Carmen Lau, Joseph De Leo, 2022. (n.d.). Retrieved January 4, 2025, from https://journals.sagepub.com/doi/abs/10.1177/00221678221085800",
      "authors": "Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns—Mitch Earleywine, Fiona Low, Carmen Lau, Joseph De Leo, 2022. (n.d.). Retrieved January 4, 2025, from https://journals.sagepub.com/doi/abs/10.1177/00221678221085800",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.sagepub.com/doi/abs/10.1177/00221678221085800",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0302",
      "fullText": "Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns. (n.d.). Blossom. Retrieved January 4, 2025, from https://blossomanalysis.com/papers/integration-in-psychedelic-assisted-treatments-recurring-themes-in-current-providers-definitions-challenges-and-concerns/",
      "authors": "Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns. (n.d.). Blossom. Retrieved January 4, 2025, from https://blossomanalysis.com/papers/integration-in-psychedelic-assisted-treatments-recurring-themes-in-current-providers-definitions-challenges-and-concerns/",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://blossomanalysis.com/papers/integration-in-psychedelic-assisted-treatments-recurring-themes-in-current-providers-definitions-challenges-and-concerns/",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "irvine_2022",
      "fullText": "Irvine, A., & Luke, D. (2022). Apophenia, absorption and anxiety: Evidence for individual differences in positive and negative experiences of Hallucinogen Persisting Perceptual Disorder. Journal of Psychedelic Studies, 6(2), 88–103. https://doi.org/10.1556/2054.2022.00195",
      "authors": "Irvine, A., & Luke, D.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2022.00195",
      "url": "https://doi.org/10.1556/2054.2022.00195",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ivory_2022",
      "fullText": "Ivory, S. T., Rotella, J.-A., Schumann, J., & Greene, S. L. (2022). A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD). Clinical Toxicology, 60(8), 966–969. https://doi.org/10.1080/15563650.2022.2053150",
      "authors": "Ivory, S. T., Rotella, J.-A., Schumann, J., & Greene, S. L.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1080/15563650.2022.2053150",
      "url": "https://doi.org/10.1080/15563650.2022.2053150",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "izmi_2024a",
      "fullText": "Izmi, N., Carhart-Harris, R. L., & Kettner, H. (2024a). Psychological effects of psychedelics in adolescents. Frontiers in Child and Adolescent Psychiatry, 3. https://doi.org/10.3389/frcha.2024.1364617",
      "authors": "Izmi, N., Carhart-Harris, R. L., & Kettner, H.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.3389/frcha.2024.1364617",
      "url": "https://doi.org/10.3389/frcha.2024.1364617",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "izmi_2024b",
      "fullText": "Izmi, N., Carhart-Harris, R. L., & Kettner, H. (2024b). Psychological effects of psychedelics in adolescents. Frontiers in Child and Adolescent Psychiatry, 3. https://doi.org/10.3389/frcha.2024.1364617",
      "authors": "Izmi, N., Carhart-Harris, R. L., & Kettner, H.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.3389/frcha.2024.1364617",
      "url": "https://doi.org/10.3389/frcha.2024.1364617",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "jacobs_2023",
      "fullText": "Jacobs, E. (2023). Transformative experience and informed consent to psychedelic-assisted psychotherapy. Frontiers in Psychology, 14, 1108333. https://doi.org/10.3389/fpsyg.2023.1108333",
      "authors": "Jacobs, E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2023.1108333",
      "url": "https://doi.org/10.3389/fpsyg.2023.1108333",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "jagtiani_2024",
      "fullText": "Jagtiani, A. (2024). Novel treatments of depression: Bridging the gap in current therapeutic approaches. Exploration of Neuroscience, 3(4), 272–286. https://doi.org/10.37349/en.2024.00049",
      "authors": "Jagtiani, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.37349/en.2024.00049",
      "url": "https://doi.org/10.37349/en.2024.00049",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "jahn_2021",
      "fullText": "Jahn, Z. W., Lopez, J., Salle, S. de la, Faber, S., & Williams, M. T. (2021). Racial/ethnic differences in prevalence of hallucinogen use by age cohort: Findings from the 2018 National Survey on Drug Use and Health. https://doi.org/10.1556/2054.2021.00166",
      "authors": "Jahn, Z. W., Lopez, J., Salle, S. de la, Faber, S., & Williams, M. T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2021.00166",
      "url": "https://doi.org/10.1556/2054.2021.00166",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "james_2024",
      "fullText": "James, E., Erritzoe, D., Benway, T., Joel, Z., Timmermann, C., Good, M., Agnorelli, C., Weiss, B. M., Barba, T., Campbell, G., Baker Jones, M., Hughes, C., Topping, H., Boyce, M., & Routledge, C. (2024). Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: A randomized, placebo-controlled phase 1 trial. Frontiers in Psychiatry, 14, 1305796. https://doi.org/10.3389/fpsyt.2023.1305796",
      "authors": "James, E., Erritzoe, D., Benway, T., Joel, Z., Timmermann, C., Good, M., Agnorelli, C., Weiss, B. M., Barba, T., Campbell, G., Baker Jones, M., Hughes, C., Topping, H., Boyce, M., & Routledge, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1305796",
      "url": "https://doi.org/10.3389/fpsyt.2023.1305796",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "jegede_2024",
      "fullText": "Jegede, O., Nunes, J. C., Tumenta, T., Black, C., & Aquino, J. P. D. (2024). What Would Equitable Harm Reduction Look Like? AMA Journal of Ethics, 26(7), 572–579. https://doi.org/10.1001/amajethics.2024.572",
      "authors": "Jegede, O., Nunes, J. C., Tumenta, T., Black, C., & Aquino, J. P. D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/amajethics.2024.572",
      "url": "https://doi.org/10.1001/amajethics.2024.572",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "jiang_2023",
      "fullText": "Jiang, Y., Du, Z., Shen, Y., Zhou, Q., & Zhu, H. (2023). The correlation of Esketamine with specific adverse events: A deep dive into the FAERS database. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-023-01732-5",
      "authors": "Jiang, Y., Du, Z., Shen, Y., Zhou, Q., & Zhu, H.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00406-023-01732-5",
      "url": "https://doi.org/10.1007/s00406-023-01732-5",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "jivanescu_2022",
      "fullText": "Jivanescu, V. (2022). Long-term transformative effects and integration challenges of psychedelic experiences: A mixed methods phenomenological study of the Romanian population. Consciousness, Spirituality & Transpersonal Psychology, 3, 1–17. https://doi.org/10.53074/cstp.2022.29",
      "authors": "Jivanescu, V.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.53074/cstp.2022.29",
      "url": "https://doi.org/10.53074/cstp.2022.29",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "johansen_2015",
      "fullText": "Johansen, P.-Ø., & Krebs, T. S. (2015). Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology, 29(3), 270–279. https://doi.org/10.1177/0269881114568039",
      "authors": "Johansen, P.-Ø., & Krebs, T. S.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881114568039",
      "url": "https://doi.org/10.1177/0269881114568039",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johns_2022",
      "fullText": "Johns, B. (2022). Narrative therapy in psychedelic harm reduction: Supporting safety, agency and meaning-making. The International Journal of Narrative Therapy and Community Work, 2022(2), 61–71. https://doi.org/10.4320/MCBZ5745",
      "authors": "Johns, B.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.4320/MCBZ5745",
      "url": "https://doi.org/10.4320/MCBZ5745",
      "categories": [
        "safety",
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "johnson_2014",
      "fullText": "Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983–992. https://doi.org/10.1177/0269881114548296",
      "authors": "Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881114548296",
      "url": "https://doi.org/10.1177/0269881114548296",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johnson_2018",
      "fullText": "Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 142, 143–166. https://doi.org/10.1016/j.neuropharm.2018.05.012",
      "authors": "Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neuropharm.2018.05.012",
      "url": "https://doi.org/10.1016/j.neuropharm.2018.05.012",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johnson_2019",
      "fullText": "Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019). Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics, 197, 83–102. https://doi.org/10.1016/j.pharmthera.2018.11.010",
      "authors": "Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.pharmthera.2018.11.010",
      "url": "https://doi.org/10.1016/j.pharmthera.2018.11.010",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johnson_2008a",
      "fullText": "Johnson, M., Richards, W., & Griffiths, R. (2008a). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology (Oxford, England), 22(6), 603–620. https://doi.org/10.1177/0269881108093587",
      "authors": "Johnson, M., Richards, W., & Griffiths, R.",
      "year": "2008a",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881108093587",
      "url": "https://doi.org/10.1177/0269881108093587",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johnson_2008b",
      "fullText": "Johnson, M., Richards, W., & Griffiths, R. (2008b). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620. https://doi.org/10.1177/0269881108093587",
      "authors": "Johnson, M., Richards, W., & Griffiths, R.",
      "year": "2008b",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881108093587",
      "url": "https://doi.org/10.1177/0269881108093587",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "johnstad_2018",
      "fullText": "Johnstad, P. G. (2018). Powerful substances in tiny amounts: An interview study of psychedelic microdosing. Nordic Studies on Alcohol and Drugs, 35(1), 39–51. https://doi.org/10.1177/1455072517753339",
      "authors": "Johnstad, P. G.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/1455072517753339",
      "url": "https://doi.org/10.1177/1455072517753339",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "johnstad_2020",
      "fullText": "Johnstad, P. G. (2020). A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76. History of Psychiatry, 31(2), 217–226. https://doi.org/10.1177/0957154X19894537",
      "authors": "Johnstad, P. G.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1177/0957154X19894537",
      "url": "https://doi.org/10.1177/0957154X19894537",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "johnstad_2021a",
      "fullText": "Johnstad, P. G. (2021a). Day trip to hell: A mixed methods study of challenging psychedelic experiences. Journal of Psychedelic Studies, 5(2), 114–127. https://doi.org/10.1556/2054.2021.00155",
      "authors": "Johnstad, P. G.",
      "year": "2021a",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2021.00155",
      "url": "https://doi.org/10.1556/2054.2021.00155",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "johnstad_2021b",
      "fullText": "Johnstad, P. G. (2021b). Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences. Nordic Studies on Alcohol and Drugs, 38(1), 35–49. https://doi.org/10.1177/1455072520963787",
      "authors": "Johnstad, P. G.",
      "year": "2021b",
      "title": "",
      "journal": "",
      "doi": "10.1177/1455072520963787",
      "url": "https://doi.org/10.1177/1455072520963787",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "johnston_2023",
      "fullText": "Johnston, C. B., Mangini, M., Grob, C., & Anderson, B. (2023). The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 31(1), 44–53. https://doi.org/10.1016/j.jagp.2022.08.007",
      "authors": "Johnston, C. B., Mangini, M., Grob, C., & Anderson, B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jagp.2022.08.007",
      "url": "https://doi.org/10.1016/j.jagp.2022.08.007",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2023",
      "fullText": "Jones, G. M. (2023). Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. Journal of Psychopharmacology, 37(1), 61–69. https://doi.org/10.1177/02698811221127304",
      "authors": "Jones, G. M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221127304",
      "url": "https://doi.org/10.1177/02698811221127304",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2022a",
      "fullText": "Jones, G. M., & Nock, M. K. (2022a). Exploring protective associations between the use of classic psychedelics and cocaine use disorder: A population-based survey study. Scientific Reports, 12(1), 2574. https://doi.org/10.1038/s41598-022-06580-2",
      "authors": "Jones, G. M., & Nock, M. K.",
      "year": "2022a",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-022-06580-2",
      "url": "https://doi.org/10.1038/s41598-022-06580-2",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2022b",
      "fullText": "Jones, G. M., & Nock, M. K. (2022b). MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of Psychopharmacology (Oxford, England), 36(1), 46–56. https://doi.org/10.1177/02698811211058923",
      "authors": "Jones, G. M., & Nock, M. K.",
      "year": "2022b",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211058923",
      "url": "https://doi.org/10.1177/02698811211058923",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2022c",
      "fullText": "Jones, G. M., & Nock, M. K. (2022c). Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. Journal of Psychopharmacology (Oxford, England), 36(1), 66–73. https://doi.org/10.1177/02698811211058933",
      "authors": "Jones, G. M., & Nock, M. K.",
      "year": "2022c",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211058933",
      "url": "https://doi.org/10.1177/02698811211058933",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2022d",
      "fullText": "Jones, G. M., & Nock, M. K. (2022d). Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality. Scientific Reports, 12(1), 16976. https://doi.org/10.1038/s41598-022-18645-3",
      "authors": "Jones, G. M., & Nock, M. K.",
      "year": "2022d",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-022-18645-3",
      "url": "https://doi.org/10.1038/s41598-022-18645-3",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "jones_2024",
      "fullText": "Jones, J. C., & Mohammed, A. (2024). How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe? AMA Journal of Ethics, 26(11), 842–849. https://doi.org/10.1001/amajethics.2024.842",
      "authors": "Jones, J. C., & Mohammed, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/amajethics.2024.842",
      "url": "https://doi.org/10.1001/amajethics.2024.842",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "juillet_1980",
      "fullText": "Juillet, Y., Seurot, M., Gaux, J. C., Fiessinger, J. N., & Housset, E. (1980). [Severe ischemia of the lower limbs after ingestion of LSD]. Archives Des Maladies Du Coeur Et Des Vaisseaux, 73(11), 1359–1363.",
      "authors": "Juillet, Y., Seurot, M., Gaux, J. C., Fiessinger, J. N., & Housset, E.",
      "year": "1980",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kaelen_2018",
      "fullText": "Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., Roseman, L., Feilding, A., Nutt, D., & Carhart-Harris, R. (2018). The hidden therapist: Evidence for a central role of music in psychedelic therapy. Psychopharmacology, 235(2), 505–519. https://doi.org/10.1007/s00213-017-4820-5",
      "authors": "Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., Roseman, L., Feilding, A., Nutt, D., & Carhart-Harris, R.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-017-4820-5",
      "url": "https://doi.org/10.1007/s00213-017-4820-5",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "khnen_2023",
      "fullText": "Kähönen, J. (2023). Psychedelic unselfing: Self-transcendence and change of values in psychedelic experiences. Frontiers in Psychology, 14, 1104627. https://doi.org/10.3389/fpsyg.2023.1104627",
      "authors": "Kähönen, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2023.1104627",
      "url": "https://doi.org/10.3389/fpsyg.2023.1104627",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kargbo_2024",
      "fullText": "Kargbo, R. B. (2024). Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment. ACS Medicinal Chemistry Letters, 15(11), 1812–1814. https://doi.org/10.1021/acsmedchemlett.4c00490",
      "authors": "Kargbo, R. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1021/acsmedchemlett.4c00490",
      "url": "https://doi.org/10.1021/acsmedchemlett.4c00490",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kelly_2023",
      "fullText": "Kelly, D. F., Heinzerling, K., Sharma, A., Gowrinathan, S., Sergi, K., & Mallari, R. J. (2023). Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Neurosurgery, 92(4), 680–694. https://doi.org/10.1227/neu.0000000000002275",
      "authors": "Kelly, D. F., Heinzerling, K., Sharma, A., Gowrinathan, S., Sergi, K., & Mallari, R. J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1227/neu.0000000000002275",
      "url": "https://doi.org/10.1227/neu.0000000000002275",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0338",
      "fullText": "Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (n.d.-a).",
      "authors": "Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (n.d.-a).",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0339",
      "fullText": "Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (n.d.-b).",
      "authors": "Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (n.d.-b).",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "keyes_2023a",
      "fullText": "Keyes, K. M., & Patrick, M. E. (2023a). Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021. Addiction, 118(12), 2449–2454. https://doi.org/10.1111/add.16259",
      "authors": "Keyes, K. M., & Patrick, M. E.",
      "year": "2023a",
      "title": "",
      "journal": "",
      "doi": "10.1111/add.16259",
      "url": "https://doi.org/10.1111/add.16259",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "keyes_2023b",
      "fullText": "Keyes, K. M., & Patrick, M. E. (2023b). Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021. Addiction, 118(12), 2449–2454. https://doi.org/10.1111/add.16259",
      "authors": "Keyes, K. M., & Patrick, M. E.",
      "year": "2023b",
      "title": "",
      "journal": "",
      "doi": "10.1111/add.16259",
      "url": "https://doi.org/10.1111/add.16259",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kilpatrick_2012",
      "fullText": "Kilpatrick, Z. P., & Bard Ermentrout, G. (2012). Hallucinogen persisting perception disorder in neuronal networks with adaptation. Journal of Computational Neuroscience, 32(1), 25–53. https://doi.org/10.1007/s10827-011-0335-y",
      "authors": "Kilpatrick, Z. P., & Bard Ermentrout, G.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": "10.1007/s10827-011-0335-y",
      "url": "https://doi.org/10.1007/s10827-011-0335-y",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kious_2023",
      "fullText": "Kious, B., Schwartz, Z., & Lewis, B. (2023). Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers. Journal of Psychopharmacology (Oxford, England), 37(1), 45–48. https://doi.org/10.1177/02698811221133461",
      "authors": "Kious, B., Schwartz, Z., & Lewis, B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221133461",
      "url": "https://doi.org/10.1177/02698811221133461",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kirkham_2024",
      "fullText": "Kirkham, N., & Letheby, C. (2024). Psychedelics and environmental virtues. Philosophical Psychology, 37(2), 371–395. https://doi.org/10.1080/09515089.2022.2057290",
      "authors": "Kirkham, N., & Letheby, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/09515089.2022.2057290",
      "url": "https://doi.org/10.1080/09515089.2022.2057290",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kirli_2025",
      "fullText": "Kirlić, N., Lennard-Jones, M., Atli, M., Malievskaia, E., Modlin, N. L., Peck, S. K., Gaillard, A., Goodwin, G. M., & Koelpin, D. (2025). Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions. American Journal of Psychiatry, 182(1), 126–132. https://doi.org/10.1176/appi.ajp.20230884",
      "authors": "Kirlić, N., Lennard-Jones, M., Atli, M., Malievskaia, E., Modlin, N. L., Peck, S. K., Gaillard, A., Goodwin, G. M., & Koelpin, D.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230884",
      "url": "https://doi.org/10.1176/appi.ajp.20230884",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kishon_2024",
      "fullText": "Kishon, R., Modlin, N. L., Cycowicz, Y. M., Mourtada, H., Wilson, T., Williamson, V., Cleare, A., & Rucker, J. (2024). A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials. Npj Mental Health Research, 3(1), 33. https://doi.org/10.1038/s44184-024-00068-9",
      "authors": "Kishon, R., Modlin, N. L., Cycowicz, Y. M., Mourtada, H., Wilson, T., Williamson, V., Cleare, A., & Rucker, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s44184-024-00068-9",
      "url": "https://doi.org/10.1038/s44184-024-00068-9",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0347",
      "fullText": "Klaiber, A., Humbert-Droz, M., Ley, L., Schmid, Y., & Liechti, M. E. (n.d.). Safety pharmacology of acute mescaline administration in healthy participants. British Journal of Clinical Pharmacology, n/a(n/a). https://doi.org/10.1111/bcp.16349",
      "authors": "Klaiber, A., Humbert-Droz, M., Ley, L., Schmid, Y., & Liechti, M. E. (n.d.). Safety pharmacology of acute mescaline administration in healthy participants. British Journal of Clinical Pharmacology, n/a(n/a). https://doi.org/10.1111/bcp.16349",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1111/bcp.16349",
      "url": "https://doi.org/10.1111/bcp.16349",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "klock_1974",
      "fullText": "Klock, J. C., Boerner, U., & Becker, C. E. (1974). Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases. The Western Journal of Medicine, 120(3), 183–188.",
      "authors": "Klock, J. C., Boerner, U., & Becker, C. E.",
      "year": "1974",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kloft_2022",
      "fullText": "Kloft, L., Otgaar, H., Blokland, A., Toennes, S. W., & Ramaekers, J. G. (2022). Remembering Molly: Immediate and delayed false memory formation after acute MDMA exposure. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 57, 59–68. https://doi.org/10.1016/j.euroneuro.2022.01.005",
      "authors": "Kloft, L., Otgaar, H., Blokland, A., Toennes, S. W., & Ramaekers, J. G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.euroneuro.2022.01.005",
      "url": "https://doi.org/10.1016/j.euroneuro.2022.01.005",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "klute_2024",
      "fullText": "Klute, K. A., Lukas, L., Hwang, S., Gwon, Y., Krishnan, M., Grem, J., Hingorani, S., & Kellas, J. K. (2024). Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma. Cancer Research, 84(2_Supplement), C001. https://doi.org/10.1158/1538-7445.PANCA2023-C001",
      "authors": "Klute, K. A., Lukas, L., Hwang, S., Gwon, Y., Krishnan, M., Grem, J., Hingorani, S., & Kellas, J. K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1158/1538-7445.PANCA2023-C001",
      "url": "https://doi.org/10.1158/1538-7445.PANCA2023-C001",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "knuijver_2018",
      "fullText": "Knuijver, T., Belgers, M., Markus, W., Verkes, R.-J., Van Oosteren, T., & Schellekens, A. (2018). Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. Journal of Clinical Psychopharmacology, 38(6), 646–648. https://doi.org/10.1097/JCP.0000000000000966",
      "authors": "Knuijver, T., Belgers, M., Markus, W., Verkes, R.-J., Van Oosteren, T., & Schellekens, A.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1097/JCP.0000000000000966",
      "url": "https://doi.org/10.1097/JCP.0000000000000966",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "knuijver_2022",
      "fullText": "Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., Kramers, K., & Verkes, R. (2022). Safety of ibogaine administration in detoxification of opioid-dependent individuals: A descriptive open-label observational study. Addiction (Abingdon, England), 117(1), 118–128. https://doi.org/10.1111/add.15448",
      "authors": "Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., Kramers, K., & Verkes, R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1111/add.15448",
      "url": "https://doi.org/10.1111/add.15448",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "korov_2021",
      "fullText": "Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021). Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Frontiers in Psychiatry, 12, 661233. https://doi.org/10.3389/fpsyt.2021.661233",
      "authors": "Kočárová, R., Horáček, J., & Carhart-Harris, R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.661233",
      "url": "https://doi.org/10.3389/fpsyt.2021.661233",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "koenig_2015",
      "fullText": "Koenig, X., & Hilber, K. (2015). The anti-addiction drug ibogaine and the heart: A delicate relation. Molecules (Basel, Switzerland), 20(2), 2208–2228. https://doi.org/10.3390/molecules20022208",
      "authors": "Koenig, X., & Hilber, K.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.3390/molecules20022208",
      "url": "https://doi.org/10.3390/molecules20022208",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kohek_2023",
      "fullText": "Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023). Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands. Journal of Psychoactive Drugs, 55(3), 247–258. https://doi.org/10.1080/02791072.2022.2077155",
      "authors": "Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2077155",
      "url": "https://doi.org/10.1080/02791072.2022.2077155",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "koning_2021",
      "fullText": "Koning, R. P. J., Benschop, A., Wijffels, C., & Noijen, J. (2021). Visitors of the Dutch drug checking services: Profile and drug use experience. The International Journal on Drug Policy, 95, 103293. https://doi.org/10.1016/j.drugpo.2021.103293",
      "authors": "Koning, R. P. J., Benschop, A., Wijffels, C., & Noijen, J.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugpo.2021.103293",
      "url": "https://doi.org/10.1016/j.drugpo.2021.103293",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kopra_2022",
      "fullText": "Kopra, E. I., Ferris, J. A., Rucker, J. J., McClure, B., Young, A. H., Copeland, C. S., & Winstock, A. R. (2022). Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). Journal of Psychopharmacology, 36(8), 956–964. https://doi.org/10.1177/02698811221099650",
      "authors": "Kopra, E. I., Ferris, J. A., Rucker, J. J., McClure, B., Young, A. H., Copeland, C. S., & Winstock, A. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221099650",
      "url": "https://doi.org/10.1177/02698811221099650",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0358",
      "fullText": "Kopra, E. I., Ferris, J. A., Winstock, A. R., Young, A. H., & Rucker, J. J. (n.d.). Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.",
      "authors": "Kopra, E. I., Ferris, J. A., Winstock, A. R., Young, A. H., & Rucker, J. J. (n.d.). Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "kopra_2025",
      "fullText": "Kopra, E. I., Penttinen, J., Rucker, J. J., & Copeland, C. S. (2025). Psychedelic-related deaths in England, Wales and Northern Ireland (1997–2022). Progress in Neuro-Psychopharmacology and Biological Psychiatry, 136, 111177. https://doi.org/10.1016/j.pnpbp.2024.111177",
      "authors": "Kopra, E. I., Penttinen, J., Rucker, J. J., & Copeland, C. S.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.pnpbp.2024.111177",
      "url": "https://doi.org/10.1016/j.pnpbp.2024.111177",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "korman_2023",
      "fullText": "Korman, B. A. (2023). Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers. Journal of Psychedelic Studies, 7(2), 90–99. https://doi.org/10.1556/2054.2023.00246",
      "authors": "Korman, B. A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2023.00246",
      "url": "https://doi.org/10.1556/2054.2023.00246",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "korthuis_2024",
      "fullText": "Korthuis, P. T., Wilson‐Poe, A. R., Black, J. C., & Monte, A. (2024). Commentary on Darke et al .: Expanded psychedelic access requires new safety monitoring systems. Addiction, 119(9), 1572–1574. https://doi.org/10.1111/add.16589",
      "authors": "Korthuis, P. T., Wilson‐Poe, A. R., Black, J. C., & Monte, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1111/add.16589",
      "url": "https://doi.org/10.1111/add.16589",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "koslowski_2024",
      "fullText": "Koslowski, M., & Gasser, P. (2024). Guiding Through Challenging Psychedelic Experiences and “Bad Trips.” Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2024_515",
      "authors": "Koslowski, M., & Gasser, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2024_515",
      "url": "https://doi.org/10.1007/7854_2024_515",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "krebs_2013",
      "fullText": "Krebs, T. S., & Johansen, P.-Ø. (2013). Psychedelics and Mental Health: A Population Study. PLoS ONE, 8(8), e63972. https://doi.org/10.1371/journal.pone.0063972",
      "authors": "Krebs, T. S., & Johansen, P.-Ø.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0063972",
      "url": "https://doi.org/10.1371/journal.pone.0063972",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kruger_2024",
      "fullText": "Kruger, D. J., Aday, J. S., Fields, C. W., Kolbman, N., Glynos, N., Barron, J., Herberholz, M., & Boehnke, K. F. (2024). Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users. Psychedelic Medicine. https://doi.org/10.1089/psymed.2024.0011",
      "authors": "Kruger, D. J., Aday, J. S., Fields, C. W., Kolbman, N., Glynos, N., Barron, J., Herberholz, M., & Boehnke, K. F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2024.0011",
      "url": "https://doi.org/10.1089/psymed.2024.0011",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "kruger_2023",
      "fullText": "Kruger, D. J., Barron, J., Herberholz, M., & Boehnke, K. F. (2023). Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics. Journal of Psychoactive Drugs, 55(5), 650–659. https://doi.org/10.1080/02791072.2023.2228784",
      "authors": "Kruger, D. J., Barron, J., Herberholz, M., & Boehnke, K. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2023.2228784",
      "url": "https://doi.org/10.1080/02791072.2023.2228784",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kruger_2023_1",
      "fullText": "Kruger, D. J., Enghoff, O., Herberholz, M., Barron, J., & Boehnke, K. F. (2023). “How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics. Journal of Psychoactive Drugs, 55(5), 631–639. https://doi.org/10.1080/02791072.2023.2201263",
      "authors": "Kruger, D. J., Enghoff, O., Herberholz, M., Barron, J., & Boehnke, K. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2023.2201263",
      "url": "https://doi.org/10.1080/02791072.2023.2201263",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kruger_2023_2",
      "fullText": "Kruger, D. J., Glynos, N. G., Fields, C. W., Herberholz, M., & Boehnke, K. F. (2023). An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically. Journal of Psychoactive Drugs, 55(4), 420–424. https://doi.org/10.1080/02791072.2022.2142709",
      "authors": "Kruger, D. J., Glynos, N. G., Fields, C. W., Herberholz, M., & Boehnke, K. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2142709",
      "url": "https://doi.org/10.1080/02791072.2022.2142709",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kuc_2022a",
      "fullText": "Kuc, J., Kettner, H., Rosas, F., Erritzoe, D., Haijen, E., Kaelen, M., Nutt, D., & Carhart-Harris, R. L. (2022a). Psychedelic experience dose-dependently modulated by cannabis: Results of a prospective online survey. Psychopharmacology, 239(5), 1425–1440. https://doi.org/10.1007/s00213-021-05999-1",
      "authors": "Kuc, J., Kettner, H., Rosas, F., Erritzoe, D., Haijen, E., Kaelen, M., Nutt, D., & Carhart-Harris, R. L.",
      "year": "2022a",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-05999-1",
      "url": "https://doi.org/10.1007/s00213-021-05999-1",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kuc_2022b",
      "fullText": "Kuc, J., Kettner, H., Rosas, F., Erritzoe, D., Haijen, E., Kaelen, M., Nutt, D., & Carhart-Harris, R. L. (2022b). Psychedelic experience dose-dependently modulated by cannabis: Results of a prospective online survey. Psychopharmacology, 239(5), 1425–1440. https://doi.org/10.1007/s00213-021-05999-1",
      "authors": "Kuc, J., Kettner, H., Rosas, F., Erritzoe, D., Haijen, E., Kaelen, M., Nutt, D., & Carhart-Harris, R. L.",
      "year": "2022b",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-05999-1",
      "url": "https://doi.org/10.1007/s00213-021-05999-1",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kucsera_2023",
      "fullText": "Kucsera, A., Suppes, T., & Haug, N. A. (2023). Psychologists’ and psychotherapists’ knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics. Clinical Psychology & Psychotherapy, 30(6), 1369–1379. https://doi.org/10.1002/cpp.2880",
      "authors": "Kucsera, A., Suppes, T., & Haug, N. A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1002/cpp.2880",
      "url": "https://doi.org/10.1002/cpp.2880",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "kuiper_2024",
      "fullText": "Kuiper, H., Alley, C., Harris, Z., Kuiper Rauch, C., Robbins, M., Rodriguez, P., Tomczak, P., Urrutia, J., & Magar, V. (2024). Psychedelic public health: State of the field and implications for equity. Social Science & Medicine (1982), 357, 117134. https://doi.org/10.1016/j.socscimed.2024.117134",
      "authors": "Kuiper, H., Alley, C., Harris, Z., Kuiper Rauch, C., Robbins, M., Rodriguez, P., Tomczak, P., Urrutia, J., & Magar, V.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.socscimed.2024.117134",
      "url": "https://doi.org/10.1016/j.socscimed.2024.117134",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kurtom_2019",
      "fullText": "Kurtom, M., Henning, A., & Espiridion, E. D. (2019). Hallucinogen-persisting Perception Disorder in a 21-year-old Man. Cureus. https://doi.org/10.7759/cureus.4077",
      "authors": "Kurtom, M., Henning, A., & Espiridion, E. D.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.7759/cureus.4077",
      "url": "https://doi.org/10.7759/cureus.4077",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kusumadewi_2021",
      "fullText": "Kusumadewi, A. F. (2021). Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication. Archives of The Medicine and Case Reports, 1(2), 31–34. https://doi.org/10.37275/amcr.v1i2.7",
      "authors": "Kusumadewi, A. F.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.37275/amcr.v1i2.7",
      "url": "https://doi.org/10.37275/amcr.v1i2.7",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "kuypers_2020",
      "fullText": "Kuypers, K. P. C. (2020). The therapeutic potential of microdosing psychedelics in depression. Therapeutic Advances in Psychopharmacology, 10, 2045125320950567. https://doi.org/10.1177/2045125320950567",
      "authors": "Kuypers, K. P. C.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1177/2045125320950567",
      "url": "https://doi.org/10.1177/2045125320950567",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kuypers_2005",
      "fullText": "Kuypers, K. P. C., & Ramaekers, J. G. (2005). Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine. Journal of Psychopharmacology (Oxford, England), 19(6), 633–639. https://doi.org/10.1177/0269881105056670",
      "authors": "Kuypers, K. P. C., & Ramaekers, J. G.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881105056670",
      "url": "https://doi.org/10.1177/0269881105056670",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kuypers_2007",
      "fullText": "Kuypers, K. P. C., & Ramaekers, J. G. (2007). Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology, 189(4), 557–563. https://doi.org/10.1007/s00213-006-0321-7",
      "authors": "Kuypers, K. P. C., & Ramaekers, J. G.",
      "year": "2007",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-006-0321-7",
      "url": "https://doi.org/10.1007/s00213-006-0321-7",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "kwany_2024",
      "fullText": "Kwaśny, A., Wilkowska, A., & Cubała, W. J. (2024). Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: A systematic review of clinical trials. Frontiers in Psychiatry, 15, 1477996. https://doi.org/10.3389/fpsyt.2024.1477996",
      "authors": "Kwaśny, A., Wilkowska, A., & Cubała, W. J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2024.1477996",
      "url": "https://doi.org/10.3389/fpsyt.2024.1477996",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "latorre_2024",
      "fullText": "La Torre, J. T., Gallo, J., Mahammadli, M., Zalewa, D., & Williams, M. T. (2024). Experiences of psychedelic drug use among people with psychotic symptoms and disorders: Personal growth and mystical experiences. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00348",
      "authors": "La Torre, J. T., Gallo, J., Mahammadli, M., Zalewa, D., & Williams, M. T.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00348",
      "url": "https://doi.org/10.1556/2054.2024.00348",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lacroix_2024",
      "fullText": "Lacroix, E., Fatur, K., Hay, P., Touyz, S., & Keshen, A. (2024). Psychedelics and the treatment of eating disorders: Considerations for future research and practice. Journal of Eating Disorders, 12(1), 165. https://doi.org/10.1186/s40337-024-01125-6",
      "authors": "Lacroix, E., Fatur, K., Hay, P., Touyz, S., & Keshen, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1186/s40337-024-01125-6",
      "url": "https://doi.org/10.1186/s40337-024-01125-6",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lake_2023",
      "fullText": "Lake, S., & Lucas, P. (2023). The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs. Psychedelic Medicine, 1(2), 98–110. https://doi.org/10.1089/psymed.2023.0002",
      "authors": "Lake, S., & Lucas, P.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0002",
      "url": "https://doi.org/10.1089/psymed.2023.0002",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lake_2024a",
      "fullText": "Lake, S., & Lucas, P. (2024a). Co-use of psychedelics with other substances: Findings from the global psychedelic survey. Journal of Psychopharmacology, 02698811241292956. https://doi.org/10.1177/02698811241292956",
      "authors": "Lake, S., & Lucas, P.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241292956",
      "url": "https://doi.org/10.1177/02698811241292956",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lake_2024b",
      "fullText": "Lake, S., & Lucas, P. (2024b). The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world. The International Journal on Drug Policy, 130, 104507. https://doi.org/10.1016/j.drugpo.2024.104507",
      "authors": "Lake, S., & Lucas, P.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugpo.2024.104507",
      "url": "https://doi.org/10.1016/j.drugpo.2024.104507",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lancelotta_2020",
      "fullText": "Lancelotta, R. L., & Davis, A. K. (2020). Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects. Journal of Psychoactive Drugs, 52(3), 273–281. https://doi.org/10.1080/02791072.2020.1737763",
      "authors": "Lancelotta, R. L., & Davis, A. K.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2020.1737763",
      "url": "https://doi.org/10.1080/02791072.2020.1737763",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "langlitz_2023",
      "fullText": "Langlitz, N. (2023). The making of a mushroom people: Toward a moral anthropology of psychedelics beyond hype and anti‐hype. Anthropology Today, 39(3), 10–12. https://doi.org/10.1111/1467-8322.12813",
      "authors": "Langlitz, N.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1111/1467-8322.12813",
      "url": "https://doi.org/10.1111/1467-8322.12813",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lankenau_2005",
      "fullText": "Lankenau, S. E., & Clatts, M. C. (2005). Patterns of Polydrug Use Among Ketamine Injectors in New York City. Substance Use & Misuse, 40(9–10), 1381–1397. https://doi.org/10.1081/JA-200066936",
      "authors": "Lankenau, S. E., & Clatts, M. C.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1081/JA-200066936",
      "url": "https://doi.org/10.1081/JA-200066936",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "larsen_2016",
      "fullText": "Larsen, J. K. (2016). Neurotoxicity and LSD treatment: A follow-up study of 151 patients in Denmark. History of Psychiatry, 27(2), 172–189. https://doi.org/10.1177/0957154X16629902",
      "authors": "Larsen, J. K.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0957154X16629902",
      "url": "https://doi.org/10.1177/0957154X16629902",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lawn_2014",
      "fullText": "Lawn, W., Barratt, M., Williams, M., Horne, A., & Winstock, A. (2014). The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology, 28(8), 780–788. https://doi.org/10.1177/0269881114523866",
      "authors": "Lawn, W., Barratt, M., Williams, M., Horne, A., & Winstock, A.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881114523866",
      "url": "https://doi.org/10.1177/0269881114523866",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ledar_2022",
      "fullText": "Le Daré, B., Pelletier, R., Couette, A., Morel, I., & Gicquel, T. (2022). Magic truffle intoxication: A case report. Emergency Care Journal, 18(2). https://doi.org/10.4081/ecj.2022.10347",
      "authors": "Le Daré, B., Pelletier, R., Couette, A., Morel, I., & Gicquel, T.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.4081/ecj.2022.10347",
      "url": "https://doi.org/10.4081/ecj.2022.10347",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lea_2020",
      "fullText": "Lea, T., Amada, N., & Jungaberle, H. (2020). Psychedelic Microdosing: A Subreddit Analysis. Journal of Psychoactive Drugs, 52(2), 101–112. https://doi.org/10.1080/02791072.2019.1683260",
      "authors": "Lea, T., Amada, N., & Jungaberle, H.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2019.1683260",
      "url": "https://doi.org/10.1080/02791072.2019.1683260",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lea_2020a",
      "fullText": "Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. (2020a). Microdosing psychedelics: Motivations, subjective effects and harm reduction. International Journal of Drug Policy, 75, 102600. https://doi.org/10.1016/j.drugpo.2019.11.008",
      "authors": "Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M.",
      "year": "2020a",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugpo.2019.11.008",
      "url": "https://doi.org/10.1016/j.drugpo.2019.11.008",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "lea_2020b",
      "fullText": "Lea, T., Amada, N., Jungaberle, H., Schecke, H., Scherbaum, N., & Klein, M. (2020b). Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. Psychopharmacology, 237(5), 1521–1532. https://doi.org/10.1007/s00213-020-05477-0",
      "authors": "Lea, T., Amada, N., Jungaberle, H., Schecke, H., Scherbaum, N., & Klein, M.",
      "year": "2020b",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-020-05477-0",
      "url": "https://doi.org/10.1007/s00213-020-05477-0",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lebedev_2021",
      "fullText": "Lebedev, A. V., Acar, K., Garzón, B., Almeida, R., Råback, J., Åberg, A., Martinsson, S., Olsson, A., Louzolo, A., Pärnamets, P., Lövden, M., Atlas, L., Ingvar, M., & Petrovic, P. (2021). Psychedelic drug use and schizotypy in young adults. Scientific Reports, 11(1), 15058. https://doi.org/10.1038/s41598-021-94421-z",
      "authors": "Lebedev, A. V., Acar, K., Garzón, B., Almeida, R., Råback, J., Åberg, A., Martinsson, S., Olsson, A., Louzolo, A., Pärnamets, P., Lövden, M., Atlas, L., Ingvar, M., & Petrovic, P.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-021-94421-z",
      "url": "https://doi.org/10.1038/s41598-021-94421-z",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ledwos_2022",
      "fullText": "Ledwos, N., Rosenblat, J. D., Blumberger, D. M., Castle, D. J., McIntyre, R. S., Mulsant, B. H., & Husain, M. I. (2022). A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap. Journal of Clinical Psychopharmacology, 42(6), 581–588. https://doi.org/10.1097/JCP.0000000000001608",
      "authors": "Ledwos, N., Rosenblat, J. D., Blumberger, D. M., Castle, D. J., McIntyre, R. S., Mulsant, B. H., & Husain, M. I.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1097/JCP.0000000000001608",
      "url": "https://doi.org/10.1097/JCP.0000000000001608",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "leemccabe_1972",
      "fullText": "Lee McCabe, O., Savage, C., Kurland, A., & Unger, S. (1972). Psychedelic (LSD) Therapy of Neurotic Disorders: Short-Term Effects. Journal of Psychedelic Drugs, 5(1), 18–28. https://doi.org/10.1080/02791072.1972.10471465",
      "authors": "Lee McCabe, O., Savage, C., Kurland, A., & Unger, S.",
      "year": "1972",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.1972.10471465",
      "url": "https://doi.org/10.1080/02791072.1972.10471465",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "leistenschneider_2024a",
      "fullText": "Leistenschneider, G., Majić, T., Reiche, S., & Riemer, T. G. (2024a). Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls. Scientific Reports, 14(1), 32159. https://doi.org/10.1038/s41598-024-82216-x",
      "authors": "Leistenschneider, G., Majić, T., Reiche, S., & Riemer, T. G.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-82216-x",
      "url": "https://doi.org/10.1038/s41598-024-82216-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "leistenschneider_2024b",
      "fullText": "Leistenschneider, G., Majić, T., Reiche, S., & Riemer, T. G. (2024b). Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls. Scientific Reports, 14(1), 32159. https://doi.org/10.1038/s41598-024-82216-x",
      "authors": "Leistenschneider, G., Majić, T., Reiche, S., & Riemer, T. G.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-82216-x",
      "url": "https://doi.org/10.1038/s41598-024-82216-x",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "leonard_2018",
      "fullText": "Leonard, J. B., Anderson, B., & Klein-Schwartz, W. (2018). Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. Journal of Psychopharmacology (Oxford, England), 32(12), 1286–1294. https://doi.org/10.1177/0269881118793086",
      "authors": "Leonard, J. B., Anderson, B., & Klein-Schwartz, W.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881118793086",
      "url": "https://doi.org/10.1177/0269881118793086",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lerner_2014",
      "fullText": "Lerner, A. G., & Goodman, C. (2014). LSD Flashbacks – The Appearance of New Visual Imagery Not Experienced During Initial Intoxication: Two Case Reports. Isr J Psychiatry Relat Sci, 51(4).",
      "authors": "Lerner, A. G., & Goodman, C.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lerner_2000",
      "fullText": "Lerner, A. G., Gelkopf, M., Oyffe, I., Finkel, B., Katz, S., Sigal, M., & Weizman, A. (2000). LSD-induced hallucinogen persisting perception disorder treatment with clonidine: An open pilot study. International Clinical Psychopharmacology, 15(1), 35–37. https://doi.org/10.1097/00004850-200015010-00005",
      "authors": "Lerner, A. G., Gelkopf, M., Oyffe, I., Finkel, B., Katz, S., Sigal, M., & Weizman, A.",
      "year": "2000",
      "title": "",
      "journal": "",
      "doi": "10.1097/00004850-200015010-00005",
      "url": "https://doi.org/10.1097/00004850-200015010-00005",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lerner_2002",
      "fullText": "Lerner, A. G., Gelkopf, M., Skladman, I., Oyffe, I., Finkel, B., Sigal, M., & Weizman, A. (2002). Flashback and Hallucinogen Persisting Perception Disorder: Clinical aspects and pharmacological treatment approach. The Israel Journal of Psychiatry and Related Sciences, 39(2), 92–99.",
      "authors": "Lerner, A. G., Gelkopf, M., Skladman, I., Oyffe, I., Finkel, B., Sigal, M., & Weizman, A.",
      "year": "2002",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "lerner_2003",
      "fullText": "Lerner, A. G., Gelkopf, M., Skladman, I., Rudinski, D., Nachshon, H., & Bleich, A. (2003). Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. International Clinical Psychopharmacology, 18(2), 101–105. https://doi.org/10.1097/00004850-200303000-00007",
      "authors": "Lerner, A. G., Gelkopf, M., Skladman, I., Rudinski, D., Nachshon, H., & Bleich, A.",
      "year": "2003",
      "title": "",
      "journal": "",
      "doi": "10.1097/00004850-200303000-00007",
      "url": "https://doi.org/10.1097/00004850-200303000-00007",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lerner_2014_1",
      "fullText": "Lerner, A. G., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: A Clinical-oriented Concise Review. Isr J Psychiatry Relat Sci, 51(4).",
      "authors": "Lerner, A. G., Rudinski, D., Bor, O., & Goodman, C.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "levran_2014",
      "fullText": "Lev-Ran, S., Feingold, D., Frenkel, A., & Lerner, A. G. (2014). Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: A preliminary investigation. Journal of Dual Diagnosis, 10(2), 79–83. https://doi.org/10.1080/15504263.2014.906155",
      "authors": "Lev-Ran, S., Feingold, D., Frenkel, A., & Lerner, A. G.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1080/15504263.2014.906155",
      "url": "https://doi.org/10.1080/15504263.2014.906155",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "levran_2017",
      "fullText": "Lev-Ran, S., Feingold, D., Goodman, C., & Lerner, A. G. (2017). Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use: Comparing Triggers to HPPD Type I and II. The American Journal on Addictions, 26(6), 568–571. https://doi.org/10.1111/ajad.12577",
      "authors": "Lev-Ran, S., Feingold, D., Goodman, C., & Lerner, A. G.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1111/ajad.12577",
      "url": "https://doi.org/10.1111/ajad.12577",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "levran_2015",
      "fullText": "Lev‐Ran, S., Feingold, D., Rudinski, D., Katz, S., & Arturo, L. G. (2015). Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation. The American Journal on Addictions, 24(3), 197–199. https://doi.org/10.1111/ajad.12204",
      "authors": "Lev‐Ran, S., Feingold, D., Rudinski, D., Katz, S., & Arturo, L. G.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1111/ajad.12204",
      "url": "https://doi.org/10.1111/ajad.12204",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "li_2019",
      "fullText": "Li, C., Tang, M. H., Chong, Y., Chan, T. Y., & Mak, T. W. (2019). Lysergic acid diethylamide–associated intoxication in Hong Kong: A case series. Hong Kong Medical Journal, 25(4), 323–325. https://doi.org/10.12809/hkmj197942",
      "authors": "Li, C., Tang, M. H., Chong, Y., Chan, T. Y., & Mak, T. W.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.12809/hkmj197942",
      "url": "https://doi.org/10.12809/hkmj197942",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0407",
      "fullText": "Liechti Lab | Department of Biomedicine | University of Basel. (n.d.). Retrieved January 23, 2025, from https://biomedizin.unibas.ch/en/research/research-groups/liechti-lab/?utm_source=substack&utm_medium=email",
      "authors": "Liechti Lab | Department of Biomedicine | University of Basel. (n.d.). Retrieved January 23, 2025, from https://biomedizin.unibas.ch/en/research/research-groups/liechti-lab/?utm_source=substack&utm_medium=email",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://biomedizin.unibas.ch/en/research/research-groups/liechti-lab/?utm_source=substack&utm_medium=email",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "liester_2014",
      "fullText": "Liester, M. B. (2014). A review of lysergic acid diethylamide (LSD) in the treatment of addictions: Historical perspectives and future prospects. Current Drug Abuse Reviews, 7(3), 146–156. https://doi.org/10.2174/1874473708666150107120522",
      "authors": "Liester, M. B.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.2174/1874473708666150107120522",
      "url": "https://doi.org/10.2174/1874473708666150107120522",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lindahl_2020",
      "fullText": "Lindahl, J. R., Cooper, D. J., Fisher, N. E., Kirmayer, L. J., & Britton, W. B. (2020). Progress or Pathology? Differential Diagnosis and Intervention Criteria for Meditation-Related Challenges: Perspectives From Buddhist Meditation Teachers and Practitioners. Frontiers in Psychology, 11. https://doi.org/10.3389/fpsyg.2020.01905",
      "authors": "Lindahl, J. R., Cooper, D. J., Fisher, N. E., Kirmayer, L. J., & Britton, W. B.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2020.01905",
      "url": "https://doi.org/10.3389/fpsyg.2020.01905",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "litjens_2014",
      "fullText": "Litjens, R. P. W., Brunt, T. M., Alderliefste, G.-J., & Westerink, R. H. S. (2014). Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 24(8), 1309–1323. https://doi.org/10.1016/j.euroneuro.2014.05.008",
      "authors": "Litjens, R. P. W., Brunt, T. M., Alderliefste, G.-J., & Westerink, R. H. S.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.euroneuro.2014.05.008",
      "url": "https://doi.org/10.1016/j.euroneuro.2014.05.008",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "liu_2016",
      "fullText": "Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016). Ketamine abuse potential and use disorder. Brain Research Bulletin, 126(Pt 1), 68–73. https://doi.org/10.1016/j.brainresbull.2016.05.016",
      "authors": "Liu, Y., Lin, D., Wu, B., & Zhou, W.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.brainresbull.2016.05.016",
      "url": "https://doi.org/10.1016/j.brainresbull.2016.05.016",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "livne_2022",
      "fullText": "Livne, O., Shmulewitz, D., Walsh, C., & Hasin, D. S. (2022). Adolescent and adult time trends in US hallucinogen use, 2002–19: Any use, and use of ecstasy, LSD and PCP. Addiction, 117(12), 3099–3109. https://doi.org/10.1111/add.15987",
      "authors": "Livne, O., Shmulewitz, D., Walsh, C., & Hasin, D. S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1111/add.15987",
      "url": "https://doi.org/10.1111/add.15987",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "loizagavelder_2024",
      "fullText": "Loizaga-Velder, A., & Loizaga Pazzi, A. (2024). Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders. Journal of Studies on Alcohol and Drugs, 85(5), 595–606. https://doi.org/10.15288/jsad.23-00011",
      "authors": "Loizaga-Velder, A., & Loizaga Pazzi, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.15288/jsad.23-00011",
      "url": "https://doi.org/10.15288/jsad.23-00011",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0414",
      "fullText": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/382313168_Longitudinal_experiences_of_Canadians_receiving_compassionate_access_to_psilocybin-assisted_psychotherapy",
      "authors": "Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/382313168_Longitudinal_experiences_of_Canadians_receiving_compassionate_access_to_psilocybin-assisted_psychotherapy",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/382313168_Longitudinal_experiences_of_Canadians_receiving_compassionate_access_to_psilocybin-assisted_psychotherapy",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "lowe_2022",
      "fullText": "Lowe, H., Toyang, N., Steele, B., Grant, J., Ali, A., Gordon, L., & Ngwa, W. (2022). Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Molecules, 27(8), 2520. https://doi.org/10.3390/molecules27082520",
      "authors": "Lowe, H., Toyang, N., Steele, B., Grant, J., Ali, A., Gordon, L., & Ngwa, W.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3390/molecules27082520",
      "url": "https://doi.org/10.3390/molecules27082520",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "luan_2024",
      "fullText": "Luan, L. X., Eckernäs, E., Ashton, M., Rosas, F. E., Uthaug, M. V., Bartha, A., Jagger, S., Gascon-Perai, K., Gomes, L., Nutt, D. J., Erritzøe, D., Carhart-Harris, R. L., & Timmermann, C. (2024). Psychological and physiological effects of extended DMT. Journal of Psychopharmacology (Oxford, England), 38(1), 56–67. https://doi.org/10.1177/02698811231196877",
      "authors": "Luan, L. X., Eckernäs, E., Ashton, M., Rosas, F. E., Uthaug, M. V., Bartha, A., Jagger, S., Gascon-Perai, K., Gomes, L., Nutt, D. J., Erritzøe, D., Carhart-Harris, R. L., & Timmermann, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231196877",
      "url": "https://doi.org/10.1177/02698811231196877",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lutfy_2023",
      "fullText": "Lutfy, K., Pechnick, R. N., & Darmani, N. A. (2023). Editorial: Pharmacology of new psychoactive substances. Frontiers in Pharmacology, 14, 1208957. https://doi.org/10.3389/fphar.2023.1208957",
      "authors": "Lutfy, K., Pechnick, R. N., & Darmani, N. A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2023.1208957",
      "url": "https://doi.org/10.3389/fphar.2023.1208957",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "lutkajtis_2023",
      "fullText": "Lutkajtis, A., & Evans, J. (2023). Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands. Journal of Psychedelic Studies, 6(3), 211–221. https://doi.org/10.1556/2054.2022.00232",
      "authors": "Lutkajtis, A., & Evans, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2022.00232",
      "url": "https://doi.org/10.1556/2054.2022.00232",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0419",
      "fullText": "MacConnel, H. A. (n.d.). Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm.",
      "authors": "MacConnel, H. A. (n.d.). Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "maclean_2011",
      "fullText": "MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453–1461. https://doi.org/10.1177/0269881111420188",
      "authors": "MacLean, K. A., Johnson, M. W., & Griffiths, R. R.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881111420188",
      "url": "https://doi.org/10.1177/0269881111420188",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "makunts_2023",
      "fullText": "Makunts, T., Dahill, D., Jerome, L., de Boer, A., & Abagyan, R. (2023). Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system. Frontiers in Psychiatry, 14, 1149766. https://doi.org/10.3389/fpsyt.2023.1149766",
      "authors": "Makunts, T., Dahill, D., Jerome, L., de Boer, A., & Abagyan, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1149766",
      "url": "https://doi.org/10.3389/fpsyt.2023.1149766",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "makunts_2021",
      "fullText": "Makunts, T., Jerome, L., Abagyan, R., & de Boer, A. (2021). Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Frontiers in Psychiatry, 12, 824288. https://doi.org/10.3389/fpsyt.2021.824288",
      "authors": "Makunts, T., Jerome, L., Abagyan, R., & de Boer, A.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.824288",
      "url": "https://doi.org/10.3389/fpsyt.2021.824288",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "malcolm_2022",
      "fullText": "Malcolm, B., & Thomas, K. (2022). Serotonin toxicity of serotonergic psychedelics. Psychopharmacology, 239(6), 1881–1891. https://doi.org/10.1007/s00213-021-05876-x",
      "authors": "Malcolm, B., & Thomas, K.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-05876-x",
      "url": "https://doi.org/10.1007/s00213-021-05876-x",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "marazziti_2024",
      "fullText": "Marazziti, D., Weiss, F., Gurrieri, R., Russomanno, G., Gambini, M., Magnesa, A., Coccoglioniti, A., & Perugi, G. (2024). Evaluating the value and risks of psychedelics for psychiatric medicine: A clinical perspective. Expert Review of Neurotherapeutics, 1–14. https://doi.org/10.1080/14737175.2024.2445016",
      "authors": "Marazziti, D., Weiss, F., Gurrieri, R., Russomanno, G., Gambini, M., Magnesa, A., Coccoglioniti, A., & Perugi, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/14737175.2024.2445016",
      "url": "https://doi.org/10.1080/14737175.2024.2445016",
      "categories": [
        "safety",
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "marchi_2024",
      "fullText": "Marchi, M., Farina, R., Rachedi, K., Laonigro, F., Žuljević, M. F., Pingani, L., Ferrari, S., Somers, M., Boks, M. P. M., & Galeazzi, G. M. (2024). Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis. Journal of Psychopharmacology (Oxford, England), 2698811241303594. https://doi.org/10.1177/02698811241303594",
      "authors": "Marchi, M., Farina, R., Rachedi, K., Laonigro, F., Žuljević, M. F., Pingani, L., Ferrari, S., Somers, M., Boks, M. P. M., & Galeazzi, G. M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241303594",
      "url": "https://doi.org/10.1177/02698811241303594",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "marcus_2023",
      "fullText": "Marcus, O. (2023). ‘Everybody’s creating it along the way’: Ethical tensions among globalized ayahuasca shamanisms and therapeutic integration practices. Interdisciplinary Science Reviews, 48(5), 712–731. https://doi.org/10.1080/03080188.2022.2075201",
      "authors": "Marcus, O.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/03080188.2022.2075201",
      "url": "https://doi.org/10.1080/03080188.2022.2075201",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0427",
      "fullText": "Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (n.d.). Psychiatric risks for worsened mental health after psychedelic use.",
      "authors": "Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (n.d.). Psychiatric risks for worsened mental health after psychedelic use.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "martin_2022",
      "fullText": "Martin, J. M., & Sterzer, P. (2022). How Level is the “Cognitive Playing Field”?: Context Shapes Alterations in Self-Conception During the Psychedelic Experience. Philosophy and the Mind Sciences, 3. https://doi.org/10.33735/phimisci.2022.9326",
      "authors": "Martin, J. M., & Sterzer, P.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.33735/phimisci.2022.9326",
      "url": "https://doi.org/10.33735/phimisci.2022.9326",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "martinotti_2018",
      "fullText": "Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Di Giannantonio, M., & Lerner, A. (2018). Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences, 8(3), 47. https://doi.org/10.3390/brainsci8030047",
      "authors": "Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Di Giannantonio, M., & Lerner, A.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.3390/brainsci8030047",
      "url": "https://doi.org/10.3390/brainsci8030047",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "martins_2023",
      "fullText": "Martins, D., Gil-Martins, E., Cagide, F., Da Fonseca, C., Benfeito, S., Fernandes, C., Chavarria, D., Remião, F., Silva, R., & Borges, F. (2023). Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N-Benzylphenethylamine (NBOMe) Analogues. Pharmaceuticals, 16(8), 1158. https://doi.org/10.3390/ph16081158",
      "authors": "Martins, D., Gil-Martins, E., Cagide, F., Da Fonseca, C., Benfeito, S., Fernandes, C., Chavarria, D., Remião, F., Silva, R., & Borges, F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3390/ph16081158",
      "url": "https://doi.org/10.3390/ph16081158",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mash_2000",
      "fullText": "Mash, D. C., Kovera, C. A., Pablo, J., Tyndale, R. F., Ervin, F. D., Williams, I. C., Singleton, E. G., & Mayor, M. (2000). Ibogaine: Complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Annals of the New York Academy of Sciences, 914, 394–401. https://doi.org/10.1111/j.1749-6632.2000.tb05213.x",
      "authors": "Mash, D. C., Kovera, C. A., Pablo, J., Tyndale, R. F., Ervin, F. D., Williams, I. C., Singleton, E. G., & Mayor, M.",
      "year": "2000",
      "title": "",
      "journal": "",
      "doi": "10.1111/j.1749-6632.2000.tb05213.x",
      "url": "https://doi.org/10.1111/j.1749-6632.2000.tb05213.x",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "matzopoulos_2022",
      "fullText": "Matzopoulos, R., Morlock, R., Morlock, A., Lerer, B., & Lerer, L. (2022). Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.780696",
      "authors": "Matzopoulos, R., Morlock, R., Morlock, A., Lerer, B., & Lerer, L.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.780696",
      "url": "https://doi.org/10.3389/fpsyt.2021.780696",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "maxwell_2005",
      "fullText": "Maxwell, J. C. (2005). Party Drugs: Properties, Prevalence, Patterns, and Problems. Substance Use & Misuse, 40(9–10), 1203–1240. https://doi.org/10.1081/JA-200066736",
      "authors": "Maxwell, J. C.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1081/JA-200066736",
      "url": "https://doi.org/10.1081/JA-200066736",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcalpine_2024",
      "fullText": "McAlpine, R. G., Sacchet, M. D., Simonsson, O., Khan, M., Krajnovic, K., Morometescu, L., & Kamboj, S. K. (2024). Development of a digital intervention for psychedelic preparation (DIPP). Scientific Reports, 14(1), 4072. https://doi.org/10.1038/s41598-024-54642-4",
      "authors": "McAlpine, R. G., Sacchet, M. D., Simonsson, O., Khan, M., Krajnovic, K., Morometescu, L., & Kamboj, S. K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-54642-4",
      "url": "https://doi.org/10.1038/s41598-024-54642-4",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcclintock_2008",
      "fullText": "McClintock, R. L., Watts, D. J., & Melanson, S. (2008). Unrecognized magic mushroom abuse in a 28-year-old man. The American Journal of Emergency Medicine, 26(8), 972.e3-4. https://doi.org/10.1016/j.ajem.2008.01.058",
      "authors": "McClintock, R. L., Watts, D. J., & Melanson, S.",
      "year": "2008",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.ajem.2008.01.058",
      "url": "https://doi.org/10.1016/j.ajem.2008.01.058",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcconnell_2023",
      "fullText": "McConnell, A., He, W., McConnell, H., & Sowman, P. F. (2023). Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances. PsyArXiv. https://doi.org/10.31234/osf.io/xeg96",
      "authors": "McConnell, A., He, W., McConnell, H., & Sowman, P. F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/xeg96",
      "url": "https://doi.org/10.31234/osf.io/xeg96",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcgovern_2024",
      "fullText": "McGovern, H. T., Grimmer, H. J., Doss, M. K., Hutchinson, B. T., Timmermann, C., Lyon, A., Corlett, P. R., & Laukkonen, R. E. (2024). An Integrated theory of false insights and beliefs under psychedelics. Communications Psychology, 2(1), 1–13. https://doi.org/10.1038/s44271-024-00120-6",
      "authors": "McGovern, H. T., Grimmer, H. J., Doss, M. K., Hutchinson, B. T., Timmermann, C., Lyon, A., Corlett, P. R., & Laukkonen, R. E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s44271-024-00120-6",
      "url": "https://doi.org/10.1038/s44271-024-00120-6",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcguire_2024",
      "fullText": "McGuire, A. L., Cohen, I. G., Sisti, D., Baggott, M., Celidwen, Y., Devenot, N., Gracias, S., Grob, C., Harvey, I., Kious, B., Marks, M., Mithoefer, M., Nielson, E., Öngür, D., Pallas, A., Peterson, A., Schenberg, E. E., Summergrad, P., Waters, B., … Yaden, D. B. (2024). Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Network Open, 7(6), e2414650. https://doi.org/10.1001/jamanetworkopen.2024.14650",
      "authors": "McGuire, A. L., Cohen, I. G., Sisti, D., Baggott, M., Celidwen, Y., Devenot, N., Gracias, S., Grob, C., Harvey, I., Kious, B., Marks, M., Mithoefer, M., Nielson, E., Öngür, D., Pallas, A., Peterson, A., Schenberg, E. E., Summergrad, P., Waters, B., … Yaden, D. B.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamanetworkopen.2024.14650",
      "url": "https://doi.org/10.1001/jamanetworkopen.2024.14650",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "mcintyre_2025",
      "fullText": "McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T., Stahl, S. M., & Rosenblat, J. D. (2025). Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research. American Journal of Psychiatry, 182(1), 21–32. https://doi.org/10.1176/appi.ajp.20230902",
      "authors": "McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T., Stahl, S. M., & Rosenblat, J. D.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230902",
      "url": "https://doi.org/10.1176/appi.ajp.20230902",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcnamee_2023",
      "fullText": "McNamee, S., Devenot, N., & Buisson, M. (2023). Studying Harms Is Key to Improving Psychedelic-Assisted Therapy-Participants Call for Changes to Research Landscape. JAMA Psychiatry, 80(5), 411–412. https://doi.org/10.1001/jamapsychiatry.2023.0099",
      "authors": "McNamee, S., Devenot, N., & Buisson, M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2023.0099",
      "url": "https://doi.org/10.1001/jamapsychiatry.2023.0099",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mcwilliams_1973",
      "fullText": "McWilliams, S. A., & Tuttle, R. J. (1973). Long-term psychological effects of LSD. Psychological Bulletin, 79(6), 341–351. https://doi.org/10.1037/h0034411",
      "authors": "McWilliams, S. A., & Tuttle, R. J.",
      "year": "1973",
      "title": "",
      "journal": "",
      "doi": "10.1037/h0034411",
      "url": "https://doi.org/10.1037/h0034411",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mehtani_2024",
      "fullText": "Mehtani, N. J., Johnson, M. O., Hendricks, P. S., Mitchell, J., & Anderson, B. T. (2024). Psilocybin-assisted therapy and HIV-related shame. Scientific Reports, 14(1), 17919. https://doi.org/10.1038/s41598-024-68908-4",
      "authors": "Mehtani, N. J., Johnson, M. O., Hendricks, P. S., Mitchell, J., & Anderson, B. T.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-68908-4",
      "url": "https://doi.org/10.1038/s41598-024-68908-4",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "menon_2024",
      "fullText": "Menon, V., Ramamurthy, P., Venu, S., & Andrade, C. (2024). Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13778",
      "authors": "Menon, V., Ramamurthy, P., Venu, S., & Andrade, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1111/acps.13778",
      "url": "https://doi.org/10.1111/acps.13778",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "meyer_2025",
      "fullText": "Meyer, T. D., Ibrahim, M., Vale, L. N., & Soares, J. C. (2025). Psychedelic use and bipolar disorder – An investigation of recreational use and its impact on mental health. Journal of Affective Disorders, 373, 505–511. https://doi.org/10.1016/j.jad.2024.12.044",
      "authors": "Meyer, T. D., Ibrahim, M., Vale, L. N., & Soares, J. C.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2024.12.044",
      "url": "https://doi.org/10.1016/j.jad.2024.12.044",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mian_2025",
      "fullText": "Mian, M. N., Dinh, M. T., Coker, A. R., Mitchell, J. M., & Anderson, B. T. (2025). Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options. American Journal of Psychiatry, 182(1), 6–9. https://doi.org/10.1176/appi.ajp.20230787",
      "authors": "Mian, M. N., Dinh, M. T., Coker, A. R., Mitchell, J. M., & Anderson, B. T.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230787",
      "url": "https://doi.org/10.1176/appi.ajp.20230787",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "micelimcmillan_2022",
      "fullText": "Miceli McMillan, R. (2022). Psychedelic injustice: Should bioethics tune in to the voices of psychedelic-using communities? Medical Humanities, 48(3), 269–272. https://doi.org/10.1136/medhum-2021-012299",
      "authors": "Miceli McMillan, R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1136/medhum-2021-012299",
      "url": "https://doi.org/10.1136/medhum-2021-012299",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "miller_2024",
      "fullText": "Miller, E., Bojovic, V., Maddren, O., Rao, P., Adesina, D., Petrenko, A., & Ponton, R. (2024). Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration. Journal of Psychoactive Drugs, 1–10. https://doi.org/10.1080/02791072.2024.2304554",
      "authors": "Miller, E., Bojovic, V., Maddren, O., Rao, P., Adesina, D., Petrenko, A., & Ponton, R.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2304554",
      "url": "https://doi.org/10.1080/02791072.2024.2304554",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "miller_1992",
      "fullText": "Miller, P. L., Gay, G. R., Ferris, K. C., & Anderson, S. (1992). Treatment of acute, adverse psychedelic reactions: “I’ve tripped and I can’t get down.” Journal of Psychoactive Drugs, 24(3), 277–279. https://doi.org/10.1080/02791072.1992.10471649",
      "authors": "Miller, P. L., Gay, G. R., Ferris, K. C., & Anderson, S.",
      "year": "1992",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.1992.10471649",
      "url": "https://doi.org/10.1080/02791072.1992.10471649",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "millire_2018",
      "fullText": "Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F.-M., & Berkovich-Ohana, A. (2018). Psychedelics, Meditation, and Self-Consciousness. Frontiers in Psychology, 9, 1475. https://doi.org/10.3389/fpsyg.2018.01475",
      "authors": "Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F.-M., & Berkovich-Ohana, A.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2018.01475",
      "url": "https://doi.org/10.3389/fpsyg.2018.01475",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mitchell_2021",
      "fullText": "Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025–1033. https://doi.org/10.1038/s41591-021-01336-3",
      "authors": "Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., … Doblin, R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41591-021-01336-3",
      "url": "https://doi.org/10.1038/s41591-021-01336-3",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mithoefer_2013",
      "fullText": "Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology (Oxford, England), 27(1), 28–39. https://doi.org/10.1177/0269881112456611",
      "authors": "Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881112456611",
      "url": "https://doi.org/10.1177/0269881112456611",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "modak_2019",
      "fullText": "Modak, T., Bhad, R., & Rao, R. (2019). A rare case of physical dependence with psychedelic LSD - A case report. Journal of Substance Use, 24(4), 347–349. https://doi.org/10.1080/14659891.2019.1581286",
      "authors": "Modak, T., Bhad, R., & Rao, R.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1080/14659891.2019.1581286",
      "url": "https://doi.org/10.1080/14659891.2019.1581286",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "modlin_2024_1",
      "fullText": "Modlin, N. L., McPhee, T., Zazon, N., Sarang, M., Hignett, R., Pick, S., Cleare, A., Williamson, V., & Rucker, J. (2024). Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis. Psychedelic Medicine. https://doi.org/10.1089/psymed.2024.0027",
      "authors": "Modlin, N. L., McPhee, T., Zazon, N., Sarang, M., Hignett, R., Pick, S., Cleare, A., Williamson, V., & Rucker, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2024.0027",
      "url": "https://doi.org/10.1089/psymed.2024.0027",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "modlin_2023",
      "fullText": "Modlin, N. L., Miller, T. M., Rucker, J. J., Kirlic, N., Lennard-Jones, M., Schlosser, D., & Aaronson, S. T. (2023). Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation. Journal of Affective Disorders, 326, 18–25. https://doi.org/10.1016/j.jad.2023.01.077",
      "authors": "Modlin, N. L., Miller, T. M., Rucker, J. J., Kirlic, N., Lennard-Jones, M., Schlosser, D., & Aaronson, S. T.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2023.01.077",
      "url": "https://doi.org/10.1016/j.jad.2023.01.077",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "modlin_2024",
      "fullText": "Modlin, N., Creed, M., Sarang, M., Maggio, C., Rucker, J., & Williamson, V. (2024). Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. Neuropsychiatric Disease and Treatment, Volume 20, 109–135. https://doi.org/10.2147/NDT.S432537",
      "authors": "Modlin, N., Creed, M., Sarang, M., Maggio, C., Rucker, J., & Williamson, V.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.2147/NDT.S432537",
      "url": "https://doi.org/10.2147/NDT.S432537",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "morgan_2010",
      "fullText": "Morgan, C. J. A., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J., & Curran, H. V. (2010). Harms associated with psychoactive substances: Findings of the UK National Drug Survey. Journal of Psychopharmacology (Oxford, England), 24(2), 147–153. https://doi.org/10.1177/0269881109106915",
      "authors": "Morgan, C. J. A., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J., & Curran, H. V.",
      "year": "2010",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881109106915",
      "url": "https://doi.org/10.1177/0269881109106915",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "mr_2013",
      "fullText": "Móró, L., & Rácz, J. (2013). Online drug user-led harm reduction in Hungary: A review of “Daath.” Harm Reduction Journal, 10(1), 18. https://doi.org/10.1186/1477-7517-10-18",
      "authors": "Móró, L., & Rácz, J.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1186/1477-7517-10-18",
      "url": "https://doi.org/10.1186/1477-7517-10-18",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "mr_2011",
      "fullText": "Móró, L., Simon, K., Bárd, I., & Rácz, J. (2011). Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users. Journal of Psychoactive Drugs, 43(3), 188–198. https://doi.org/10.1080/02791072.2011.605661",
      "authors": "Móró, L., Simon, K., Bárd, I., & Rácz, J.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2011.605661",
      "url": "https://doi.org/10.1080/02791072.2011.605661",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "morton_2023",
      "fullText": "Morton, E., Sakai, K., Ashtari, A., Pleet, M., Michalak, E. E., & Woolley, J. (2023). Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption. Journal of Psychopharmacology, 37(1), 49–60. https://doi.org/10.1177/02698811221131997",
      "authors": "Morton, E., Sakai, K., Ashtari, A., Pleet, M., Michalak, E. E., & Woolley, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221131997",
      "url": "https://doi.org/10.1177/02698811221131997",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "mller_2022",
      "fullText": "Müller, F., Kraus, E., Holze, F., Becker, A., Ley, L., Schmid, Y., Vizeli, P., Liechti, M. E., & Borgwardt, S. (2022). Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology, 239(6), 1933–1943. https://doi.org/10.1007/s00213-022-06066-z",
      "authors": "Müller, F., Kraus, E., Holze, F., Becker, A., Ley, L., Schmid, Y., Vizeli, P., Liechti, M. E., & Borgwardt, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06066-z",
      "url": "https://doi.org/10.1007/s00213-022-06066-z",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "mller_2020",
      "fullText": "Müller, F., Mühlhauser, M., Holze, F., Lang, U. E., Walter, M., Liechti, M. E., & Borgwardt, S. (2020). Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects. Frontiers in Psychiatry, 11, 573953. https://doi.org/10.3389/fpsyt.2020.573953",
      "authors": "Müller, F., Mühlhauser, M., Holze, F., Lang, U. E., Walter, M., Liechti, M. E., & Borgwardt, S.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2020.573953",
      "url": "https://doi.org/10.3389/fpsyt.2020.573953",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "mller_2013",
      "fullText": "Müller, K., Püschel, K., & Iwersen-Bergmann, S. (2013). [Suicide under the influence of “magic mushrooms”]. Archiv Fur Kriminologie, 231(5–6), 193–198.",
      "authors": "Müller, K., Püschel, K., & Iwersen-Bergmann, S.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "murphy_2024",
      "fullText": "Murphy, R. J., Muthukumaraswamy, S., & de Wit, H. (2024). Microdosing Psychedelics: Current Evidence From Controlled Studies. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(5), 500–511. https://doi.org/10.1016/j.bpsc.2024.01.002",
      "authors": "Murphy, R. J., Muthukumaraswamy, S., & de Wit, H.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.bpsc.2024.01.002",
      "url": "https://doi.org/10.1016/j.bpsc.2024.01.002",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "murray_2022",
      "fullText": "Murray, C. H., Tare, I., Perry, C. M., Malina, M., Lee, R., & De Wit, H. (2022). Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Psychopharmacology, 239(6), 1735–1747. https://doi.org/10.1007/s00213-021-05991-9",
      "authors": "Murray, C. H., Tare, I., Perry, C. M., Malina, M., Lee, R., & De Wit, H.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-021-05991-9",
      "url": "https://doi.org/10.1007/s00213-021-05991-9",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "murrough_2015",
      "fullText": "Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V. (2015). Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: A randomized controlled trial. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 40(5), 1084–1090. https://doi.org/10.1038/npp.2014.298",
      "authors": "Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1038/npp.2014.298",
      "url": "https://doi.org/10.1038/npp.2014.298",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "muthukumaraswamy_2013",
      "fullText": "Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., Feilding, A., Friston, K. J., & Nutt, D. J. (2013). Broadband Cortical Desynchronization Underlies the Human Psychedelic State. The Journal of Neuroscience, 33(38), 15171–15183. https://doi.org/10.1523/JNEUROSCI.2063-13.2013",
      "authors": "Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., Feilding, A., Friston, K. J., & Nutt, D. J.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1523/JNEUROSCI.2063-13.2013",
      "url": "https://doi.org/10.1523/JNEUROSCI.2063-13.2013",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "muthukumaraswamy_2022",
      "fullText": "Muthukumaraswamy, S., Forsyth, A., & Sumner, R. L. (2022). The challenges ahead for psychedelic “medicine.” The Australian and New Zealand Journal of Psychiatry, 56(11), 1378–1383. https://doi.org/10.1177/00048674221081763",
      "authors": "Muthukumaraswamy, S., Forsyth, A., & Sumner, R. L.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/00048674221081763",
      "url": "https://doi.org/10.1177/00048674221081763",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "naudet_2022",
      "fullText": "Naudet, F., Fried, E. I., Cosgrove, L., Turner, E., Braillon, A., & Cristea, I. A. (2022). Psychedelic drugs: More emphasis on safety issues. Nature, 611(7936), 449–449. https://doi.org/10.1038/d41586-022-03680-x",
      "authors": "Naudet, F., Fried, E. I., Cosgrove, L., Turner, E., Braillon, A., & Cristea, I. A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1038/d41586-022-03680-x",
      "url": "https://doi.org/10.1038/d41586-022-03680-x",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "nayak_2021",
      "fullText": "Nayak, S. M., Gukasyan, N., Barrett, F. S., Erowid, E., Erowid, F., & Griffiths, R. R. (2021). Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry, 54(5), 240–245. https://doi.org/10.1055/a-1524-2794",
      "authors": "Nayak, S. M., Gukasyan, N., Barrett, F. S., Erowid, E., Erowid, F., & Griffiths, R. R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1055/a-1524-2794",
      "url": "https://doi.org/10.1055/a-1524-2794",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nayak_2023",
      "fullText": "Nayak, S. M., Jackson, H., Sepeda, N. D., Mathai, D. S., So, S., Yaffe, A., Zaki, H., Brasher, T. J., Lowe, M. X., Jolly, D. R. P., Barrett, F. S., Griffiths, R. R., Strickland, J. C., Johnson, M. W., Jackson, H., & Garcia-Romeu, A. (2023). Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: Results from a prospective, longitudinal survey. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1199642",
      "authors": "Nayak, S. M., Jackson, H., Sepeda, N. D., Mathai, D. S., So, S., Yaffe, A., Zaki, H., Brasher, T. J., Lowe, M. X., Jolly, D. R. P., Barrett, F. S., Griffiths, R. R., Strickland, J. C., Johnson, M. W., Jackson, H., & Garcia-Romeu, A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1199642",
      "url": "https://doi.org/10.3389/fpsyt.2023.1199642",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nayak_2023_1",
      "fullText": "Nayak, S. M., White, S., Hilbert, S., Lowe, M. X., Jackson, H., Griffiths, R. R., Garcia-Romeu, A., & Yaden, D. B. (2023). Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study. PsyArXiv. https://doi.org/10.31234/osf.io/auycp",
      "authors": "Nayak, S. M., White, S., Hilbert, S., Lowe, M. X., Jackson, H., Griffiths, R. R., Garcia-Romeu, A., & Yaden, D. B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/auycp",
      "url": "https://doi.org/10.31234/osf.io/auycp",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "neicun_2020",
      "fullText": "Neicun, J., Yang, J. C., Shih, H., Nadella, P., Kessel, R. van, Negri, A., Czabanowska, K., Brayne, C., & Roman-Urrestarazu, A. (2020). Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014. PLOS ONE, 15(10), e0241056. https://doi.org/10.1371/journal.pone.0241056",
      "authors": "Neicun, J., Yang, J. C., Shih, H., Nadella, P., Kessel, R. van, Negri, A., Czabanowska, K., Brayne, C., & Roman-Urrestarazu, A.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0241056",
      "url": "https://doi.org/10.1371/journal.pone.0241056",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "neitzkespruill_2022",
      "fullText": "Neitzke-Spruill, L. (2022). Psychedelics and Desistance From Crime: Lessons From the Concord Prison Experiment. Journal of Humanistic Psychology, 00221678221136233. https://doi.org/10.1177/00221678221136233",
      "authors": "Neitzke-Spruill, L.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/00221678221136233",
      "url": "https://doi.org/10.1177/00221678221136233",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "neitzkespruill_2024",
      "fullText": "Neitzke-Spruill, L., Beit, C., Robinson, J., Blevins, K., Reynolds, J., Evans, N. G., & McGuire, A. L. (2024). A Transformative Trip? Experiences of Psychedelic Use. Neuroethics, 17(2), 33. https://doi.org/10.1007/s12152-024-09567-0",
      "authors": "Neitzke-Spruill, L., Beit, C., Robinson, J., Blevins, K., Reynolds, J., Evans, N. G., & McGuire, A. L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s12152-024-09567-0",
      "url": "https://doi.org/10.1007/s12152-024-09567-0",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "neitzkespruill_2024_1",
      "fullText": "Neitzke-Spruill, L., Devenot, N., Sisti, D., Averill, L. A., & McGuire, A. L. (2024). Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications. Perspectives in Biology and Medicine, 67(1), 117–142.",
      "authors": "Neitzke-Spruill, L., Devenot, N., Sisti, D., Averill, L. A., & McGuire, A. L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "nesvg_2015",
      "fullText": "Nesvåg, R., Bramness, J. G., & Ystrom, E. (2015). The link between use of psychedelic drugs and mental health problems. Journal of Psychopharmacology, 29(9), 1035–1040. https://doi.org/10.1177/0269881115596156",
      "authors": "Nesvåg, R., Bramness, J. G., & Ystrom, E.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881115596156",
      "url": "https://doi.org/10.1177/0269881115596156",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "neubert_2024",
      "fullText": "Neubert, J. J., Anderson, K., & Mason, N. L. (2024). Psychedelic intimacy: Altered states of consciousness in romantic relationships. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00319",
      "authors": "Neubert, J. J., Anderson, K., & Mason, N. L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00319",
      "url": "https://doi.org/10.1556/2054.2024.00319",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "neumann_2024",
      "fullText": "Neumann, J., Dhein, S., Kirchhefer, U., Hofmann, B., & Gergs, U. (2024). Effects of hallucinogenic drugs on the human heart. Frontiers in Pharmacology, 15, 1334218. https://doi.org/10.3389/fphar.2024.1334218",
      "authors": "Neumann, J., Dhein, S., Kirchhefer, U., Hofmann, B., & Gergs, U.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2024.1334218",
      "url": "https://doi.org/10.3389/fphar.2024.1334218",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "neven_2014",
      "fullText": "Neven, A., & Blom, J. D. (2014). Synesthesieën in het kader van de persisterende waarnemingsstoornis door hallucinogenen na gebruik van lsd. TIJDSCHRIFT VOOR PSYCHIATRIE.",
      "authors": "Neven, A., & Blom, J. D.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0480",
      "fullText": "New insights into the clinical and nonclinical effects of psychedelic substances: An integrative review. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/351474838_New_insights_into_the_clinical_and_nonclinical_effects_of_psychedelic_substances_an_integrative_review",
      "authors": "New insights into the clinical and nonclinical effects of psychedelic substances: An integrative review. (n.d.). ResearchGate. Retrieved January 14, 2025, from https://www.researchgate.net/publication/351474838_New_insights_into_the_clinical_and_nonclinical_effects_of_psychedelic_substances_an_integrative_review",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/351474838_New_insights_into_the_clinical_and_nonclinical_effects_of_psychedelic_substances_an_integrative_review",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "nichols_2016",
      "fullText": "Nichols, D. E., & Barker, E. L. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478",
      "authors": "Nichols, D. E., & Barker, E. L.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1124/pr.115.011478",
      "url": "https://doi.org/10.1124/pr.115.011478",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nogueira_2025",
      "fullText": "Nogueira, M., García-Hernández, S., Roberto, G. S., & Marques, L. Z. (2025). Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions. International Journal of Medicinal Mushrooms, 27(2). https://doi.org/10.1615/IntJMedMushrooms.2024057053",
      "authors": "Nogueira, M., García-Hernández, S., Roberto, G. S., & Marques, L. Z.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1615/IntJMedMushrooms.2024057053",
      "url": "https://doi.org/10.1615/IntJMedMushrooms.2024057053",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "noorani_2021",
      "fullText": "Noorani, T. (2021). Containment Matters: Set and Setting in Contemporary Psychedelic Psychiatry. Philosophy, Psychiatry, & Psychology, 28(3), 201–216. https://doi.org/10.1353/ppp.2021.0032",
      "authors": "Noorani, T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1353/ppp.2021.0032",
      "url": "https://doi.org/10.1353/ppp.2021.0032",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nour_2017",
      "fullText": "Nour, M. M., Evans, L., & Carhart-Harris, R. L. (2017). Psychedelics, Personality and Political Perspectives. Journal of Psychoactive Drugs, 49(3), 182–191. https://doi.org/10.1080/02791072.2017.1312643",
      "authors": "Nour, M. M., Evans, L., & Carhart-Harris, R. L.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2017.1312643",
      "url": "https://doi.org/10.1080/02791072.2017.1312643",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "noushad_2015",
      "fullText": "Noushad, F. (2015). 25 years of Hallucinogen Persisting Perception Disorder- A diagnostic challenge. 8(1).",
      "authors": "Noushad, F.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "novak_1997",
      "fullText": "Novak, S. J. (1997). LSD before Leary. Sidney Cohen’s critique of 1950s psychedelic drug research. Isis; an International Review Devoted to the History of Science and Its Cultural Influences, 88(1), 87–110. https://doi.org/10.1086/383628",
      "authors": "Novak, S. J.",
      "year": "1997",
      "title": "",
      "journal": "",
      "doi": "10.1086/383628",
      "url": "https://doi.org/10.1086/383628",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nutt_2021",
      "fullText": "Nutt, D., & Carhart-Harris, R. (2021). The Current Status of Psychedelics in Psychiatry. JAMA Psychiatry, 78(2), 121–122. https://doi.org/10.1001/jamapsychiatry.2020.2171",
      "authors": "Nutt, D., & Carhart-Harris, R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2020.2171",
      "url": "https://doi.org/10.1001/jamapsychiatry.2020.2171",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "nutting_2021",
      "fullText": "Nutting, S., Bruinsma, T., Anderson, M., & Jolly, T. (2021). Psychotic and Still Tripping—Hallucinogen Persisting Perception Disorder and First Break Psychosis in an Adolescent. International Journal of Mental Health and Addiction, 19(6), 2440–2442. https://doi.org/10.1007/s11469-020-00338-5",
      "authors": "Nutting, S., Bruinsma, T., Anderson, M., & Jolly, T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1007/s11469-020-00338-5",
      "url": "https://doi.org/10.1007/s11469-020-00338-5",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "odonnell_2025a",
      "fullText": "O’Donnell, K. C., Grigsby, J., & Grob, C. S. (2025a). Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research. American Journal of Psychiatry, 182(1), 13–16. https://doi.org/10.1176/appi.ajp.20230785",
      "authors": "O’Donnell, K. C., Grigsby, J., & Grob, C. S.",
      "year": "2025a",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230785",
      "url": "https://doi.org/10.1176/appi.ajp.20230785",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "odonnell_2025b",
      "fullText": "O’Donnell, K. C., Grigsby, J., & Grob, C. S. (2025b). Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research. American Journal of Psychiatry, 182(1), 13–16. https://doi.org/10.1176/appi.ajp.20230785",
      "authors": "O’Donnell, K. C., Grigsby, J., & Grob, C. S.",
      "year": "2025b",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230785",
      "url": "https://doi.org/10.1176/appi.ajp.20230785",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "okano_2022",
      "fullText": "Okano, L., Jones, G., Deyo, B., Brandenburg, A., & Hale, W. (2022). Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder. Frontiers in Psychiatry, 13, 965641. https://doi.org/10.3389/fpsyt.2022.965641",
      "authors": "Okano, L., Jones, G., Deyo, B., Brandenburg, A., & Hale, W.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.965641",
      "url": "https://doi.org/10.3389/fpsyt.2022.965641",
      "categories": [
        "harm_reduction",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0492",
      "fullText": "Oliver, D. (n.d.-a). Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020).",
      "authors": "Oliver, D. (n.d.-a). Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020).",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0493",
      "fullText": "Oliver, D. (n.d.-b). Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020).",
      "authors": "Oliver, D. (n.d.-b). Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020).",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "olson_2022",
      "fullText": "Olson, D. E. (2022). Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity. Biochemistry, 61(3), 127–136. https://doi.org/10.1021/acs.biochem.1c00812",
      "authors": "Olson, D. E.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1021/acs.biochem.1c00812",
      "url": "https://doi.org/10.1021/acs.biochem.1c00812",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ona_2018",
      "fullText": "Ona, G. (2018). Inside bad trips: Exploring extra-pharmacological factors. Journal of Psychedelic Studies, 2(1), 53–60. https://doi.org/10.1556/2054.2018.001",
      "authors": "Ona, G.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2018.001",
      "url": "https://doi.org/10.1556/2054.2018.001",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "orowski_2022",
      "fullText": "Orłowski, P., Ruban, A., Szczypiński, J., Hobot, J., Bielecki, M., & Bola, M. (2022). Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences. Journal of Psychopharmacology, 36(8), 987–1000. https://doi.org/10.1177/02698811221089034",
      "authors": "Orłowski, P., Ruban, A., Szczypiński, J., Hobot, J., Bielecki, M., & Bola, M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221089034",
      "url": "https://doi.org/10.1177/02698811221089034",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "orsolini_2017",
      "fullText": "Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017). The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. Frontiers in Psychiatry, 8, 240. https://doi.org/10.3389/fpsyt.2017.00240",
      "authors": "Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2017.00240",
      "url": "https://doi.org/10.3389/fpsyt.2017.00240",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ortizbernal_2022",
      "fullText": "Ortiz Bernal, A. M., Raison, C. L., Lancelotta, R. L., & Davis, A. K. (2022). Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence. Frontiers in Psychiatry, 13, 1049643. https://doi.org/10.3389/fpsyt.2022.1049643",
      "authors": "Ortiz Bernal, A. M., Raison, C. L., Lancelotta, R. L., & Davis, A. K.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.1049643",
      "url": "https://doi.org/10.3389/fpsyt.2022.1049643",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pagni_2025",
      "fullText": "Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P. (2025). Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial. American Journal of Psychiatry, 182(1), 114–125. https://doi.org/10.1176/appi.ajp.20230887",
      "authors": "Pagni, B. A., Zeifman, R. J., Mennenga, S. E., Carrithers, B. M., Goldway, N., Bhatt, S., O’Donnell, K. C., Ross, S., & Bogenschutz, M. P.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230887",
      "url": "https://doi.org/10.1176/appi.ajp.20230887",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2020",
      "fullText": "Palamar, J. J., & Acosta, P. (2020). A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Human Psychopharmacology: Clinical and Experimental, 35(1), e2719. https://doi.org/10.1002/hup.2719",
      "authors": "Palamar, J. J., & Acosta, P.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1002/hup.2719",
      "url": "https://doi.org/10.1002/hup.2719",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2018",
      "fullText": "Palamar, J. J., & Le, A. (2018). Trends in DMT and other tryptamine use among young adults in the United States. The American Journal on Addictions, 27(7), 578–585. https://doi.org/10.1111/ajad.12803",
      "authors": "Palamar, J. J., & Le, A.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1111/ajad.12803",
      "url": "https://doi.org/10.1111/ajad.12803",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2015",
      "fullText": "Palamar, J. J., Martins, S. S., Su, M. K., & Ompad, D. C. (2015). Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence, 156, 112–119. https://doi.org/10.1016/j.drugalcdep.2015.08.028",
      "authors": "Palamar, J. J., Martins, S. S., Su, M. K., & Ompad, D. C.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugalcdep.2015.08.028",
      "url": "https://doi.org/10.1016/j.drugalcdep.2015.08.028",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2025a",
      "fullText": "Palamar, J. J., Rutherford, C., & Keyes, K. M. (2025a). Diversion of Undistributed Pharmaceutical Ketamine in the US. JAMA, 333(3), 252–254. https://doi.org/10.1001/jama.2024.23014",
      "authors": "Palamar, J. J., Rutherford, C., & Keyes, K. M.",
      "year": "2025a",
      "title": "",
      "journal": "",
      "doi": "10.1001/jama.2024.23014",
      "url": "https://doi.org/10.1001/jama.2024.23014",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2025b",
      "fullText": "Palamar, J. J., Rutherford, C., & Keyes, K. M. (2025b). Diversion of Undistributed Pharmaceutical Ketamine in the US. JAMA, 333(3), 252–254. https://doi.org/10.1001/jama.2024.23014",
      "authors": "Palamar, J. J., Rutherford, C., & Keyes, K. M.",
      "year": "2025b",
      "title": "",
      "journal": "",
      "doi": "10.1001/jama.2024.23014",
      "url": "https://doi.org/10.1001/jama.2024.23014",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2024",
      "fullText": "Palamar, J. J., Rutherford, C., Le, A., & Keyes, K. M. (2024). Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City. Journal of Psychoactive Drugs, 56(4), 467–474. https://doi.org/10.1080/02791072.2023.2240322",
      "authors": "Palamar, J. J., Rutherford, C., Le, A., & Keyes, K. M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2023.2240322",
      "url": "https://doi.org/10.1080/02791072.2023.2240322",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "palamar_2023",
      "fullText": "Palamar, J. J., Wilkinson, S. T., Carr, T. H., Rutherford, C., & Cottler, L. B. (2023). Trends in Illicit Ketamine Seizures in the US From 2017 to 2022. JAMA Psychiatry, 80(7), 750–751. https://doi.org/10.1001/jamapsychiatry.2023.1423",
      "authors": "Palamar, J. J., Wilkinson, S. T., Carr, T. H., Rutherford, C., & Cottler, L. B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2023.1423",
      "url": "https://doi.org/10.1001/jamapsychiatry.2023.1423",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "plenek_2013",
      "fullText": "Páleníček, T., Fujáková, M., Brunovský, M., Horáček, J., Gorman, I., Balíková, M., Rambousek, L., Syslová, K., Kačer, P., Zach, P., Bubeníková-Valešová, V., Tylš, F., Kubešová, A., Puskarčíková, J., & Höschl, C. (2013). Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology, 225(1), 75–93. https://doi.org/10.1007/s00213-012-2797-7",
      "authors": "Páleníček, T., Fujáková, M., Brunovský, M., Horáček, J., Gorman, I., Balíková, M., Rambousek, L., Syslová, K., Kačer, P., Zach, P., Bubeníková-Valešová, V., Tylš, F., Kubešová, A., Puskarčíková, J., & Höschl, C.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-012-2797-7",
      "url": "https://doi.org/10.1007/s00213-012-2797-7",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0508",
      "fullText": "Palitsky, R., Canby, N. K., Van Dam, N. T., Levin-Aspenson, H. F., Kaplan, D. M., Maples-Keller, J., Raison, C. L., Grant, G. H., Dunlop, B. W., & Britton, W. B. (n.d.). Leveraging meditation research for the study of psychedelic-related adverse effects. International Review of Psychiatry, 0(0), 1–15. https://doi.org/10.1080/09540261.2024.2420745",
      "authors": "Palitsky, R., Canby, N. K., Van Dam, N. T., Levin-Aspenson, H. F., Kaplan, D. M., Maples-Keller, J., Raison, C. L., Grant, G. H., Dunlop, B. W., & Britton, W. B. (n.d.). Leveraging meditation research for the study of psychedelic-related adverse effects. International Review of Psychiatry, 0(0), 1–15. https://doi.org/10.1080/09540261.2024.2420745",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/09540261.2024.2420745",
      "url": "https://doi.org/10.1080/09540261.2024.2420745",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "palitsky_2024",
      "fullText": "Palitsky, R., Kaplan, D. M., Perna, J., Bosshardt, Z., Maples-Keller, J. L., Levin-Aspenson, H. F., Zarrabi, A. J., Peacock, C., Mletzko, T., Rothbaum, B. O., Raison, C. L., Grant, G. H., & Dunlop, B. W. (2024). A framework for assessment of adverse events occurring in psychedelic-assisted therapies. Journal of Psychopharmacology, 38(8), 690–700. https://doi.org/10.1177/02698811241265756",
      "authors": "Palitsky, R., Kaplan, D. M., Perna, J., Bosshardt, Z., Maples-Keller, J. L., Levin-Aspenson, H. F., Zarrabi, A. J., Peacock, C., Mletzko, T., Rothbaum, B. O., Raison, C. L., Grant, G. H., & Dunlop, B. W.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241265756",
      "url": "https://doi.org/10.1177/02698811241265756",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0509",
      "fullText": "Palitsky, R., Kaplan, D. M., Perna, J., Bosshardt, Z., Maples-Keller, J. L., Levin-Aspenson, H. F., Zarrabi, A. J., Peacock, C., Mletzko, T., Rothbaum, B. O., Raison, C. L., Grant, G. H., & Dunlop, B. W. (n.d.). A framework for assessment of adverse events occurring in psychedelic-assisted therapies.",
      "authors": "Palitsky, R., Kaplan, D. M., Perna, J., Bosshardt, Z., Maples-Keller, J. L., Levin-Aspenson, H. F., Zarrabi, A. J., Peacock, C., Mletzko, T., Rothbaum, B. O., Raison, C. L., Grant, G. H., & Dunlop, B. W. (n.d.). A framework for assessment of adverse events occurring in psychedelic-assisted therapies.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "palmer_2022",
      "fullText": "Palmer, M., & Maynard, O. M. (2022). Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience. Harm Reduction Journal, 19(1), 81. https://doi.org/10.1186/s12954-022-00662-0",
      "authors": "Palmer, M., & Maynard, O. M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1186/s12954-022-00662-0",
      "url": "https://doi.org/10.1186/s12954-022-00662-0",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "pantoni_2022",
      "fullText": "Pantoni, M. M., Kim, J. L., Van Alstyne, K. R., & Anagnostaras, S. G. (2022). MDMA and memory, addiction, and depression: Dose-effect analysis. Psychopharmacology, 239(3), 935–949. https://doi.org/10.1007/s00213-022-06086-9",
      "authors": "Pantoni, M. M., Kim, J. L., Van Alstyne, K. R., & Anagnostaras, S. G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06086-9",
      "url": "https://doi.org/10.1007/s00213-022-06086-9",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "papaseit_2016",
      "fullText": "Papaseit, E., Pérez-Mañá, C., Mateus, J.-A., Pujadas, M., Fonseca, F., Torrens, M., Olesti, E., de la Torre, R., & Farré, M. (2016). Human Pharmacology of Mephedrone in Comparison with MDMA. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 41(11), 2704–2713. https://doi.org/10.1038/npp.2016.75",
      "authors": "Papaseit, E., Pérez-Mañá, C., Mateus, J.-A., Pujadas, M., Fonseca, F., Torrens, M., Olesti, E., de la Torre, R., & Farré, M.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1038/npp.2016.75",
      "url": "https://doi.org/10.1038/npp.2016.75",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "papaseit_2018",
      "fullText": "Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. (2018). Key interindividual determinants in MDMA pharmacodynamics. Expert Opinion on Drug Metabolism & Toxicology, 14(2), 183–195. https://doi.org/10.1080/17425255.2018.1424832",
      "authors": "Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1080/17425255.2018.1424832",
      "url": "https://doi.org/10.1080/17425255.2018.1424832",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "parrott_2014",
      "fullText": "Parrott, A. C. (2014). The Potential Dangers of Using MDMA for Psychotherapy. Journal of Psychoactive Drugs, 46(1), 37–43. https://doi.org/10.1080/02791072.2014.873690",
      "authors": "Parrott, A. C.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2014.873690",
      "url": "https://doi.org/10.1080/02791072.2014.873690",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pashdag_2024",
      "fullText": "Pashdag, J. (2024). Non-hallucinogenic psychedelic psychotherapy: Decreasing risk and increasing access, or missing the point? Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00385",
      "authors": "Pashdag, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00385",
      "url": "https://doi.org/10.1556/2054.2024.00385",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "passie_2018",
      "fullText": "Passie, T., & Brandt, S. D. (2018). Self-Experiments with Psychoactive Substances: A Historical Perspective. Handbook of Experimental Pharmacology, 252, 69–110. https://doi.org/10.1007/164_2018_177",
      "authors": "Passie, T., & Brandt, S. D.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1007/164_2018_177",
      "url": "https://doi.org/10.1007/164_2018_177",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "paul_2016",
      "fullText": "Paul, M. J., Chisolm, M. S., Johnson, M. W., Vandrey, R. G., & Dredze, M. (2016). Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use. Journal of Addiction Medicine, 10(5), 324. https://doi.org/10.1097/ADM.0000000000000238",
      "authors": "Paul, M. J., Chisolm, M. S., Johnson, M. W., Vandrey, R. G., & Dredze, M.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1097/ADM.0000000000000238",
      "url": "https://doi.org/10.1097/ADM.0000000000000238",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "peden_1981",
      "fullText": "Peden, N. R., Macaulay, K. E. C., Bissett, A. F., Crooks, J., & Pelosi, A. J. (1981). Clinical toxicology of ‘magic mushroom’ ingestion. Postgraduate Medical Journal, 57(671), 543–545. https://doi.org/10.1136/pgmj.57.671.543",
      "authors": "Peden, N. R., Macaulay, K. E. C., Bissett, A. F., Crooks, J., & Pelosi, A. J.",
      "year": "1981",
      "title": "",
      "journal": "",
      "doi": "10.1136/pgmj.57.671.543",
      "url": "https://doi.org/10.1136/pgmj.57.671.543",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0522",
      "fullText": "Pedersen, M. M., & Steglich-Petersen, A. (n.d.). On the social epistemology of psychedelic experience. Philosophical Psychology, 0(0), 1–19. https://doi.org/10.1080/09515089.2024.2369685",
      "authors": "Pedersen, M. M., & Steglich-Petersen, A. (n.d.). On the social epistemology of psychedelic experience. Philosophical Psychology, 0(0), 1–19. https://doi.org/10.1080/09515089.2024.2369685",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/09515089.2024.2369685",
      "url": "https://doi.org/10.1080/09515089.2024.2369685",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pestana_2021",
      "fullText": "Pestana, J., Beccaria, F., & Petrilli, E. (2021). Psychedelic substance use in the Reddit psychonaut community. A qualitative study on motives and modalities. Drugs and Alcohol Today, 21(2), 112–123. https://doi.org/10.1108/DAT-03-2020-0016",
      "authors": "Pestana, J., Beccaria, F., & Petrilli, E.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1108/DAT-03-2020-0016",
      "url": "https://doi.org/10.1108/DAT-03-2020-0016",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "petersen_2020",
      "fullText": "Petersen, M., Garg, U., & Ketha, H. (2020). Chapter 16—Hallucinogens—Psychedelics and dissociative drugs. In H. Ketha & U. Garg (Eds.), Toxicology Cases for the Clinical and Forensic Laboratory (pp. 295–303). Academic Press. https://doi.org/10.1016/B978-0-12-815846-3.00016-8",
      "authors": "Petersen, M., Garg, U., & Ketha, H.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1016/B978-0-12-815846-3.00016-8",
      "url": "https://doi.org/10.1016/B978-0-12-815846-3.00016-8",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "peterson_2023",
      "fullText": "Peterson, A., Largent, E. A., Lynch, H. F., Karlawish, J., & Sisti, D. (2023). Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias. AJOB Neuroscience, 14(2), 107–123. https://doi.org/10.1080/21507740.2022.2148771",
      "authors": "Peterson, A., Largent, E. A., Lynch, H. F., Karlawish, J., & Sisti, D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/21507740.2022.2148771",
      "url": "https://doi.org/10.1080/21507740.2022.2148771",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "petranker_2020",
      "fullText": "Petranker, R., Anderson, T., & Farb, N. (2020). Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass. Frontiers in Psychology, 11, 1681. https://doi.org/10.3389/fpsyg.2020.01681",
      "authors": "Petranker, R., Anderson, T., & Farb, N.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2020.01681",
      "url": "https://doi.org/10.3389/fpsyg.2020.01681",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "petranker_2022",
      "fullText": "Petranker, R., Anderson, T., Maier, L. J., Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2022). Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. Journal of Psychopharmacology, 36(1), 85–96. https://doi.org/10.1177/0269881120953994",
      "authors": "Petranker, R., Anderson, T., Maier, L. J., Barratt, M. J., Ferris, J. A., & Winstock, A. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881120953994",
      "url": "https://doi.org/10.1177/0269881120953994",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "petranker_2020_1",
      "fullText": "Petranker, R., Kim, J., & Anderson, T. (2020). Microdosing as a response to the meaning crisis. PsyArXiv. https://doi.org/10.31234/osf.io/2jnkf",
      "authors": "Petranker, R., Kim, J., & Anderson, T.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/2jnkf",
      "url": "https://doi.org/10.31234/osf.io/2jnkf",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pflieger_2005",
      "fullText": "Pflieger, C. (2005). Les flashbacks induits par les psychodysleptiques hallucinogènes. Psychotropes, 11(1), 9. https://doi.org/10.3917/psyt.111.0009",
      "authors": "Pflieger, C.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.3917/psyt.111.0009",
      "url": "https://doi.org/10.3917/psyt.111.0009",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "piercey_2024",
      "fullText": "Piercey, C. J., Gray, B., Sung, A., Henry, D., & Karoly, H. C. (2024). Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence. Psychedelic Medicine, 2(4), 234–242. https://doi.org/10.1089/psymed.2023.0052",
      "authors": "Piercey, C. J., Gray, B., Sung, A., Henry, D., & Karoly, H. C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2023.0052",
      "url": "https://doi.org/10.1089/psymed.2023.0052",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pierrot_2000",
      "fullText": "Pierrot, M., Josse, P., Raspiller, M. F., Goulmy, M., Rambourg, M. O., Manel, J., & Lambert, H. (2000). [Intoxications by hallucinogenic mushrooms]. Annales De Medecine Interne, 151 Suppl B, B16-19.",
      "authors": "Pierrot, M., Josse, P., Raspiller, M. F., Goulmy, M., Rambourg, M. O., Manel, J., & Lambert, H.",
      "year": "2000",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pilecki_2021",
      "fullText": "Pilecki, B., Luoma, J. B., Bathje, G. J., Rhea, J., & Narloch, V. F. (2021). Ethical and legal issues in psychedelic harm reduction and integration therapy. Harm Reduction Journal, 18(1), 40. https://doi.org/10.1186/s12954-021-00489-1",
      "authors": "Pilecki, B., Luoma, J. B., Bathje, G. J., Rhea, J., & Narloch, V. F.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1186/s12954-021-00489-1",
      "url": "https://doi.org/10.1186/s12954-021-00489-1",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "pleet_2023",
      "fullText": "Pleet, M. M., White, J., Zamaria, J. A., & Yehuda, R. (2023). Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline. Psychedelic Medicine, 1(2), 69–73. https://doi.org/10.1089/psymed.2022.0017",
      "authors": "Pleet, M. M., White, J., Zamaria, J. A., & Yehuda, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1089/psymed.2022.0017",
      "url": "https://doi.org/10.1089/psymed.2022.0017",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "pokorny_2017",
      "fullText": "Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017). Effect of Psilocybin on Empathy and Moral Decision-Making. International Journal of Neuropsychopharmacology, 20(9), 747–757. https://doi.org/10.1093/ijnp/pyx047",
      "authors": "Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyx047",
      "url": "https://doi.org/10.1093/ijnp/pyx047",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "poling_1982",
      "fullText": "Poling, A. D., & Appel, J. B. (1982). Dependence-Producing Liability of LSD and Similar Psychotomimetics. In F. Hoffmeister & G. Stille (Eds.), Psychotropic Agents: Vol. 55 / 3 (pp. 111–116). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-67770-0_6",
      "authors": "Poling, A. D., & Appel, J. B.",
      "year": "1982",
      "title": "",
      "journal": "",
      "doi": "10.1007/978-3-642-67770-0_6",
      "url": "https://doi.org/10.1007/978-3-642-67770-0_6",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "polito_2022",
      "fullText": "Polito, V., & Liknaitzky, P. (2022). The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field. Neuroscience & Biobehavioral Reviews, 139, 104706. https://doi.org/10.1016/j.neubiorev.2022.104706",
      "authors": "Polito, V., & Liknaitzky, P.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neubiorev.2022.104706",
      "url": "https://doi.org/10.1016/j.neubiorev.2022.104706",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "polito_2024",
      "fullText": "Polito, V., & Liknaitzky, P. (2024). Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Journal of Psychopharmacology, 38(8), 701–711. https://doi.org/10.1177/02698811241254831",
      "authors": "Polito, V., & Liknaitzky, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241254831",
      "url": "https://doi.org/10.1177/02698811241254831",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "polito_2019",
      "fullText": "Polito, V., & Stevenson, R. J. (2019). A systematic study of microdosing psychedelics. PLOS ONE, 14(2), e0211023. https://doi.org/10.1371/journal.pone.0211023",
      "authors": "Polito, V., & Stevenson, R. J.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0211023",
      "url": "https://doi.org/10.1371/journal.pone.0211023",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pont_2017",
      "fullText": "Ponté, C., & Lapeyre-Mestre, M. (2017). [Psychoactive effects of “legal high”: About lysergic acid amide (LSA)]. Therapie, 72(5), 605–608. https://doi.org/10.1016/j.therap.2017.01.012",
      "authors": "Ponté, C., & Lapeyre-Mestre, M.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.therap.2017.01.012",
      "url": "https://doi.org/10.1016/j.therap.2017.01.012",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0540",
      "fullText": "Ponterotto, J. G. (n.d.). Full results and participant quotes from “A qualitative  inquiry into ethical relationship and boundary-setting in underground  psychedelic healing.”",
      "authors": "Ponterotto, J. G. (n.d.). Full results and participant quotes from “A qualitative  inquiry into ethical relationship and boundary-setting in underground  psychedelic healing.”",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pontual_2021",
      "fullText": "Pontual, A. A. D. D., Tófoli, L. F., Collares, C. F., Ramaekers, J. G., & Corradi-Webster, C. M. (2021). The Setting Questionnaire for the Ayahuasca Experience: Questionnaire Development and Internal Structure. Frontiers in Psychology, 12, 679016. https://doi.org/10.3389/fpsyg.2021.679016",
      "authors": "Pontual, A. A. D. D., Tófoli, L. F., Collares, C. F., Ramaekers, J. G., & Corradi-Webster, C. M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2021.679016",
      "url": "https://doi.org/10.3389/fpsyg.2021.679016",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "pontual_2022",
      "fullText": "Pontual, A. A. de D., Tófoli, L. F., Corradi-Webster, C. M., van Oorsouw, K., Delgado, A. R. O., & Ramaekers, J. G. (2022). The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users. Frontiers in Psychology, 13, 857372. https://doi.org/10.3389/fpsyg.2022.857372",
      "authors": "Pontual, A. A. de D., Tófoli, L. F., Corradi-Webster, C. M., van Oorsouw, K., Delgado, A. R. O., & Ramaekers, J. G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2022.857372",
      "url": "https://doi.org/10.3389/fpsyg.2022.857372",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0543",
      "fullText": "Poppe, C., & Repantis, D. (n.d.). Ethical Aspects of Psychedelic-Assisted Treatments: An Overview (pp. 1–16). Springer. https://doi.org/10.1007/7854_2024_533",
      "authors": "Poppe, C., & Repantis, D. (n.d.). Ethical Aspects of Psychedelic-Assisted Treatments: An Overview (pp. 1–16). Springer. https://doi.org/10.1007/7854_2024_533",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1007/7854_2024_533",
      "url": "https://doi.org/10.1007/7854_2024_533",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "poyatos_2023",
      "fullText": "Poyatos, L., Pérez-Mañá, C., Hladun, O., Núñez-Montero, M., de la Rosa, G., Martín, S., Barriocanal, A. M., Carabias, L., Kelmendi, B., Taoussi, O., Busardò, F. P., Fonseca, F., Torrens, M., Pichini, S., Farré, M., & Papaseit, E. (2023). Pharmacological effects of methylone and MDMA in humans. Frontiers in Pharmacology, 14, 1122861. https://doi.org/10.3389/fphar.2023.1122861",
      "authors": "Poyatos, L., Pérez-Mañá, C., Hladun, O., Núñez-Montero, M., de la Rosa, G., Martín, S., Barriocanal, A. M., Carabias, L., Kelmendi, B., Taoussi, O., Busardò, F. P., Fonseca, F., Torrens, M., Pichini, S., Farré, M., & Papaseit, E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2023.1122861",
      "url": "https://doi.org/10.3389/fphar.2023.1122861",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0545",
      "fullText": "Prevalence and epidemiological associates of novel psychedelic use in the United States adult population—James D Sexton, Michael S Crawford, Noah W Sweat, Allyson Varley, Emma E Green, Peter S Hendricks, 2019. (n.d.). Retrieved January 12, 2025, from https://journals.sagepub.com/doi/10.1177/0269881119827796",
      "authors": "Prevalence and epidemiological associates of novel psychedelic use in the United States adult population—James D Sexton, Michael S Crawford, Noah W Sweat, Allyson Varley, Emma E Green, Peter S Hendricks, 2019. (n.d.). Retrieved January 12, 2025, from https://journals.sagepub.com/doi/10.1177/0269881119827796",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.sagepub.com/doi/10.1177/0269881119827796",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "price_2022",
      "fullText": "Price, C. M., Feduccia, A. A., & DeBonis, K. (2022). Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance. Journal of Clinical Psychopharmacology, 42(5), 464–469. https://doi.org/10.1097/JCP.0000000000001595",
      "authors": "Price, C. M., Feduccia, A. A., & DeBonis, K.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1097/JCP.0000000000001595",
      "url": "https://doi.org/10.1097/JCP.0000000000001595",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "pronovostmorgan_2023",
      "fullText": "Pronovost-Morgan, C., Hartogsohn, I., & Ramaekers, J. G. (2023). Harnessing placebo: Lessons from psychedelic science. Journal of Psychopharmacology, 37(9), 866–875. https://doi.org/10.1177/02698811231182602",
      "authors": "Pronovost-Morgan, C., Hartogsohn, I., & Ramaekers, J. G.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231182602",
      "url": "https://doi.org/10.1177/02698811231182602",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "psychedelicdrugcrisestoxicityandtherapeuticsrequestpdf_2024",
      "fullText": "Psychedelic Drug Crises: Toxicity and Therapeutics | Request PDF. (2024). ResearchGate. https://www.researchgate.net/publication/233116091_Psychedelic_Drug_Crises_Toxicity_and_Therapeutics",
      "authors": "Psychedelic Drug Crises: Toxicity and Therapeutics | Request PDF.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/233116091_Psychedelic_Drug_Crises_Toxicity_and_Therapeutics",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0550",
      "fullText": "Psychedelic medicalization, public discourse, and the morality of ego dissolution | Request PDF. (n.d.). Retrieved January 4, 2025, from https://www.researchgate.net/publication/352319926_Psychedelic_medicalization_public_discourse_and_the_morality_of_ego_dissolution",
      "authors": "Psychedelic medicalization, public discourse, and the morality of ego dissolution | Request PDF. (n.d.). Retrieved January 4, 2025, from https://www.researchgate.net/publication/352319926_Psychedelic_medicalization_public_discourse_and_the_morality_of_ego_dissolution",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.researchgate.net/publication/352319926_Psychedelic_medicalization_public_discourse_and_the_morality_of_ego_dissolution",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0551",
      "fullText": "Psychedelic medicalization, public discourse, and the morality of ego dissolution—Alex K Gearin, Neşe Devenot, 2021. (n.d.). Retrieved January 4, 2025, from https://journals.sagepub.com/doi/abs/10.1177/13678779211019424?journalCode=icsa",
      "authors": "Psychedelic medicalization, public discourse, and the morality of ego dissolution—Alex K Gearin, Neşe Devenot, 2021. (n.d.). Retrieved January 4, 2025, from https://journals.sagepub.com/doi/abs/10.1177/13678779211019424?journalCode=icsa",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.sagepub.com/doi/abs/10.1177/13678779211019424?journalCode=icsa",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0549",
      "fullText": "Psychedelic medicalization, public discourse, and the morality of ego dissolution. (n.d.). Blossom. Retrieved January 4, 2025, from https://blossomanalysis.com/papers/psychedelic-medicalization-public-discourse-and-the-morality-of-ego-dissolution/",
      "authors": "Psychedelic medicalization, public discourse, and the morality of ego dissolution. (n.d.). Blossom. Retrieved January 4, 2025, from https://blossomanalysis.com/papers/psychedelic-medicalization-public-discourse-and-the-morality-of-ego-dissolution/",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://blossomanalysis.com/papers/psychedelic-medicalization-public-discourse-and-the-morality-of-ego-dissolution/",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "rabinowitz_2023",
      "fullText": "Rabinowitz, J., Lev-Ran, S., & Gross, R. (2023). The association between naturalistic use of psychedelics and co-occurring substance use disorders. Frontiers in Psychiatry, 13, 1066369. https://doi.org/10.3389/fpsyt.2022.1066369",
      "authors": "Rabinowitz, J., Lev-Ran, S., & Gross, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.1066369",
      "url": "https://doi.org/10.3389/fpsyt.2022.1066369",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0553",
      "fullText": "Racial Disparities in Access to Psychedelic Treatments and Inclusion in Research Trials | Psychiatric Annals. (n.d.). Retrieved February 27, 2025, from https://journals.healio.com/doi/10.3928/00485713-20221123-01",
      "authors": "Racial Disparities in Access to Psychedelic Treatments and Inclusion in Research Trials | Psychiatric Annals. (n.d.). Retrieved February 27, 2025, from https://journals.healio.com/doi/10.3928/00485713-20221123-01",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.healio.com/doi/10.3928/00485713-20221123-01",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "rahayu_2019",
      "fullText": "Rahayu, Y., Riyanto, A., & Wibowo, A. (2019). Relationship Of Magic Mushroom Literation As A Drug With Abuse It’s Use As A Hallucination. International Journal on Advanced Science, Education, and Religion, 2(1), 27–34. https://doi.org/10.33648/ijoaser.v2i1.25",
      "authors": "Rahayu, Y., Riyanto, A., & Wibowo, A.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.33648/ijoaser.v2i1.25",
      "url": "https://doi.org/10.33648/ijoaser.v2i1.25",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "raison_2022",
      "fullText": "Raison, C. L., Jain, R., Penn, A. D., Cole, S. P., & Jain, S. (2022). Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Frontiers in Psychiatry, 13, 831092. https://doi.org/10.3389/fpsyt.2022.831092",
      "authors": "Raison, C. L., Jain, R., Penn, A. D., Cole, S. P., & Jain, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.831092",
      "url": "https://doi.org/10.3389/fpsyt.2022.831092",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "raison_2023",
      "fullText": "Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., Gukasyan, N., Nayak, S. M., Hu, X., O’Donnell, K. C., Kelmendi, B., Sloshower, J., Penn, A. D., Bradley, E., Kelly, D. F., … Griffiths, R. R. (2023). Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA, 330(9), 843–853. https://doi.org/10.1001/jama.2023.14530",
      "authors": "Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., Gukasyan, N., Nayak, S. M., Hu, X., O’Donnell, K. C., Kelmendi, B., Sloshower, J., Penn, A. D., Bradley, E., Kelly, D. F., … Griffiths, R. R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1001/jama.2023.14530",
      "url": "https://doi.org/10.1001/jama.2023.14530",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "raj_2022",
      "fullText": "Raj, G. (2022). Psychedelic use in India, its pattern and personal significance – findings from an online survey. Indian Journal of Psychiatry, 64(4), 428–429. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21",
      "authors": "Raj, G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.4103/indianjpsychiatry.indianjpsychiatry_447_21",
      "url": "https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_447_21",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "raja_2024",
      "fullText": "Raja, S. M., Guptill, J. T., Mack, M., Peterson, M., Byard, S., Twieg, R., Jordan, L., Rich, N., Castledine, R., Bourne, S., Wilmshurst, M., Oxendine, S., Avula, S. G. C., Zuleta, H., Quigley, P., Lawson, S., McQuaker, S. J., Ahmadkhaniha, R., Appelbaum, L. G., … Thomas, C. J. (2024). A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers. Clinical Pharmacology and Therapeutics, 116(5), 1314–1324. https://doi.org/10.1002/cpt.3391",
      "authors": "Raja, S. M., Guptill, J. T., Mack, M., Peterson, M., Byard, S., Twieg, R., Jordan, L., Rich, N., Castledine, R., Bourne, S., Wilmshurst, M., Oxendine, S., Avula, S. G. C., Zuleta, H., Quigley, P., Lawson, S., McQuaker, S. J., Ahmadkhaniha, R., Appelbaum, L. G., … Thomas, C. J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1002/cpt.3391",
      "url": "https://doi.org/10.1002/cpt.3391",
      "categories": [
        "safety",
        "harm_reduction",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rajwani_2022",
      "fullText": "Rajwani, K. (2022). Should Adolescents be Included in Emerging Psychedelic Research? Canadian Journal of Bioethics, 5(2), 36. https://doi.org/10.7202/1089784ar",
      "authors": "Rajwani, K.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.7202/1089784ar",
      "url": "https://doi.org/10.7202/1089784ar",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ramaekers_2006",
      "fullText": "Ramaekers, J. G., & Kuypers, K. P. C. (2006). Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol. Neuropsychopharmacology, 31(5), 1048–1055. https://doi.org/10.1038/sj.npp.1300894",
      "authors": "Ramaekers, J. G., & Kuypers, K. P. C.",
      "year": "2006",
      "title": "",
      "journal": "",
      "doi": "10.1038/sj.npp.1300894",
      "url": "https://doi.org/10.1038/sj.npp.1300894",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ramaekers_2025",
      "fullText": "Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025). Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression. American Journal of Psychiatry, 182(1), 33–46. https://doi.org/10.1176/appi.ajp.20230890",
      "authors": "Ramaekers, J. G., Reckweg, J. T., & Mason, N. L.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230890",
      "url": "https://doi.org/10.1176/appi.ajp.20230890",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ramaekers_2024",
      "fullText": "Ramaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L. (2024). Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): A first in human, designer drug study. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-02042-7",
      "authors": "Ramaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41386-024-02042-7",
      "url": "https://doi.org/10.1038/s41386-024-02042-7",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "reichelt_2022",
      "fullText": "Reichelt, A. (2022). Complexities of psychedelics for therapeutic use in obesity and eating disorders. Journal of Psychiatry and Neuroscience, 47(5), E366–E366. https://doi.org/10.1503/jpn.220135-l",
      "authors": "Reichelt, A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1503/jpn.220135-l",
      "url": "https://doi.org/10.1503/jpn.220135-l",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "rekatsina_2022",
      "fullText": "Rekatsina, M., Moka, E., Vadalouca, A., & Varrassi, G. (2022). SP56 Psychedelic drugs and pain. Invited Speakers, A64–A64. https://doi.org/10.1136/rapm-2022-ESRA.62",
      "authors": "Rekatsina, M., Moka, E., Vadalouca, A., & Varrassi, G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1136/rapm-2022-ESRA.62",
      "url": "https://doi.org/10.1136/rapm-2022-ESRA.62",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "riba_2005",
      "fullText": "Riba, J., & Barbanoj, M. J. (2005). Bringing ayahuasca to the clinical research laboratory. Journal of Psychoactive Drugs, 37(2), 219–230. https://doi.org/10.1080/02791072.2005.10399804",
      "authors": "Riba, J., & Barbanoj, M. J.",
      "year": "2005",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2005.10399804",
      "url": "https://doi.org/10.1080/02791072.2005.10399804",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "rickli_2015",
      "fullText": "Rickli, A., Luethi, D., Reinisch, J., Buchy, D., Hoener, M. C., & Liechti, M. E. (2015). Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology, 99, 546–553. https://doi.org/10.1016/j.neuropharm.2015.08.034",
      "authors": "Rickli, A., Luethi, D., Reinisch, J., Buchy, D., Hoener, M. C., & Liechti, M. E.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neuropharm.2015.08.034",
      "url": "https://doi.org/10.1016/j.neuropharm.2015.08.034",
      "categories": [
        "contraindications",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rivaposse_2018",
      "fullText": "Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., Saah, T. C., Dunlop, B. W., & McDonald, W. M. (2018). Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions. Journal of Affective Disorders, 236, 291–297. https://doi.org/10.1016/j.jad.2018.02.025",
      "authors": "Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., Saah, T. C., Dunlop, B. W., & McDonald, W. M.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2018.02.025",
      "url": "https://doi.org/10.1016/j.jad.2018.02.025",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "rms_2024",
      "fullText": "Rms*, C. (2024). Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders. Annals of Bioethics & Clinical Applications, 7(1). https://doi.org/10.23880/abca-16000266",
      "authors": "Rms*, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.23880/abca-16000266",
      "url": "https://doi.org/10.23880/abca-16000266",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "roberts_2020",
      "fullText": "Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H., & Christiansen, P. (2020). Perceived harm, motivations for use and subjective experiences of recreational psychedelic “magic” mushroom use. Journal of Psychopharmacology (Oxford, England), 34(9), 999–1007. https://doi.org/10.1177/0269881120936508",
      "authors": "Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H., & Christiansen, P.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881120936508",
      "url": "https://doi.org/10.1177/0269881120936508",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "robinson_2024",
      "fullText": "Robinson, C., Slitzky, M., Schatman, M., Yong, R., Lehman, A., Kaynar, A. M., Shivanekar, S., & Emerick, T. (2024). Ethical Considerations Regarding Psychedelics for Clinical Pain Research. Journal of Pain Research, Volume 17, 4357–4364. https://doi.org/10.2147/JPR.S491470",
      "authors": "Robinson, C., Slitzky, M., Schatman, M., Yong, R., Lehman, A., Kaynar, A. M., Shivanekar, S., & Emerick, T.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.2147/JPR.S491470",
      "url": "https://doi.org/10.2147/JPR.S491470",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "robinson_2024_1",
      "fullText": "Robinson, O. C., Evans, J., Luke, D., McAlpine, R., Sahely, A., Fisher, A., Sundeman, S., Ketzitzidou Argyri, E., Murphy-Beiner, A., Michelle, K., & Prideaux, E. (2024). Coming back together: A qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs. Frontiers in Psychology, 15, 1369715. https://doi.org/10.3389/fpsyg.2024.1369715",
      "authors": "Robinson, O. C., Evans, J., Luke, D., McAlpine, R., Sahely, A., Fisher, A., Sundeman, S., Ketzitzidou Argyri, E., Murphy-Beiner, A., Michelle, K., & Prideaux, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2024.1369715",
      "url": "https://doi.org/10.3389/fpsyg.2024.1369715",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "robinson_2024_2",
      "fullText": "Robinson, O. C., Evans, J., McAlpine, R. G., Argyri, E. K., & Luke, D. (2024). An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies. https://doi.org/10.1556/2054.2024.00420",
      "authors": "Robinson, O. C., Evans, J., McAlpine, R. G., Argyri, E. K., & Luke, D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00420",
      "url": "https://doi.org/10.1556/2054.2024.00420",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "robinson_2024_3",
      "fullText": "Robinson, O., Evans, J., Luke, D., McAlpine, R., Sahely, A., Fisher, A., Sundeman, S., Argyri, E. K., Murphy-Beiner, A., Michelle, K., & Prideaux, E. (2024). Coming Back Together: A Qualitative Survey Study of Coping and Support Strategies Used by People to Cope With Extended Difficulties After the Use of Psychedelic Drugs (SSRN Scholarly Paper No. 4687209). Social Science Research Network. https://doi.org/10.2139/ssrn.4687209",
      "authors": "Robinson, O., Evans, J., Luke, D., McAlpine, R., Sahely, A., Fisher, A., Sundeman, S., Argyri, E. K., Murphy-Beiner, A., Michelle, K., & Prideaux, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.2139/ssrn.4687209",
      "url": "https://doi.org/10.2139/ssrn.4687209",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "rocha_2023",
      "fullText": "Rocha, J. M., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & Dos Santos, R. G. (2023). Identifying setting factors associated with improved ibogaine safety: A systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience, 273(7), 1527–1542. https://doi.org/10.1007/s00406-023-01590-1",
      "authors": "Rocha, J. M., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & Dos Santos, R. G.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00406-023-01590-1",
      "url": "https://doi.org/10.1007/s00406-023-01590-1",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "rodolico_2024",
      "fullText": "Rodolico, A., Cutrufelli, P., Di Francesco, A., Aguglia, A., Catania, G., Concerto, C., Cuomo, A., Fagiolini, A., Lanza, G., Mineo, L., Natale, A., Rapisarda, L., Petralia, A., Signorelli, M. S., & Aguglia, E. (2024). Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: An overview of systematic reviews with meta-analysis. Frontiers in Psychiatry, 15, 1325399. https://doi.org/10.3389/fpsyt.2024.1325399",
      "authors": "Rodolico, A., Cutrufelli, P., Di Francesco, A., Aguglia, A., Catania, G., Concerto, C., Cuomo, A., Fagiolini, A., Lanza, G., Mineo, L., Natale, A., Rapisarda, L., Petralia, A., Signorelli, M. S., & Aguglia, E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2024.1325399",
      "url": "https://doi.org/10.3389/fpsyt.2024.1325399",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "rodrigues_2024",
      "fullText": "Rodrigues, L. S., Reis, J. A. S., Rossi, G. N., Guerra, L. T. L., Maekawa, R. M., de Lima Osório, F., Bouso, J. C., Santos, F. P., Paranhos, B. A. P. B., Yonamine, M., Hallak, J. E. C., & dos Santos, R. G. (2024). Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial. Journal of Clinical Psychopharmacology, 44(4), 402. https://doi.org/10.1097/JCP.0000000000001872",
      "authors": "Rodrigues, L. S., Reis, J. A. S., Rossi, G. N., Guerra, L. T. L., Maekawa, R. M., de Lima Osório, F., Bouso, J. C., Santos, F. P., Paranhos, B. A. P. B., Yonamine, M., Hallak, J. E. C., & dos Santos, R. G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1097/JCP.0000000000001872",
      "url": "https://doi.org/10.1097/JCP.0000000000001872",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rodrguezarenas_1997",
      "fullText": "Rodríguez Arenas, M. A., Barrio Anta, G., de la Fuente de Hoz, L., & Royuela, L. (1997). [Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants]. Revista Clinica Espanola, 197(12), 804–809.",
      "authors": "Rodríguez Arenas, M. A., Barrio Anta, G., de la Fuente de Hoz, L., & Royuela, L.",
      "year": "1997",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "rolando_2019",
      "fullText": "Rolando, S., & Beccaria, F. (2019). “The junkie abuses, the psychonaut learns”: A qualitative analysis of an online drug forum community. Drugs and Alcohol Today, 19(4), 282–294. https://doi.org/10.1108/DAT-10-2018-0052",
      "authors": "Rolando, S., & Beccaria, F.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1108/DAT-10-2018-0052",
      "url": "https://doi.org/10.1108/DAT-10-2018-0052",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "romeo_2024",
      "fullText": "Romeo, B., Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A. (2024). Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Psychiatry Research, 335, 115880. https://doi.org/10.1016/j.psychres.2024.115880",
      "authors": "Romeo, B., Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psychres.2024.115880",
      "url": "https://doi.org/10.1016/j.psychres.2024.115880",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "rosa_2022",
      "fullText": "Rosa, W. E., Sager, Z., Miller, M., Bernstein, I., Doerner Rinaldi, A., Addicott, K., Ljuslin, M., Adrian, C., Back, A. L., Beachy, J., Bossis, A. P., Breitbart, W. S., Cosimano, M. P., Fischer, S. M., Guss, J., Knighton, E., Phelps, J., Richards, B. D., Richards, W. A., … Beaussant, Y. (2022). Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Journal of Palliative Medicine, 25(8), 1273–1281. https://doi.org/10.1089/jpm.2022.0036",
      "authors": "Rosa, W. E., Sager, Z., Miller, M., Bernstein, I., Doerner Rinaldi, A., Addicott, K., Ljuslin, M., Adrian, C., Back, A. L., Beachy, J., Bossis, A. P., Breitbart, W. S., Cosimano, M. P., Fischer, S. M., Guss, J., Knighton, E., Phelps, J., Richards, B. D., Richards, W. A., … Beaussant, Y.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1089/jpm.2022.0036",
      "url": "https://doi.org/10.1089/jpm.2022.0036",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "rose_2024",
      "fullText": "Rose, J. R. (2024). Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00363",
      "authors": "Rose, J. R.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00363",
      "url": "https://doi.org/10.1556/2054.2024.00363",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "roseman_2024",
      "fullText": "Roseman, L., Erritzoe, D., Nutt, D., Carhart-Harris, R., & Timmermann, C. (2024). Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy. JAMA Network Open, 7(7), e2422181. https://doi.org/10.1001/jamanetworkopen.2024.22181",
      "authors": "Roseman, L., Erritzoe, D., Nutt, D., Carhart-Harris, R., & Timmermann, C.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamanetworkopen.2024.22181",
      "url": "https://doi.org/10.1001/jamanetworkopen.2024.22181",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "roseman_2018",
      "fullText": "Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology, 8. https://doi.org/10.3389/fphar.2017.00974",
      "authors": "Roseman, L., Nutt, D. J., & Carhart-Harris, R. L.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2017.00974",
      "url": "https://doi.org/10.3389/fphar.2017.00974",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rosenbaum_2023",
      "fullText": "Rosenbaum, D., Cho, M., Schneider, E., Hales, S., & Buchman, D. Z. (2023). Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying. AJOB Neuroscience, 14(2), 139–141. https://doi.org/10.1080/21507740.2023.2188297",
      "authors": "Rosenbaum, D., Cho, M., Schneider, E., Hales, S., & Buchman, D. Z.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/21507740.2023.2188297",
      "url": "https://doi.org/10.1080/21507740.2023.2188297",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "rosenbaum_2024",
      "fullText": "Rosenbaum, D., Hare, C., Hapke, E., Herman, Y., Abbey, S. E., Sisti, D., & Buchman, D. Z. (2024). Experiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit Analysis. Hastings Center Report, 54(4), 32–46. https://doi.org/10.1002/hast.1602",
      "authors": "Rosenbaum, D., Hare, C., Hapke, E., Herman, Y., Abbey, S. E., Sisti, D., & Buchman, D. Z.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1002/hast.1602",
      "url": "https://doi.org/10.1002/hast.1602",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "rosenbaum_2020",
      "fullText": "Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L.-A., Hui, K., & Hapke, E. (2020). Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of Psychopharmacology, 34(6), 612–622. https://doi.org/10.1177/0269881120908004",
      "authors": "Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L.-A., Hui, K., & Hapke, E.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881120908004",
      "url": "https://doi.org/10.1177/0269881120908004",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rosenblat_2023",
      "fullText": "Rosenblat, J. D., Husain, M. I., Lee, Y., McIntyre, R. S., Mansur, R. B., Castle, D., Offman, H., Parikh, S. V., Frey, B. N., Schaffer, A., Greenway, K. T., Garel, N., Beaulieu, S., Kennedy, S. H., Lam, R. W., Milev, R., Ravindran, A. V., Tourjman, V., Ameringen, M. V., … Taylor, V. (2023). The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. The Canadian Journal of Psychiatry, 68(1), 5–21. https://doi.org/10.1177/07067437221111371",
      "authors": "Rosenblat, J. D., Husain, M. I., Lee, Y., McIntyre, R. S., Mansur, R. B., Castle, D., Offman, H., Parikh, S. V., Frey, B. N., Schaffer, A., Greenway, K. T., Garel, N., Beaulieu, S., Kennedy, S. H., Lam, R. W., Milev, R., Ravindran, A. V., Tourjman, V., Ameringen, M. V., … Taylor, V.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/07067437221111371",
      "url": "https://doi.org/10.1177/07067437221111371",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ross_2016",
      "fullText": "Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for          anxiety and depression in patients with life-threatening cancer: A randomized controlled          trial. Journal of Psychopharmacology, 30(12), 1165–1180. https://doi.org/10.1177/0269881116675512",
      "authors": "Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881116675512",
      "url": "https://doi.org/10.1177/0269881116675512",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rossi_2022",
      "fullText": "Rossi, G. N., Hallak, J. E. C., Bouso Saiz, J. C., & Dos Santos, R. G. (2022). Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety, 21(6), 761–776. https://doi.org/10.1080/14740338.2022.2066650",
      "authors": "Rossi, G. N., Hallak, J. E. C., Bouso Saiz, J. C., & Dos Santos, R. G.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1080/14740338.2022.2066650",
      "url": "https://doi.org/10.1080/14740338.2022.2066650",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "rossi_2023",
      "fullText": "Rossi, G. N., Rocha, J. M., Osório, F. L., Bouso, J. C., Ona, G., Silveira, G. de O., Yonamine, M., Bertozi, G., Crevelin, E. J., Queiroz, M. E., Crippa, J. A. S., Hallak, J. E. C., & Dos Santos, R. G. (2023). Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial. Journal of Clinical Psychopharmacology, 43(4), 339–349. https://doi.org/10.1097/JCP.0000000000001691",
      "authors": "Rossi, G. N., Rocha, J. M., Osório, F. L., Bouso, J. C., Ona, G., Silveira, G. de O., Yonamine, M., Bertozi, G., Crevelin, E. J., Queiroz, M. E., Crippa, J. A. S., Hallak, J. E. C., & Dos Santos, R. G.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1097/JCP.0000000000001691",
      "url": "https://doi.org/10.1097/JCP.0000000000001691",
      "categories": [
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rouaud_2024",
      "fullText": "Rouaud, A., Calder, A. E., & Hasler, G. (2024). Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. Journal of Psychopharmacology, 38(3), 217–224. https://doi.org/10.1177/02698811231225609",
      "authors": "Rouaud, A., Calder, A. E., & Hasler, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231225609",
      "url": "https://doi.org/10.1177/02698811231225609",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ruane_2015",
      "fullText": "Ruane, D. (2015). Harm Reduction or Psychedelic Support? Caring for Drug-Related Crises at Transformational Festivals. Dancecult, 7(1), 55–75. https://doi.org/10.12801/1947-5403.2015.07.01.03",
      "authors": "Ruane, D.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.12801/1947-5403.2015.07.01.03",
      "url": "https://doi.org/10.12801/1947-5403.2015.07.01.03",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "rucker_2024",
      "fullText": "Rucker, J. J., Roberts, C., Seynaeve, M., Young, A. H., Suttle, B., Yamamoto, T., Ermakova, A. O., Dunbar, F., & Wiegand, F. (2024). Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants. Journal of Psychopharmacology, 38(8), 712–723. https://doi.org/10.1177/02698811241246857",
      "authors": "Rucker, J. J., Roberts, C., Seynaeve, M., Young, A. H., Suttle, B., Yamamoto, T., Ermakova, A. O., Dunbar, F., & Wiegand, F.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241246857",
      "url": "https://doi.org/10.1177/02698811241246857",
      "categories": [
        "safety",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "rucker_2023",
      "fullText": "Rucker, J., Seynaeve, M., Young, A. H., Roberts, C., Suttle, B., Yamamoto, T., Ermakova, A. O., Dunbar, F., & Wiegand, F. (2023). 105. Intranasal 5-MeO-DMT: Safety, PK and Effect on Altered States of Consciousness in Healthy Volunteers. Biological Psychiatry, 93(9, Supplement), S136. https://doi.org/10.1016/j.biopsych.2023.02.345",
      "authors": "Rucker, J., Seynaeve, M., Young, A. H., Roberts, C., Suttle, B., Yamamoto, T., Ermakova, A. O., Dunbar, F., & Wiegand, F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.biopsych.2023.02.345",
      "url": "https://doi.org/10.1016/j.biopsych.2023.02.345",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "russ_2019",
      "fullText": "Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. (2019). States and traits related to the quality and consequences of psychedelic experiences. Psychology of Consciousness: Theory, Research, and Practice, 6(1), 1–21. https://doi.org/10.1037/cns0000169",
      "authors": "Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1037/cns0000169",
      "url": "https://doi.org/10.1037/cns0000169",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ryan_2023",
      "fullText": "Ryan, E., & Kulkarni, J. (2023). A potential role for onabotulinumtoxinA in the management of Hallucinogen persisting perception disorder. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists, 31(2), 230–231. https://doi.org/10.1177/10398562231154107",
      "authors": "Ryan, E., & Kulkarni, J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/10398562231154107",
      "url": "https://doi.org/10.1177/10398562231154107",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ryan_2023_1",
      "fullText": "Ryan, R. S., Copello, A., & Fox, A. P. (2023). Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. BMC Psychiatry, 23(1), 160. https://doi.org/10.1186/s12888-023-04628-9",
      "authors": "Ryan, R. S., Copello, A., & Fox, A. P.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1186/s12888-023-04628-9",
      "url": "https://doi.org/10.1186/s12888-023-04628-9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sab_2024",
      "fullText": "Sabé, M., Sulstarova, A., Glangetas, A., De Pieri, M., Mallet, L., Curtis, L., Richard-Lepouriel, H., Penzenstadler, L., Seragnoli, F., Thorens, G., Zullino, D., Preller, K., Böge, K., Leucht, S., Correll, C. U., Solmi, M., Kaiser, S., & Kirschner, M. (2024). Reconsidering evidence for psychedelic-induced psychosis: An overview of reviews, a systematic review, and meta-analysis of human studies. Molecular Psychiatry, 1–33. https://doi.org/10.1038/s41380-024-02800-5",
      "authors": "Sabé, M., Sulstarova, A., Glangetas, A., De Pieri, M., Mallet, L., Curtis, L., Richard-Lepouriel, H., Penzenstadler, L., Seragnoli, F., Thorens, G., Zullino, D., Preller, K., Böge, K., Leucht, S., Correll, C. U., Solmi, M., Kaiser, S., & Kirschner, M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41380-024-02800-5",
      "url": "https://doi.org/10.1038/s41380-024-02800-5",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0599",
      "fullText": "Safety pharmacology of acute mescaline administration in healthy participants · ivySCI. (n.d.). ivySCI. Retrieved January 14, 2025, from https://www.ivysci.com/articles/7059896__Safety_pharmacology_of_acute_mescaline_administration_in_healthy_participants",
      "authors": "Safety pharmacology of acute mescaline administration in healthy participants · ivySCI. (n.d.). ivySCI. Retrieved January 14, 2025, from https://www.ivysci.com/articles/7059896__Safety_pharmacology_of_acute_mescaline_administration_in_healthy_participants",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.ivysci.com/articles/7059896__Safety_pharmacology_of_acute_mescaline_administration_in_healthy_participants",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0600",
      "fullText": "Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder. (n.d.). Psychiatrist.Com. Retrieved January 4, 2025, from https://www.psychiatrist.com/jcp/safety-tolerability-efficacy-psilocybin-patients-obsessive/",
      "authors": "Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder. (n.d.). Psychiatrist.Com. Retrieved January 4, 2025, from https://www.psychiatrist.com/jcp/safety-tolerability-efficacy-psilocybin-patients-obsessive/",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.psychiatrist.com/jcp/safety-tolerability-efficacy-psilocybin-patients-obsessive/",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "sakai_2024",
      "fullText": "Sakai, K., Bradley, E. R., Zamaria, J. A., Agin-Liebes, G., Kelley, D. P., Fish, A., Martini, V., Ferris, M. C., Morton, E., Michalak, E. E., O’Donovan, A., & Woolley, J. D. (2024). Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms. Psychopharmacology, 241(8), 1617–1630. https://doi.org/10.1007/s00213-024-06585-x",
      "authors": "Sakai, K., Bradley, E. R., Zamaria, J. A., Agin-Liebes, G., Kelley, D. P., Fish, A., Martini, V., Ferris, M. C., Morton, E., Michalak, E. E., O’Donovan, A., & Woolley, J. D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-024-06585-x",
      "url": "https://doi.org/10.1007/s00213-024-06585-x",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "salzman_2017",
      "fullText": "Salzman, C., & Abraham, H. D. (2017). Hallucinogen Persisting Perception Disorder Following Therapeutic Ketamine: A Case Report. Journal of Alcoholism & Drug Dependence, 05(05). https://doi.org/10.4172/2329-6488.1000281",
      "authors": "Salzman, C., & Abraham, H. D.",
      "year": "2017",
      "title": "",
      "journal": "",
      "doi": "10.4172/2329-6488.1000281",
      "url": "https://doi.org/10.4172/2329-6488.1000281",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "sami_2015",
      "fullText": "Sami, M., Piggott, K., Coysh, C., & Fialho, A. (2015). Psychosis, psychedelic substance misuse and head injury: A case report and 23 year follow-up. Brain Injury, 29(11), 1383–1386. https://doi.org/10.3109/02699052.2015.1046491",
      "authors": "Sami, M., Piggott, K., Coysh, C., & Fialho, A.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.3109/02699052.2015.1046491",
      "url": "https://doi.org/10.3109/02699052.2015.1046491",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sanchezpetrement_2023",
      "fullText": "Sanchez Petrement, M. (2023). Psychedelic therapy as reality transformation: A phenomenological approach. Journal of Psychedelic Studies, 7(1), 36–47. https://doi.org/10.1556/2054.2023.00231",
      "authors": "Sanchez Petrement, M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2023.00231",
      "url": "https://doi.org/10.1556/2054.2023.00231",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sanders_2008",
      "fullText": "Sanders, B., Lankenau, S. E., Bloom, J. J., & Hathazi, D. (2008). “Research Chemicals”: Tryptamine and Phenethylamine Use Among High-Risk Youth. Substance Use & Misuse, 43(3–4), 389–402. https://doi.org/10.1080/00952990701202970",
      "authors": "Sanders, B., Lankenau, S. E., Bloom, J. J., & Hathazi, D.",
      "year": "2008",
      "title": "",
      "journal": "",
      "doi": "10.1080/00952990701202970",
      "url": "https://doi.org/10.1080/00952990701202970",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "sapkota_2021",
      "fullText": "Sapkota, A., Khurshid, H., Qureshi, I. A., Jahan, N., Went, T. R., Sultan, W., & Alfonso, M. (2021). Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.17352",
      "authors": "Sapkota, A., Khurshid, H., Qureshi, I. A., Jahan, N., Went, T. R., Sultan, W., & Alfonso, M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.7759/cureus.17352",
      "url": "https://doi.org/10.7759/cureus.17352",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "sarparast_2022",
      "fullText": "Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022). Drug-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review. Psychopharmacology, 239(6), 1945–1976. https://doi.org/10.1007/s00213-022-06083-y",
      "authors": "Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-022-06083-y",
      "url": "https://doi.org/10.1007/s00213-022-06083-y",
      "categories": [
        "contraindications",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "savides_2024",
      "fullText": "Savides, I. A., & Outhoff, K. (2024). Less is more? A review of psilocybin microdosing. Journal of Psychopharmacology, 38(10), 846–860. https://doi.org/10.1177/02698811241278769",
      "authors": "Savides, I. A., & Outhoff, K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241278769",
      "url": "https://doi.org/10.1177/02698811241278769",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "scala_2024",
      "fullText": "Scala, M., Fabbri, C., Fusar-Poli, P., Di Lorenzo, G., Ferrara, M., Amerio, A., Fusar-Poli, L., Pichiecchio, A., Asteggiano, C., Menchetti, M., De Ronchi, D., MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli, G., & Serretti, A. (2024). The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges. CNS Spectrums, 1–15. https://doi.org/10.1017/S1092852924002268",
      "authors": "Scala, M., Fabbri, C., Fusar-Poli, P., Di Lorenzo, G., Ferrara, M., Amerio, A., Fusar-Poli, L., Pichiecchio, A., Asteggiano, C., Menchetti, M., De Ronchi, D., MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli, G., & Serretti, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1017/S1092852924002268",
      "url": "https://doi.org/10.1017/S1092852924002268",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "scarlatti_2023",
      "fullText": "Scarlatti, F. (2023). The Relationship between Plasticity in the Primary Visual Cortex and the Hallucinatory Persisting Perception Disorder. PsyArXiv. https://doi.org/10.31234/osf.io/gfuet",
      "authors": "Scarlatti, F.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/gfuet",
      "url": "https://doi.org/10.31234/osf.io/gfuet",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "schatten_2020",
      "fullText": "Schatten, H., Eter, N., & Mihailovic, N. (2020). „Visual snow“ bei „Hallucinogen Persisting Perception Disorder“. Der Ophthalmologe, 117(11), 1112–1115. https://doi.org/10.1007/s00347-020-01056-y",
      "authors": "Schatten, H., Eter, N., & Mihailovic, N.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00347-020-01056-y",
      "url": "https://doi.org/10.1007/s00347-020-01056-y",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "schlag_2022",
      "fullText": "Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022). Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology, 36(3), 258–272. https://doi.org/10.1177/02698811211069100",
      "authors": "Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211069100",
      "url": "https://doi.org/10.1177/02698811211069100",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "schleim_2022",
      "fullText": "Schleim, S. (2022). Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology. Frontiers in Psychiatry, 13, 906487. https://doi.org/10.3389/fpsyt.2022.906487",
      "authors": "Schleim, S.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2022.906487",
      "url": "https://doi.org/10.3389/fpsyt.2022.906487",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0614",
      "fullText": "Scopus preview—Scopus—Document details—Anticholinergic toxicity after the ingestion of serotonergic “magic mushrooms.” (n.d.). Retrieved January 4, 2025, from https://www.scopus.com/record/display.uri?eid=2-s2.0-84866140419&origin=inward&txGid=a335cb6bccc0e713f05d897c6079b26a",
      "authors": "Scopus preview—Scopus—Document details—Anticholinergic toxicity after the ingestion of serotonergic “magic mushrooms.” (n.d.). Retrieved January 4, 2025, from https://www.scopus.com/record/display.uri?eid=2-s2.0-84866140419&origin=inward&txGid=a335cb6bccc0e713f05d897c6079b26a",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.scopus.com/record/display.uri?eid=2-s2.0-84866140419&origin=inward&txGid=a335cb6bccc0e713f05d897c6079b26a",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0615",
      "fullText": "Section 1 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect1pe.htm",
      "authors": "Section 1 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect1pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect1pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0616",
      "fullText": "Section 3 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect3pe.htm",
      "authors": "Section 3 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect3pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect3pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0617",
      "fullText": "Section 4 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.-a). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "authors": "Section 4 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.-a). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0618",
      "fullText": "Section 4 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.-b). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "authors": "Section 4 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.-b). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect4pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0619",
      "fullText": "Section 5 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect5pe.htm",
      "authors": "Section 5 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect5pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect5pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0620",
      "fullText": "Section 7 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect7pe.htm",
      "authors": "Section 7 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect7pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect7pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0621",
      "fullText": "Section 8 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect8pe.htm",
      "authors": "Section 8 PE Tables—Results from the 2023 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. (n.d.). Retrieved January 27, 2025, from https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect8pe.htm",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://www.samhsa.gov/data/sites/default/files/reports/rpt47100/NSDUHDetailedTabs2023/NSDUHDetailedTabs2023/2023-nsduh-detailed-tables-sect8pe.htm",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sessa_2015",
      "fullText": "Sessa, B., & Nutt, D. (2015). Making a medicine out of MDMA. The British Journal of Psychiatry: The Journal of Mental Science, 206(1), 4–6. https://doi.org/10.1192/bjp.bp.114.152751",
      "authors": "Sessa, B., & Nutt, D.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1192/bjp.bp.114.152751",
      "url": "https://doi.org/10.1192/bjp.bp.114.152751",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sevigny_2024",
      "fullText": "Sevigny, E. L., Thyssen, S., Erowid, E., & Lea, R. (2024). Misrepresentation of MDMA in the United States, 1999–2023. Drug and Alcohol Dependence, 264, 112467. https://doi.org/10.1016/j.drugalcdep.2024.112467",
      "authors": "Sevigny, E. L., Thyssen, S., Erowid, E., & Lea, R.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.drugalcdep.2024.112467",
      "url": "https://doi.org/10.1016/j.drugalcdep.2024.112467",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sexton_2019",
      "fullText": "Sexton, J. D., Crawford, M. S., Sweat, N. W., Varley, A., Green, E. E., & Hendricks, P. S. (2019). Prevalence and epidemiological associates of novel psychedelic use in the United States adult population. Journal of Psychopharmacology. https://doi.org/10.1177/0269881119827796",
      "authors": "Sexton, J. D., Crawford, M. S., Sweat, N. W., Varley, A., Green, E. E., & Hendricks, P. S.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881119827796",
      "url": "https://doi.org/10.1177/0269881119827796",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "shane_2024",
      "fullText": "Shane, D., Cho, M., & Akhtar, S. (2024). Psychedelics in medicine—A call for educational action. Canadian Medical Education Journal, 15(4), 132–133. https://doi.org/10.36834/cmej.78844",
      "authors": "Shane, D., Cho, M., & Akhtar, S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.36834/cmej.78844",
      "url": "https://doi.org/10.36834/cmej.78844",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sharp_2021",
      "fullText": "Sharp, J. L., & Smith, M. A. (2021). The Effects of Drugs on Behavior Maintained by Social Contact: Role of Monoamines in Social Reinforcement. Frontiers in Behavioral Neuroscience, 15, 805139. https://doi.org/10.3389/fnbeh.2021.805139",
      "authors": "Sharp, J. L., & Smith, M. A.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3389/fnbeh.2021.805139",
      "url": "https://doi.org/10.3389/fnbeh.2021.805139",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "shaw_2023",
      "fullText": "Shaw, L., Rea, K., Lachowsky, N. J., & Roth, E. A. (2023). Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences. Journal of Psychoactive Drugs, 55(2), 151–158. https://doi.org/10.1080/02791072.2022.2054746",
      "authors": "Shaw, L., Rea, K., Lachowsky, N. J., & Roth, E. A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2054746",
      "url": "https://doi.org/10.1080/02791072.2022.2054746",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "short_2018",
      "fullText": "Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018). Side-effects associated with ketamine use in depression: A systematic review. The Lancet. Psychiatry, 5(1), 65–78. https://doi.org/10.1016/S2215-0366(17)30272-9",
      "authors": "Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1016/S2215-0366(17)30272-9",
      "url": "https://doi.org/10.1016/S2215-0366(17)30272-9",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sicignano_2023",
      "fullText": "Sicignano, D., Snow-Caroti, K., Hernandez, A. V., & White, C. M. (2023). The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease: A Systematic Review With Meta-analysis. American Journal of Clinical Oncology, 46(6), 236–245. https://doi.org/10.1097/COC.0000000000000998",
      "authors": "Sicignano, D., Snow-Caroti, K., Hernandez, A. V., & White, C. M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1097/COC.0000000000000998",
      "url": "https://doi.org/10.1097/COC.0000000000000998",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "sideeffectsandsafetyissuesofpsychedelicdrugsrequestpdf_2024",
      "fullText": "Side Effects and Safety Issues of Psychedelic Drugs | Request PDF. (2024). ResearchGate. https://doi.org/10.37122/kaap.2023.27.2.49",
      "authors": "Side Effects and Safety Issues of Psychedelic Drugs | Request PDF.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.37122/kaap.2023.27.2.49",
      "url": "https://doi.org/10.37122/kaap.2023.27.2.49",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "simmler_2022",
      "fullText": "Simmler, L. D., Li, Y., Hadjas, L. C., Hiver, A., van Zessen, R., & Lüscher, C. (2022). Dual action of ketamine confines addiction liability. Nature, 608(7922), 368–373. https://doi.org/10.1038/s41586-022-04993-7",
      "authors": "Simmler, L. D., Li, Y., Hadjas, L. C., Hiver, A., van Zessen, R., & Lüscher, C.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41586-022-04993-7",
      "url": "https://doi.org/10.1038/s41586-022-04993-7",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "simonmelanie_2013",
      "fullText": "Simon Melanie, H. L. (2013). Hallucinogen Persisting Perception Disorder (HPPD) and Flashback-are they Identical? Journal of Alcoholism & Drug Dependence, 01(04). https://doi.org/10.4172/2329-6488.1000121",
      "authors": "Simon Melanie, H. L.",
      "year": "2013",
      "title": "",
      "journal": "",
      "doi": "10.4172/2329-6488.1000121",
      "url": "https://doi.org/10.4172/2329-6488.1000121",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "simon_2024",
      "fullText": "Simon, M. W., Olsen, H. A., Hoyte, C. O., Black, J. C., Reynolds, K. M., Dart, R. C., & Monte, A. A. (2024). Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022. Annals of Emergency Medicine, 84(6), 605–618. https://doi.org/10.1016/j.annemergmed.2024.06.025",
      "authors": "Simon, M. W., Olsen, H. A., Hoyte, C. O., Black, J. C., Reynolds, K. M., Dart, R. C., & Monte, A. A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.annemergmed.2024.06.025",
      "url": "https://doi.org/10.1016/j.annemergmed.2024.06.025",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "simonsson_2024",
      "fullText": "Simonsson, O., Goldberg, S. B., & Hendricks, P. S. (2024). Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies. Journal of Psychopharmacology, 02698811241292944. https://doi.org/10.1177/02698811241292944",
      "authors": "Simonsson, O., Goldberg, S. B., & Hendricks, P. S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811241292944",
      "url": "https://doi.org/10.1177/02698811241292944",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "simonsson_2023a",
      "fullText": "Simonsson, O., Goldberg, S. B., Chambers, R., Osika, W., Simonsson, C., & Hendricks, P. S. (2023a). Psychedelic use and psychiatric risks. Psychopharmacology. https://doi.org/10.1007/s00213-023-06478-5",
      "authors": "Simonsson, O., Goldberg, S. B., Chambers, R., Osika, W., Simonsson, C., & Hendricks, P. S.",
      "year": "2023a",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-023-06478-5",
      "url": "https://doi.org/10.1007/s00213-023-06478-5",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "simonsson_2023b",
      "fullText": "Simonsson, O., Goldberg, S. B., Chambers, R., Osika, W., Simonsson, C., & Hendricks, P. S. (2023b). Psychedelic use and psychiatric risks. Psychopharmacology. https://doi.org/10.1007/s00213-023-06478-5",
      "authors": "Simonsson, O., Goldberg, S. B., Chambers, R., Osika, W., Simonsson, C., & Hendricks, P. S.",
      "year": "2023b",
      "title": "",
      "journal": "",
      "doi": "10.1007/s00213-023-06478-5",
      "url": "https://doi.org/10.1007/s00213-023-06478-5",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "simonsson_2023",
      "fullText": "Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W., & Goldberg, S. B. (2023). Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. Journal of Affective Disorders, 326, 105–110. https://doi.org/10.1016/j.jad.2023.01.073",
      "authors": "Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W., & Goldberg, S. B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jad.2023.01.073",
      "url": "https://doi.org/10.1016/j.jad.2023.01.073",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "simonsson_2024_1",
      "fullText": "Simonsson, O., Mosing, M. A., Osika, W., Ullén, F., Larsson, H., Lu, Y., & Wesseldijk, L. W. (2024). Adolescent Psychedelic Use and Psychotic or Manic Symptoms. JAMA Psychiatry, 81(6), 579–585. https://doi.org/10.1001/jamapsychiatry.2024.0047",
      "authors": "Simonsson, O., Mosing, M. A., Osika, W., Ullén, F., Larsson, H., Lu, Y., & Wesseldijk, L. W.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2024.0047",
      "url": "https://doi.org/10.1001/jamapsychiatry.2024.0047",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0639",
      "fullText": "Singh, G., Laucis, N. C., Anbalagan, E., Malhotra, K., & Gopalkrishna, G. (n.d.). A case study of LSD induced late psychosis in a 19-year-old woman.",
      "authors": "Singh, G., Laucis, N. C., Anbalagan, E., Malhotra, K., & Gopalkrishna, G. (n.d.). A case study of LSD induced late psychosis in a 19-year-old woman.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "singh_2021a",
      "fullText": "Singh, J. A. (2021a). Epidemiology of hospitalizations with hallucinogen use disorder: A 17-year U.S. National study. Journal of Addictive Diseases, 39(4), 545–549. https://doi.org/10.1080/10550887.2021.1907503",
      "authors": "Singh, J. A.",
      "year": "2021a",
      "title": "",
      "journal": "",
      "doi": "10.1080/10550887.2021.1907503",
      "url": "https://doi.org/10.1080/10550887.2021.1907503",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "singh_2021b",
      "fullText": "Singh, J. A. (2021b). Epidemiology of hospitalizations with hallucinogen use disorder: A 17-year U.S. National study. Journal of Addictive Diseases, 39(4), 545–549. https://doi.org/10.1080/10550887.2021.1907503",
      "authors": "Singh, J. A.",
      "year": "2021b",
      "title": "",
      "journal": "",
      "doi": "10.1080/10550887.2021.1907503",
      "url": "https://doi.org/10.1080/10550887.2021.1907503",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "skommer_2024",
      "fullText": "Skommer, J., Gunesh, K., & Polasek, T. M. (2024). Personality vulnerabilities and adverse event reporting in phase 1 clinical studies. Trials, 25(1), 488. https://doi.org/10.1186/s13063-024-08321-4",
      "authors": "Skommer, J., Gunesh, K., & Polasek, T. M.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1186/s13063-024-08321-4",
      "url": "https://doi.org/10.1186/s13063-024-08321-4",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "skryabin_2018",
      "fullText": "Skryabin, V. Y., Vinnikova, M., Nenastieva, A., & Alekseyuk, V. (2018). Hallucinogen persisting perception disorder: A literature review and three case reports. Journal of Addictive Diseases, 37(3–4), 268–278. https://doi.org/10.1080/10550887.2019.1673655",
      "authors": "Skryabin, V. Y., Vinnikova, M., Nenastieva, A., & Alekseyuk, V.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1080/10550887.2019.1673655",
      "url": "https://doi.org/10.1080/10550887.2019.1673655",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "smith_2022",
      "fullText": "Smith, D. T., Faber, S. C., Buchanan, N. T., Foster, D., & Green, L. (2022). The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision. Frontiers in Psychiatry, 12, 774736. https://doi.org/10.3389/fpsyt.2021.774736",
      "authors": "Smith, D. T., Faber, S. C., Buchanan, N. T., Foster, D., & Green, L.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.774736",
      "url": "https://doi.org/10.3389/fpsyt.2021.774736",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "smith_2021",
      "fullText": "Smith, W. R., & Sisti, D. (2021). Ethics and ego dissolution: The case of psilocybin. Journal of Medical Ethics, 47(12), 807–814. https://doi.org/10.1136/medethics-2020-106070",
      "authors": "Smith, W. R., & Sisti, D.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1136/medethics-2020-106070",
      "url": "https://doi.org/10.1136/medethics-2020-106070",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "soares_2023",
      "fullText": "Soares, C. M., Leite, Â., & Pinto, M. (2023). Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives. Journal of Psychoactive Drugs, 55(2), 159–169. https://doi.org/10.1080/02791072.2022.2071134",
      "authors": "Soares, C. M., Leite, Â., & Pinto, M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2071134",
      "url": "https://doi.org/10.1080/02791072.2022.2071134",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sobel_1971",
      "fullText": "Sobel, J., Espinas, O. E., & Friedman, S. A. (1971). Carotid Artery Obstruction Following LSD Capsule Ingestion. Archives of Internal Medicine, 127(2), 290–291. https://doi.org/10.1001/archinte.1971.00310140118016",
      "authors": "Sobel, J., Espinas, O. E., & Friedman, S. A.",
      "year": "1971",
      "title": "",
      "journal": "",
      "doi": "10.1001/archinte.1971.00310140118016",
      "url": "https://doi.org/10.1001/archinte.1971.00310140118016",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sgaardjuul_2023",
      "fullText": "Søgaard Juul, T., Ebbesen Jensen, M., & Fink-Jensen, A. (2023). The use of classic psychedelics among adults: A Danish online survey study. Nordic Journal of Psychiatry, 77(4), 367–378. https://doi.org/10.1080/08039488.2022.2125069",
      "authors": "Søgaard Juul, T., Ebbesen Jensen, M., & Fink-Jensen, A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/08039488.2022.2125069",
      "url": "https://doi.org/10.1080/08039488.2022.2125069",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "soofi_2023",
      "fullText": "Soofi, H., & Forlini, C. (2023). Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care. AJOB Neuroscience, 14(2), 131–134. https://doi.org/10.1080/21507740.2023.2188291",
      "authors": "Soofi, H., & Forlini, C.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/21507740.2023.2188291",
      "url": "https://doi.org/10.1080/21507740.2023.2188291",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "spriggs_2023",
      "fullText": "Spriggs, M. J., Murphy-Beiner, A., Murphy, R., Bornemann, J., Thurgur, H., & Schlag, A. K. (2023). ARC: A framework for access, reciprocity and conduct in psychedelic therapies. Frontiers in Psychology, 14, 1119115. https://doi.org/10.3389/fpsyg.2023.1119115",
      "authors": "Spriggs, M. J., Murphy-Beiner, A., Murphy, R., Bornemann, J., Thurgur, H., & Schlag, A. K.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyg.2023.1119115",
      "url": "https://doi.org/10.3389/fpsyg.2023.1119115",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "srirangam_2012",
      "fullText": "Srirangam, S., & Mercer, J. (2012). Ketamine bladder syndrome: An important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms. BMJ Case Reports, 2012, bcr2012006447. https://doi.org/10.1136/bcr-2012-006447",
      "authors": "Srirangam, S., & Mercer, J.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": "10.1136/bcr-2012-006447",
      "url": "https://doi.org/10.1136/bcr-2012-006447",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "st_2023",
      "fullText": "St. Arnaud, K. O., & Sharpe, D. (2023). Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users. Journal of Psychoactive Drugs, 55(1), 30–39. https://doi.org/10.1080/02791072.2022.2039815",
      "authors": "St. Arnaud, K. O., & Sharpe, D.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2022.2039815",
      "url": "https://doi.org/10.1080/02791072.2022.2039815",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "stanicic_2024",
      "fullText": "Stanicic, F., Zah, V., Grbic, D., & Angelo, D. D. (2024). Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model. PLOS ONE, 19(11), e0313569. https://doi.org/10.1371/journal.pone.0313569",
      "authors": "Stanicic, F., Zah, V., Grbic, D., & Angelo, D. D.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0313569",
      "url": "https://doi.org/10.1371/journal.pone.0313569",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "stephan_2024",
      "fullText": "Stephan, J.-F., & Karam, S. (2024). Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2024.0277",
      "authors": "Stephan, J.-F., & Karam, S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1089/jpm.2024.0277",
      "url": "https://doi.org/10.1089/jpm.2024.0277",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "strassman_1984a",
      "fullText": "Strassman, R. J. (1984a). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577–595. https://doi.org/10.1097/00005053-198410000-00001",
      "authors": "Strassman, R. J.",
      "year": "1984a",
      "title": "",
      "journal": "",
      "doi": "10.1097/00005053-198410000-00001",
      "url": "https://doi.org/10.1097/00005053-198410000-00001",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "strassman_1984b",
      "fullText": "Strassman, R. J. (1984b). ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE: The Journal of Nervous and Mental Disease, 172(10), 577–595. https://doi.org/10.1097/00005053-198410000-00001",
      "authors": "Strassman, R. J.",
      "year": "1984b",
      "title": "",
      "journal": "",
      "doi": "10.1097/00005053-198410000-00001",
      "url": "https://doi.org/10.1097/00005053-198410000-00001",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "strassman_1994",
      "fullText": "Strassman, R. J., & Qualls, C. R. (1994). Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry, 51(2), 85–97. https://doi.org/10.1001/archpsyc.1994.03950020009001",
      "authors": "Strassman, R. J., & Qualls, C. R.",
      "year": "1994",
      "title": "",
      "journal": "",
      "doi": "10.1001/archpsyc.1994.03950020009001",
      "url": "https://doi.org/10.1001/archpsyc.1994.03950020009001",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "strassman_1994_1",
      "fullText": "Strassman, R. J., Qualls, C. R., Uhlenhuth, E. H., & Kellner, R. (1994). Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 51(2), 98–108. https://doi.org/10.1001/archpsyc.1994.03950020022002",
      "authors": "Strassman, R. J., Qualls, C. R., Uhlenhuth, E. H., & Kellner, R.",
      "year": "1994",
      "title": "",
      "journal": "",
      "doi": "10.1001/archpsyc.1994.03950020022002",
      "url": "https://doi.org/10.1001/archpsyc.1994.03950020022002",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "straumann_2024",
      "fullText": "Straumann, I., Holze, F., Becker, A. M., Ley, L., Halter, N., & Liechti, M. E. (2024). Safety pharmacology of acute psilocybin administration in healthy participants. Neuroscience Applied, 3, 104060. https://doi.org/10.1016/j.nsa.2024.104060",
      "authors": "Straumann, I., Holze, F., Becker, A. M., Ley, L., Halter, N., & Liechti, M. E.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.nsa.2024.104060",
      "url": "https://doi.org/10.1016/j.nsa.2024.104060",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "strauss_2022",
      "fullText": "Strauss, D., Salle, S. de la, Sloshower, J., & Williams, M. T. (2022). Research abuses against people of colour and other vulnerable groups in early psychedelic research. Journal of Medical Ethics, 48(10), 728–737. https://doi.org/10.1136/medethics-2021-107262",
      "authors": "Strauss, D., Salle, S. de la, Sloshower, J., & Williams, M. T.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1136/medethics-2021-107262",
      "url": "https://doi.org/10.1136/medethics-2021-107262",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0661",
      "fullText": "Strickland, J. C., Garcia-Romeu, A., & Johnson, M. W. (n.d.). Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy.",
      "authors": "Strickland, J. C., Garcia-Romeu, A., & Johnson, M. W. (n.d.). Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "strumila_2021",
      "fullText": "Strumila, R., Nobile, B., Korsakova, L., Lengvenyte, A., Olie, E., Lopez-Castroman, J., ... & Courtet, P. (2021). Psilocybin, a naturally occurring indoleamine compound, could be useful to prevent suicidal behaviors. Pharmaceuticals, 14(12), 1213. https://doi.org/10.3390/ph14121213",
      "authors": "Strumila, R., Nobile, B., Korsakova, L., Lengvenyte, A., Olie, E., Lopez-Castroman, J., ... & Courtet, P.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.3390/ph14121213",
      "url": "https://doi.org/10.3390/ph14121213",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0663",
      "fullText": "Studerus, E. (n.d.). Tolerability, Assessment, and Prediction of Psilocybin-Induced Altered States of Consciousness.",
      "authors": "Studerus, E. (n.d.). Tolerability, Assessment, and Prediction of Psilocybin-Induced Altered States of Consciousness.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "studerus_2012",
      "fullText": "Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012). Prediction of psilocybin response in healthy volunteers. PloS One, 7(2), e30800. https://doi.org/10.1371/journal.pone.0030800",
      "authors": "Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X.",
      "year": "2012",
      "title": "",
      "journal": "",
      "doi": "10.1371/journal.pone.0030800",
      "url": "https://doi.org/10.1371/journal.pone.0030800",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "studerus_2011",
      "fullText": "Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies. Journal of Psychopharmacology, 25(11), 1434–1452. https://doi.org/10.1177/0269881110382466",
      "authors": "Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881110382466",
      "url": "https://doi.org/10.1177/0269881110382466",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "subramanian_2014",
      "fullText": "Subramanian, N., & Doran, M. (2014). Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: Case report. Irish Journal of Psychological Medicine, 31(1), 47–49. https://doi.org/10.1017/ipm.2013.59",
      "authors": "Subramanian, N., & Doran, M.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1017/ipm.2013.59",
      "url": "https://doi.org/10.1017/ipm.2013.59",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sumnall_2011",
      "fullText": "Sumnall, H., Measham, F., Brandt, S., & Cole, J. (2011). Salvia divinorum use and phenomenology: Results from an online survey. Journal of Psychopharmacology, 25(11), 1496–1507. https://doi.org/10.1177/0269881110385596",
      "authors": "Sumnall, H., Measham, F., Brandt, S., & Cole, J.",
      "year": "2011",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881110385596",
      "url": "https://doi.org/10.1177/0269881110385596",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "supprian_2001",
      "fullText": "Supprian, T., Frey, U., Supprian, R., Rösler, M., & Wanke, K. (2001). [Psychoactive mushrooms—An update]. Fortschritte Der Neurologie-Psychiatrie, 69(12), 597–602. https://doi.org/10.1055/s-2001-19180",
      "authors": "Supprian, T., Frey, U., Supprian, R., Rösler, M., & Wanke, K.",
      "year": "2001",
      "title": "",
      "journal": "",
      "doi": "10.1055/s-2001-19180",
      "url": "https://doi.org/10.1055/s-2001-19180",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0669",
      "fullText": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences—Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, Katherine A MacLean, Robert Jesse, Matthew W Johnson, Roland R Griffiths, 2016. (n.d.). Retrieved January 12, 2025, from https://journals.sagepub.com/doi/10.1177/0269881116662634",
      "authors": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences—Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, Katherine A MacLean, Robert Jesse, Matthew W Johnson, Roland R Griffiths, 2016. (n.d.). Retrieved January 12, 2025, from https://journals.sagepub.com/doi/10.1177/0269881116662634",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.sagepub.com/doi/10.1177/0269881116662634",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "sutherland_2025",
      "fullText": "Sutherland, I., Ho, M.-F., & Croarkin, P. E. (2025). Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0082",
      "authors": "Sutherland, I., Ho, M.-F., & Croarkin, P. E.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1089/cap.2024.0082",
      "url": "https://doi.org/10.1089/cap.2024.0082",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "suzuki_2015",
      "fullText": "Suzuki, J., Dekker, M. A., Valenti, E. S., Arbelo Cruz, F. A., Correa, A. M., Poklis, J. L., & Poklis, A. (2015). Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: A review of the literature. Psychosomatics, 56(2), 129–139. https://doi.org/10.1016/j.psym.2014.11.002",
      "authors": "Suzuki, J., Dekker, M. A., Valenti, E. S., Arbelo Cruz, F. A., Correa, A. M., Poklis, J. L., & Poklis, A.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psym.2014.11.002",
      "url": "https://doi.org/10.1016/j.psym.2014.11.002",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "swanson_2024",
      "fullText": "Swanson, L. R., Jungers, S., Varghese, R., Cullen, K. R., Evans, M. D., Nielson, J. L., & Schallmo, M.-P. (2024). Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial. Journal of Vision, 24(12), 5. https://doi.org/10.1167/jov.24.12.5",
      "authors": "Swanson, L. R., Jungers, S., Varghese, R., Cullen, K. R., Evans, M. D., Nielson, J. L., & Schallmo, M.-P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1167/jov.24.12.5",
      "url": "https://doi.org/10.1167/jov.24.12.5",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "swieczkowski_2025",
      "fullText": "Swieczkowski, D., Kwaśny, A., Pruc, M., Gaca, Z., Szarpak, L., & Cubała, W. J. (2025). Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials. Psychiatry Research, 344, 116337. https://doi.org/10.1016/j.psychres.2024.116337",
      "authors": "Swieczkowski, D., Kwaśny, A., Pruc, M., Gaca, Z., Szarpak, L., & Cubała, W. J.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psychres.2024.116337",
      "url": "https://doi.org/10.1016/j.psychres.2024.116337",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0674",
      "fullText": "Syed, O. A., Petranker, R., Fewster, E. C., Sobolenko, V., Beidas, Z., Husain, M. I., Lake, S., & Lucas, P. (n.d.-a). Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use. Journal of Psychoactive Drugs, 0(0), 1–11. https://doi.org/10.1080/02791072.2024.2424284",
      "authors": "Syed, O. A., Petranker, R., Fewster, E. C., Sobolenko, V., Beidas, Z., Husain, M. I., Lake, S., & Lucas, P. (n.d.-a). Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use. Journal of Psychoactive Drugs, 0(0), 1–11. https://doi.org/10.1080/02791072.2024.2424284",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2424284",
      "url": "https://doi.org/10.1080/02791072.2024.2424284",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0675",
      "fullText": "Syed, O. A., Petranker, R., Fewster, E. C., Sobolenko, V., Beidas, Z., Husain, M. I., Lake, S., & Lucas, P. (n.d.-b). Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey. Journal of Psychoactive Drugs, 0(0), 1–11. https://doi.org/10.1080/02791072.2024.2446445",
      "authors": "Syed, O. A., Petranker, R., Fewster, E. C., Sobolenko, V., Beidas, Z., Husain, M. I., Lake, S., & Lucas, P. (n.d.-b). Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey. Journal of Psychoactive Drugs, 0(0), 1–11. https://doi.org/10.1080/02791072.2024.2446445",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2446445",
      "url": "https://doi.org/10.1080/02791072.2024.2446445",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "szigeti_2021",
      "fullText": "Szigeti, B., Kartner, L., Blemings, A., Rosas, F., Feilding, A., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2021). Self-blinding citizen science to explore psychedelic microdosing. eLife, 10, e62878. https://doi.org/10.7554/eLife.62878",
      "authors": "Szigeti, B., Kartner, L., Blemings, A., Rosas, F., Feilding, A., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.7554/eLife.62878",
      "url": "https://doi.org/10.7554/eLife.62878",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "szigeti_2018",
      "fullText": "Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J. (2018). Are ecstasy induced serotonergic alterations overestimated for the majority of users? Journal of Psychopharmacology (Oxford, England), 32(7), 741–748. https://doi.org/10.1177/0269881118767646",
      "authors": "Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881118767646",
      "url": "https://doi.org/10.1177/0269881118767646",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "tabaac_2024",
      "fullText": "Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K., Evans, V. D., Fasano, C., & Muir, O. S. (2024). Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin. American Journal of Therapeutics, 31(2), e121–e132. https://doi.org/10.1097/MJT.0000000000001724",
      "authors": "Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K., Evans, V. D., Fasano, C., & Muir, O. S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1097/MJT.0000000000001724",
      "url": "https://doi.org/10.1097/MJT.0000000000001724",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0678",
      "fullText": "Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K., Evans, V. D., Fasano, C., & Muir, O. S. (n.d.). Psychedelic Therapy: A Primer for Primary Care... : American Journal of Therapeutics. Retrieved January 4, 2025, from https://journals.lww.com/americantherapeutics/fulltext/2024/04000/psychedelic_therapy__a_primer_for_primary_care.1.aspx",
      "authors": "Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K., Evans, V. D., Fasano, C., & Muir, O. S. (n.d.). Psychedelic Therapy: A Primer for Primary Care... : American Journal of Therapeutics. Retrieved January 4, 2025, from https://journals.lww.com/americantherapeutics/fulltext/2024/04000/psychedelic_therapy__a_primer_for_primary_care.1.aspx",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": "https://journals.lww.com/americantherapeutics/fulltext/2024/04000/psychedelic_therapy__a_primer_for_primary_care.1.aspx",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "tagen_2023",
      "fullText": "Tagen, M., Mantuani, D., van Heerden, L., Holstein, A., Klumpers, L. E., & Knowles, R. (2023). The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. Journal of Psychopharmacology (Oxford, England), 37(9), 876–890. https://doi.org/10.1177/02698811231190865",
      "authors": "Tagen, M., Mantuani, D., van Heerden, L., Holstein, A., Klumpers, L. E., & Knowles, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811231190865",
      "url": "https://doi.org/10.1177/02698811231190865",
      "categories": [
        "safety",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "tailleferdelaportalire_2023a",
      "fullText": "Taillefer de Laportalière, T., Jullien, A., Yrondi, A., Cestac, P., & Montastruc, F. (2023a). Reporting of harms in clinical trials of esketamine in depression: A systematic review. Psychological Medicine, 53(10), 4305–4315. https://doi.org/10.1017/S0033291723001058",
      "authors": "Taillefer de Laportalière, T., Jullien, A., Yrondi, A., Cestac, P., & Montastruc, F.",
      "year": "2023a",
      "title": "",
      "journal": "",
      "doi": "10.1017/S0033291723001058",
      "url": "https://doi.org/10.1017/S0033291723001058",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "tailleferdelaportalire_2023b",
      "fullText": "Taillefer de Laportalière, T., Jullien, A., Yrondi, A., Cestac, P., & Montastruc, F. (2023b). Reporting of harms in clinical trials of esketamine in depression: A systematic review. Psychological Medicine, 53(10), 4305–4315. https://doi.org/10.1017/S0033291723001058",
      "authors": "Taillefer de Laportalière, T., Jullien, A., Yrondi, A., Cestac, P., & Montastruc, F.",
      "year": "2023b",
      "title": "",
      "journal": "",
      "doi": "10.1017/S0033291723001058",
      "url": "https://doi.org/10.1017/S0033291723001058",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0683",
      "fullText": "Targosz, D. (n.d.). Zatrucia grzybami halucynogennymi w Krakowie.",
      "authors": "Targosz, D. (n.d.). Zatrucia grzybami halucynogennymi w Krakowie.",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": null,
      "url": null,
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "tariq_2023",
      "fullText": "Tariq, R. (2023). Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms. Current Reviews in Clinical and Experimental Pharmacology, 18(2), 94–109. https://doi.org/10.2174/2772432817666220321142707",
      "authors": "Tariq, R.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.2174/2772432817666220321142707",
      "url": "https://doi.org/10.2174/2772432817666220321142707",
      "categories": [
        "harm_reduction",
        "clinical",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "tate_2023",
      "fullText": "Tate, S., Garel, N., Nash, K., & Lembke, A. (2023). Trends in Hallucinogen-associated Emergency Department Visits and Hospitalizations in California from 2016–2021 (p. 2023.08.18.23294275). medRxiv. https://doi.org/10.1101/2023.08.18.23294275",
      "authors": "Tate, S., Garel, N., Nash, K., & Lembke, A.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1101/2023.08.18.23294275",
      "url": "https://doi.org/10.1101/2023.08.18.23294275",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "teixeira_2021",
      "fullText": "Teixeira, P. J., Johnson, M., Timmermann, C., Watts, R., Erritzoe, D., Douglass, H., Kettner, H., & Carhart-Harris, R. (2021). Psychedelics and Health Behavior Change—Journal of Psychopharmacology (in press). PsyArXiv. https://doi.org/10.31234/osf.io/8vks6",
      "authors": "Teixeira, P. J., Johnson, M., Timmermann, C., Watts, R., Erritzoe, D., Douglass, H., Kettner, H., & Carhart-Harris, R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/8vks6",
      "url": "https://doi.org/10.31234/osf.io/8vks6",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "thal_2022",
      "fullText": "Thal, S. B., Engel, L. B., & Bright, S. J. (2022). Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions. Addiction Research & Theory, 30(5), 382–390. https://doi.org/10.1080/16066359.2022.2065268",
      "authors": "Thal, S. B., Engel, L. B., & Bright, S. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1080/16066359.2022.2065268",
      "url": "https://doi.org/10.1080/16066359.2022.2065268",
      "categories": [
        "contraindications"
      ],
      "citedIn": []
    },
    {
      "id": "thal_2022_1",
      "fullText": "Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P. M., Baker, P., Bruno, R., Wenge, T., & Bright, S. J. (2022). Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy-A systematized review. Journal of Psychopharmacology (Oxford, England), 36(11), 1191–1207. https://doi.org/10.1177/02698811221127954",
      "authors": "Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P. M., Baker, P., Bruno, R., Wenge, T., & Bright, S. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811221127954",
      "url": "https://doi.org/10.1177/02698811221127954",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "thal_2022_2",
      "fullText": "Thal, S., Engel, L. B., & Bright, S. J. (2022). Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers. Journal of Humanistic Psychology, 00221678221081380. https://doi.org/10.1177/00221678221081380",
      "authors": "Thal, S., Engel, L. B., & Bright, S. J.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/00221678221081380",
      "url": "https://doi.org/10.1177/00221678221081380",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "therenaissanceofpsychedelicsinpsychiatryevidence_2024",
      "fullText": "THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTS | Request PDF. (2024). ResearchGate. https://doi.org/10.1016/j.jaac.2022.07.661",
      "authors": "THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTS | Request PDF.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.jaac.2022.07.661",
      "url": "https://doi.org/10.1016/j.jaac.2022.07.661",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "timmermann_2022",
      "fullText": "Timmermann, C., Watts, R., & Dupuis, D. (2022). Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. Transcultural Psychiatry, 59(5), 691–704. https://doi.org/10.1177/13634615221082796",
      "authors": "Timmermann, C., Watts, R., & Dupuis, D.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1177/13634615221082796",
      "url": "https://doi.org/10.1177/13634615221082796",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "tupper_2008a",
      "fullText": "Tupper, K. W. (2008a). Drugs, discourses and education: A critical discourse analysis of a high school drug education text. Discourse: Studies in the Cultural Politics of Education, 29(2), 223–238. https://doi.org/10.1080/01596300801966864",
      "authors": "Tupper, K. W.",
      "year": "2008a",
      "title": "",
      "journal": "",
      "doi": "10.1080/01596300801966864",
      "url": "https://doi.org/10.1080/01596300801966864",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "tupper_2008b",
      "fullText": "Tupper, K. W. (2008b). Teaching teachers to just say “know”: Reflections on drug education. Teaching and Teacher Education, 24(2), 356–367. https://doi.org/10.1016/j.tate.2007.08.007",
      "authors": "Tupper, K. W.",
      "year": "2008b",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.tate.2007.08.007",
      "url": "https://doi.org/10.1016/j.tate.2007.08.007",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "tupper_2014",
      "fullText": "Tupper, K. W. (2014). Sex, drugs and the honour roll: The perennial challenges of addressing moral purity issues in schools. Critical Public Health, 24(2), 115–131. https://doi.org/10.1080/09581596.2013.862517",
      "authors": "Tupper, K. W.",
      "year": "2014",
      "title": "",
      "journal": "",
      "doi": "10.1080/09581596.2013.862517",
      "url": "https://doi.org/10.1080/09581596.2013.862517",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "turkia_2022",
      "fullText": "Turkia, M. (2022). Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study. Psychiatry Research Case Reports, 1(2), 100029. https://doi.org/10.1016/j.psycr.2022.100029",
      "authors": "Turkia, M.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psycr.2022.100029",
      "url": "https://doi.org/10.1016/j.psycr.2022.100029",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "universidaddechile_2018",
      "fullText": "Universidad de Chile, & Lolas Stepke, F. (2018). Para una ética de la estructuración farmacológica de las relaciones sociales. Persona, 1(021), 101–107. https://doi.org/10.26439/persona2018.n021.1992",
      "authors": "Universidad de Chile, & Lolas Stepke, F.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.26439/persona2018.n021.1992",
      "url": "https://doi.org/10.26439/persona2018.n021.1992",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "urrutia_2023",
      "fullText": "Urrutia, J., Anderson, B. T., Belouin, S. J., Berger, A., Griffiths, R. R., Grob, C. S., Henningfield, J. E., Labate, B. C., Maier, L. J., Maternowska, M. C., Weichold, F., Yaden, D. B., & Magar, V. (2023). Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs, 55(5), 523–538. https://doi.org/10.1080/02791072.2023.2258367",
      "authors": "Urrutia, J., Anderson, B. T., Belouin, S. J., Berger, A., Griffiths, R. R., Grob, C. S., Henningfield, J. E., Labate, B. C., Maier, L. J., Maternowska, M. C., Weichold, F., Yaden, D. B., & Magar, V.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2023.2258367",
      "url": "https://doi.org/10.1080/02791072.2023.2258367",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "uthaug_2022a",
      "fullText": "Uthaug, M. V., Davis, A. K., Haas, T. F., Davis, D., Dolan, S. B., Lancelotta, R., Timmermann, C., & Ramaekers, J. G. (2022a). The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology (Oxford, England), 36(3), 309–320. https://doi.org/10.1177/02698811211013583",
      "authors": "Uthaug, M. V., Davis, A. K., Haas, T. F., Davis, D., Dolan, S. B., Lancelotta, R., Timmermann, C., & Ramaekers, J. G.",
      "year": "2022a",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211013583",
      "url": "https://doi.org/10.1177/02698811211013583",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "uthaug_2022b",
      "fullText": "Uthaug, M. V., Davis, A. K., Haas, T. F., Davis, D., Dolan, S. B., Lancelotta, R., Timmermann, C., & Ramaekers, J. G. (2022b). The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology, 36(3), 309–320. https://doi.org/10.1177/02698811211013583",
      "authors": "Uthaug, M. V., Davis, A. K., Haas, T. F., Davis, D., Dolan, S. B., Lancelotta, R., Timmermann, C., & Ramaekers, J. G.",
      "year": "2022b",
      "title": "",
      "journal": "",
      "doi": "10.1177/02698811211013583",
      "url": "https://doi.org/10.1177/02698811211013583",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vamvakopoulou_2023",
      "fullText": "Vamvakopoulou, I. A., Narine, K. A. D., Campbell, I., Dyck, J. R. B., & Nutt, D. J. (2023). Mescaline: The forgotten psychedelic. Neuropharmacology, 222, 109294. https://doi.org/10.1016/j.neuropharm.2022.109294",
      "authors": "Vamvakopoulou, I. A., Narine, K. A. D., Campbell, I., Dyck, J. R. B., & Nutt, D. J.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.neuropharm.2022.109294",
      "url": "https://doi.org/10.1016/j.neuropharm.2022.109294",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vanamsterdam_2015",
      "fullText": "van Amsterdam, J., Nutt, D., Phillips, L., & van den Brink, W. (2015). European rating of drug harms. Journal of Psychopharmacology (Oxford, England), 29(6), 655–660. https://doi.org/10.1177/0269881115581980",
      "authors": "van Amsterdam, J., Nutt, D., Phillips, L., & van den Brink, W.",
      "year": "2015",
      "title": "",
      "journal": "",
      "doi": "10.1177/0269881115581980",
      "url": "https://doi.org/10.1177/0269881115581980",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vanbeek_2009",
      "fullText": "Van Beek, I. (2009). HARM REDUCTION—AN ETHICAL IMPERATIVE. Addiction, 104(3), 342–343. https://doi.org/10.1111/j.1360-0443.2008.02418.x",
      "authors": "Van Beek, I.",
      "year": "2009",
      "title": "",
      "journal": "",
      "doi": "10.1111/j.1360-0443.2008.02418.x",
      "url": "https://doi.org/10.1111/j.1360-0443.2008.02418.x",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "vandongen_2021",
      "fullText": "van Dongen, R. M., Alderliefste, G. J., Onderwater, G. L. J., Ferrari, M. D., & Terwindt, G. M. (2021). Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without. European Journal of Neurology, 28(8), 2631–2638. https://doi.org/10.1111/ene.14914",
      "authors": "van Dongen, R. M., Alderliefste, G. J., Onderwater, G. L. J., Ferrari, M. D., & Terwindt, G. M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1111/ene.14914",
      "url": "https://doi.org/10.1111/ene.14914",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vandongen_2021_1",
      "fullText": "Van Dongen, R. M., Alderliefste, G. J., Onderwater, G. L. J., Ferrari, M. D., & Terwindt, G. M. (2021). Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without. European Journal of Neurology, 28(8), 2631–2638. https://doi.org/10.1111/ene.14914",
      "authors": "Van Dongen, R. M., Alderliefste, G. J., Onderwater, G. L. J., Ferrari, M. D., & Terwindt, G. M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1111/ene.14914",
      "url": "https://doi.org/10.1111/ene.14914",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vanelk_2023",
      "fullText": "Van Elk, M., & Fried, E. I. (2023). History repeating: A roadmap to address common problems in psychedelic science. PsyArXiv. https://doi.org/10.31234/osf.io/ak6gx",
      "authors": "Van Elk, M., & Fried, E. I.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/ak6gx",
      "url": "https://doi.org/10.31234/osf.io/ak6gx",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vanderzwaag_2024",
      "fullText": "VanderZwaag, B., Garcia-Romeu, A., & Garcia-Barrera, M. A. (2024). Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery. Therapeutic Advances in Psychopharmacology, 14, 20451253241264812. https://doi.org/10.1177/20451253241264812",
      "authors": "VanderZwaag, B., Garcia-Romeu, A., & Garcia-Barrera, M. A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/20451253241264812",
      "url": "https://doi.org/10.1177/20451253241264812",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vejmola_2021",
      "fullText": "Vejmola, Č., Tylš, F., Piorecká, V., Koudelka, V., Kadeřábek, L., Novák, T., & Páleníček, T. (2021). Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Translational Psychiatry, 11(1), 506. https://doi.org/10.1038/s41398-021-01603-4",
      "authors": "Vejmola, Č., Tylš, F., Piorecká, V., Koudelka, V., Kadeřábek, L., Novák, T., & Páleníček, T.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41398-021-01603-4",
      "url": "https://doi.org/10.1038/s41398-021-01603-4",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "verne_2024",
      "fullText": "Verne, Z., & Zabinski, J. (2024). How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? AMA Journal of Ethics, 26(11), 868–874. https://doi.org/10.1001/amajethics.2024.868",
      "authors": "Verne, Z., & Zabinski, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/amajethics.2024.868",
      "url": "https://doi.org/10.1001/amajethics.2024.868",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "villalobos_2004a",
      "fullText": "Villalobos, C. A., Bull, P., Sáez, P., Cassels, B. K., & Huidobro-Toro, J. P. (2004a). 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. British Journal of Pharmacology, 141(7), 1167–1174. https://doi.org/10.1038/sj.bjp.0705722",
      "authors": "Villalobos, C. A., Bull, P., Sáez, P., Cassels, B. K., & Huidobro-Toro, J. P.",
      "year": "2004a",
      "title": "",
      "journal": "",
      "doi": "10.1038/sj.bjp.0705722",
      "url": "https://doi.org/10.1038/sj.bjp.0705722",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "villalobos_2004b",
      "fullText": "Villalobos, C. A., Bull, P., Sáez, P., Cassels, B. K., & Huidobro-Toro, J. P. (2004b). 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. British Journal of Pharmacology, 141(7), 1167–1174. https://doi.org/10.1038/sj.bjp.0705722",
      "authors": "Villalobos, C. A., Bull, P., Sáez, P., Cassels, B. K., & Huidobro-Toro, J. P.",
      "year": "2004b",
      "title": "",
      "journal": "",
      "doi": "10.1038/sj.bjp.0705722",
      "url": "https://doi.org/10.1038/sj.bjp.0705722",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "villiger_2024a",
      "fullText": "Villiger, D. (2024a). Giving Consent to the Ineffable. Neuroethics, 17(1), 11. https://doi.org/10.1007/s12152-024-09545-6",
      "authors": "Villiger, D.",
      "year": "2024a",
      "title": "",
      "journal": "",
      "doi": "10.1007/s12152-024-09545-6",
      "url": "https://doi.org/10.1007/s12152-024-09545-6",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "villiger_2024b",
      "fullText": "Villiger, D. (2024b). How to Make Psychedelic-Assisted Therapy Safer. Cambridge Quarterly of Healthcare Ethics, 1–15. https://doi.org/10.1017/S0963180124000604",
      "authors": "Villiger, D.",
      "year": "2024b",
      "title": "",
      "journal": "",
      "doi": "10.1017/S0963180124000604",
      "url": "https://doi.org/10.1017/S0963180124000604",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "villiger_2023",
      "fullText": "Villiger, D., & Trachsel, M. (2023). With great power comes great vulnerability: An ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis. Journal of Medical Ethics, 49(12), 826–832. https://doi.org/10.1136/jme-2022-108816",
      "authors": "Villiger, D., & Trachsel, M.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1136/jme-2022-108816",
      "url": "https://doi.org/10.1136/jme-2022-108816",
      "categories": [
        "harm_reduction",
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "via_2023",
      "fullText": "Viña, S. M., & Stephens, A. L. (2023). Psychedelics and workplace harm. Frontiers in Psychiatry, 14, 1186541. https://doi.org/10.3389/fpsyt.2023.1186541",
      "authors": "Viña, S. M., & Stephens, A. L.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2023.1186541",
      "url": "https://doi.org/10.3389/fpsyt.2023.1186541",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vogt_2023",
      "fullText": "Vogt, S. B., Ley, L., Erne, L., Straumann, I., Becker, A. M., Klaiber, A., ... & Liechti, M. E. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational Psychiatry, 13(1), 172. https://doi.org/10.1038/s41398-023-02477-4",
      "authors": "Vogt, S. B., Ley, L., Erne, L., Straumann, I., Becker, A. M., Klaiber, A., ... & Liechti, M. E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41398-023-02477-4",
      "url": "https://doi.org/10.1038/s41398-023-02477-4",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vollenweider_2020",
      "fullText": "Vollenweider, F. X., & Preller, K. H. (2020). Psychedelic drugs: Neurobiology and potential for treatment of psychiatric disorders. Nature Reviews Neuroscience, 21(11), 611–624. https://doi.org/10.1038/s41583-020-0367-2",
      "authors": "Vollenweider, F. X., & Preller, K. H.",
      "year": "2020",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41583-020-0367-2",
      "url": "https://doi.org/10.1038/s41583-020-0367-2",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "vollenweider_2022",
      "fullText": "Vollenweider, F. X., & Smallridge, J. W. (2022). Classic Psychedelic Drugs: Update on Biological Mechanisms. Pharmacopsychiatry, 55(03), 121–138. https://doi.org/10.1055/a-1721-2914",
      "authors": "Vollenweider, F. X., & Smallridge, J. W.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1055/a-1721-2914",
      "url": "https://doi.org/10.1055/a-1721-2914",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vollenweider_1998",
      "fullText": "Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naïve healthy volunteers. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 19(4), 241–251. https://doi.org/10.1016/S0893-133X(98)00013-X",
      "authors": "Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T.",
      "year": "1998",
      "title": "",
      "journal": "",
      "doi": "10.1016/S0893-133X(98)00013-X",
      "url": "https://doi.org/10.1016/S0893-133X(98)00013-X",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "vorobyeva_2022",
      "fullText": "Vorobyeva, N., & Kozlova, A. A. (2022). Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Frontiers in Pharmacology, 13, 927984. https://doi.org/10.3389/fphar.2022.927984",
      "authors": "Vorobyeva, N., & Kozlova, A. A.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.3389/fphar.2022.927984",
      "url": "https://doi.org/10.3389/fphar.2022.927984",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "wahba_2024",
      "fullText": "Wahba, M., Hayes, C., Kletter, M., & McAllister-Williams, R. H. (2024). Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant’s experience. BJPsych Open, 10(6), e229. https://doi.org/10.1192/bjo.2024.768",
      "authors": "Wahba, M., Hayes, C., Kletter, M., & McAllister-Williams, R. H.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1192/bjo.2024.768",
      "url": "https://doi.org/10.1192/bjo.2024.768",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "walther_2024",
      "fullText": "Walther, R. F. E., & van Schie, H. T. (2024). ‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change. Psychoactives, 3(3), Article 3. https://doi.org/10.3390/psychoactives3030026",
      "authors": "Walther, R. F. E., & van Schie, H. T.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.3390/psychoactives3030026",
      "url": "https://doi.org/10.3390/psychoactives3030026",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "waltzer_1972",
      "fullText": "Waltzer, H. (1972). Depersonalization and the use of LSD: A psychodynamic study. American Journal of Psychoanalysis, 32(1), 45–52. https://doi.org/10.1007/BF01872483",
      "authors": "Waltzer, H.",
      "year": "1972",
      "title": "",
      "journal": "",
      "doi": "10.1007/BF01872483",
      "url": "https://doi.org/10.1007/BF01872483",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wang_2024",
      "fullText": "Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports, 14(1), 28022. https://doi.org/10.1038/s41598-024-78736-1",
      "authors": "Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-78736-1",
      "url": "https://doi.org/10.1038/s41598-024-78736-1",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "weiss_2023",
      "fullText": "Weiss, B., Sleep, C. E., Beller, N. M., Erritzoe, D., & Campbell, W. K. (2023). Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model. https://doi.org/10.1556/2054.2023.00291",
      "authors": "Weiss, B., Sleep, C. E., Beller, N. M., Erritzoe, D., & Campbell, W. K.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2023.00291",
      "url": "https://doi.org/10.1556/2054.2023.00291",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "weiss_2023_1",
      "fullText": "Weiss, B., Wingert, A., Erritzoe, D., & Campbell, W. K. (2023). Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca. Scientific Reports, 13(1), 9438. https://doi.org/10.1038/s41598-023-36184-3",
      "authors": "Weiss, B., Wingert, A., Erritzoe, D., & Campbell, W. K.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-023-36184-3",
      "url": "https://doi.org/10.1038/s41598-023-36184-3",
      "categories": [
        "safety",
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "weleff_2024",
      "fullText": "Weleff, J., Anand, A., Dewey, E. N., & Barnett, B. S. (2024). LSD use in the United States: Examining user demographics and their evolution from 2015–2019. https://doi.org/10.1556/2054.2024.00309",
      "authors": "Weleff, J., Anand, A., Dewey, E. N., & Barnett, B. S.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2024.00309",
      "url": "https://doi.org/10.1556/2054.2024.00309",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wells_2024",
      "fullText": "Wells, A., Fernandes, M., & Reynolds, L. (2024). Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review. Journal of Psychedelic Studies, 8(1), 43–62. https://doi.org/10.1556/2054.2023.00294",
      "authors": "Wells, A., Fernandes, M., & Reynolds, L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2023.00294",
      "url": "https://doi.org/10.1556/2054.2023.00294",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wells_2024_1",
      "fullText": "Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., Applebaum, A. J., Parkinson, H., & Reynolds, L. (2024). PAM trial protocol: A randomised feasibility study of psychedelic microdosing–assisted meaning-centred psychotherapy in advanced stage cancer patients. Pilot and Feasibility Studies, 10(1), 29. https://doi.org/10.1186/s40814-024-01449-9",
      "authors": "Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., Applebaum, A. J., Parkinson, H., & Reynolds, L.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1186/s40814-024-01449-9",
      "url": "https://doi.org/10.1186/s40814-024-01449-9",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "white_2024",
      "fullText": "White, E., Kennedy, T., Ruffell, S., Perkins, D., & Sarris, J. (2024). Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review. International Journal of Toxicology, 43(3), 327–339. https://doi.org/10.1177/10915818241230916",
      "authors": "White, E., Kennedy, T., Ruffell, S., Perkins, D., & Sarris, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1177/10915818241230916",
      "url": "https://doi.org/10.1177/10915818241230916",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "wilkinson_2024",
      "fullText": "Wilkinson, S. T., Palamar, J. J., & Sanacora, G. (2024). The Rapidly Shifting Ketamine Landscape in the US. JAMA Psychiatry, 81(3), 221–222. https://doi.org/10.1001/jamapsychiatry.2023.4945",
      "authors": "Wilkinson, S. T., Palamar, J. J., & Sanacora, G.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1001/jamapsychiatry.2023.4945",
      "url": "https://doi.org/10.1001/jamapsychiatry.2023.4945",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "williams_2021a",
      "fullText": "Williams, M. L., Korevaar, D., Harvey, R., Fitzgerald, P. B., Liknaitzky, P., O’Carroll, S., Puspanathan, P., Ross, M., Strauss, N., & Bennett-Levy, J. (2021a). Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Frontiers in Psychiatry, 12, 737738. https://doi.org/10.3389/fpsyt.2021.737738",
      "authors": "Williams, M. L., Korevaar, D., Harvey, R., Fitzgerald, P. B., Liknaitzky, P., O’Carroll, S., Puspanathan, P., Ross, M., Strauss, N., & Bennett-Levy, J.",
      "year": "2021a",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.737738",
      "url": "https://doi.org/10.3389/fpsyt.2021.737738",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "williams_2021b",
      "fullText": "Williams, M. L., Korevaar, D., Harvey, R., Fitzgerald, P. B., Liknaitzky, P., O’Carroll, S., Puspanathan, P., Ross, M., Strauss, N., & Bennett-Levy, J. (2021b). Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Frontiers in Psychiatry, 12, 737738. https://doi.org/10.3389/fpsyt.2021.737738",
      "authors": "Williams, M. L., Korevaar, D., Harvey, R., Fitzgerald, P. B., Liknaitzky, P., O’Carroll, S., Puspanathan, P., Ross, M., Strauss, N., & Bennett-Levy, J.",
      "year": "2021b",
      "title": "",
      "journal": "",
      "doi": "10.3389/fpsyt.2021.737738",
      "url": "https://doi.org/10.3389/fpsyt.2021.737738",
      "categories": [
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "williams_2019",
      "fullText": "Williams, M. T., & Labate, B. C. (2019). Diversity, equity, and access in psychedelic medicine. Journal of Psychedelic Studies, 4(1), 1–3. https://doi.org/10.1556/2054.2019.032",
      "authors": "Williams, M. T., & Labate, B. C.",
      "year": "2019",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2019.032",
      "url": "https://doi.org/10.1556/2054.2019.032",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "williams_2021",
      "fullText": "Williams, M. T., Davis, A. K., Xin, Y., Sepeda, N. D., Grigas, P. C., Sinnott, S., & Haeny, A. M. (2021). People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs: Education, Prevention and Policy, 28(3), 215–226. https://doi.org/10.1080/09687637.2020.1854688",
      "authors": "Williams, M. T., Davis, A. K., Xin, Y., Sepeda, N. D., Grigas, P. C., Sinnott, S., & Haeny, A. M.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1080/09687637.2020.1854688",
      "url": "https://doi.org/10.1080/09687637.2020.1854688",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wilsonpoe_2024",
      "fullText": "Wilson-Poe, A., Hoffman, K., Pertl, K., Luoma, J., Bazinet, A., Stauffer, C., McCarty, D., & Korthuis, P. (2024). Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts. Journal of Psychoactive Drugs, 1–8. https://doi.org/10.1080/02791072.2024.2401982",
      "authors": "Wilson-Poe, A., Hoffman, K., Pertl, K., Luoma, J., Bazinet, A., Stauffer, C., McCarty, D., & Korthuis, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1080/02791072.2024.2401982",
      "url": "https://doi.org/10.1080/02791072.2024.2401982",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wolfgang_2025",
      "fullText": "Wolfgang, A. S., Fonzo, G. A., Gray, J. C., Krystal, J. H., Grzenda, A., Widge, A. S., Kraguljac, N. V., McDonald, W. M., Rodriguez, C. I., & Nemeroff, C. B. (2025). MDMA and MDMA-Assisted Therapy. American Journal of Psychiatry, 182(1), 79–103. https://doi.org/10.1176/appi.ajp.20230681",
      "authors": "Wolfgang, A. S., Fonzo, G. A., Gray, J. C., Krystal, J. H., Grzenda, A., Widge, A. S., Kraguljac, N. V., McDonald, W. M., Rodriguez, C. I., & Nemeroff, C. B.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20230681",
      "url": "https://doi.org/10.1176/appi.ajp.20230681",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wolfgang_2025_1",
      "fullText": "Wolfgang, A. S., McClair, V. L., Schnurr, P. P., Holtzheimer, P. E., Woolley, J. D., Stauffer, C. S., Wolf, R. C., States, L. J., Benedek, D. M., Capaldi, V. F., Bradley, J., Fuller, M. A., Smyth, M. J., Hermes, E. D. A., Tenhula, W., & Wiechers, I. R. (2025). Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration. American Journal of Psychiatry, 182(1), 17–20. https://doi.org/10.1176/appi.ajp.20240751",
      "authors": "Wolfgang, A. S., McClair, V. L., Schnurr, P. P., Holtzheimer, P. E., Woolley, J. D., Stauffer, C. S., Wolf, R. C., States, L. J., Benedek, D. M., Capaldi, V. F., Bradley, J., Fuller, M. A., Smyth, M. J., Hermes, E. D. A., Tenhula, W., & Wiechers, I. R.",
      "year": "2025",
      "title": "",
      "journal": "",
      "doi": "10.1176/appi.ajp.20240751",
      "url": "https://doi.org/10.1176/appi.ajp.20240751",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wolfson_2023",
      "fullText": "Wolfson, E. (2023). Psychedelic-supportive psychotherapy: A psychotherapeutic model for, before and beyond the medicine experience. Journal of Psychedelic Studies, 6(3), 191–202. https://doi.org/10.1556/2054.2022.00192",
      "authors": "Wolfson, E.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1556/2054.2022.00192",
      "url": "https://doi.org/10.1556/2054.2022.00192",
      "categories": [
        "harm_reduction"
      ],
      "citedIn": []
    },
    {
      "id": "wood_2024",
      "fullText": "Wood, M. J., McAlpine, R. G., & Kamboj, S. K. (2024). Strategies for resolving challenging psychedelic experiences: Insights from a mixed-methods study. Scientific Reports, 14(1), 28817. https://doi.org/10.1038/s41598-024-79931-w",
      "authors": "Wood, M. J., McAlpine, R. G., & Kamboj, S. K.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1038/s41598-024-79931-w",
      "url": "https://doi.org/10.1038/s41598-024-79931-w",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "wright_2018",
      "fullText": "Wright, K. N., & Kabbaj, M. (2018). Sex differences in sub-anesthetic ketamine’s antidepressant effects and abuse liability. Current Opinion in Behavioral Sciences, 23, 36–41. https://doi.org/10.1016/j.cobeha.2018.02.001",
      "authors": "Wright, K. N., & Kabbaj, M.",
      "year": "2018",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.cobeha.2018.02.001",
      "url": "https://doi.org/10.1016/j.cobeha.2018.02.001",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "yaden_2022",
      "fullText": "Yaden, D. B., Earp, B. D., & Griffiths, R. R. (2022). Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care. Cambridge Quarterly of Healthcare Ethics, 31(4), 464–471. https://doi.org/10.1017/S096318012200007X",
      "authors": "Yaden, D. B., Earp, B. D., & Griffiths, R. R.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.1017/S096318012200007X",
      "url": "https://doi.org/10.1017/S096318012200007X",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "yang_2024",
      "fullText": "Yang, J., Wang, N., Luo, W., & Gao, J. (2024). The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials. Psychiatry Research, 339, 116043. https://doi.org/10.1016/j.psychres.2024.116043",
      "authors": "Yang, J., Wang, N., Luo, W., & Gao, J.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1016/j.psychres.2024.116043",
      "url": "https://doi.org/10.1016/j.psychres.2024.116043",
      "categories": [
        "safety",
        "clinical"
      ],
      "citedIn": []
    },
    {
      "id": "yildirim_2024",
      "fullText": "Yildirim, B., Sahin, S. S., Gee, A., Jauhar, S., Rucker, J., Salgado-Pineda, P., Pomarol-Clotet, E., & McKenna, P. (2024). Adverse psychiatric effects of psychedelic drugs: A systematic review of case reports. Psychological Medicine, 54(15), 4035–4047. https://doi.org/10.1017/S0033291724002496",
      "authors": "Yildirim, B., Sahin, S. S., Gee, A., Jauhar, S., Rucker, J., Salgado-Pineda, P., Pomarol-Clotet, E., & McKenna, P.",
      "year": "2024",
      "title": "",
      "journal": "",
      "doi": "10.1017/S0033291724002496",
      "url": "https://doi.org/10.1017/S0033291724002496",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "zeifman_2021",
      "fullText": "Zeifman, R. J., Singhal, N., Breslow, L., & Weissman, C. R. (2021). On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review. ACS Pharmacology & Translational Science, 4(2), 436–451. https://doi.org/10.1021/acsptsci.1c00024",
      "authors": "Zeifman, R. J., Singhal, N., Breslow, L., & Weissman, C. R.",
      "year": "2021",
      "title": "",
      "journal": "",
      "doi": "10.1021/acsptsci.1c00024",
      "url": "https://doi.org/10.1021/acsptsci.1c00024",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    },
    {
      "id": "ref_0745",
      "fullText": "Zeller, M. (n.d.). Psychedelic therapies and belief change: Are there risks of epistemic harm or epistemic injustice? Philosophical Psychology, 0(0), 1–32. https://doi.org/10.1080/09515089.2024.2362284",
      "authors": "Zeller, M. (n.d.). Psychedelic therapies and belief change: Are there risks of epistemic harm or epistemic injustice? Philosophical Psychology, 0(0), 1–32. https://doi.org/10.1080/09515089.2024.2362284",
      "year": "n.d.",
      "title": "",
      "journal": "",
      "doi": "10.1080/09515089.2024.2362284",
      "url": "https://doi.org/10.1080/09515089.2024.2362284",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "zhou_2022",
      "fullText": "Zhou, K., De Wied, D., Carhart-Harris, R., & Kettner, H. (2022). Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use. PsyArXiv. https://doi.org/10.31234/osf.io/txzha",
      "authors": "Zhou, K., De Wied, D., Carhart-Harris, R., & Kettner, H.",
      "year": "2022",
      "title": "",
      "journal": "",
      "doi": "10.31234/osf.io/txzha",
      "url": "https://doi.org/10.31234/osf.io/txzha",
      "categories": [
        "general"
      ],
      "citedIn": []
    },
    {
      "id": "zhu_2016",
      "fullText": "Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. (2016). Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant. Neuroscience Bulletin, 32(6), 557–564. https://doi.org/10.1007/s12264-016-0081-2",
      "authors": "Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L.",
      "year": "2016",
      "title": "",
      "journal": "",
      "doi": "10.1007/s12264-016-0081-2",
      "url": "https://doi.org/10.1007/s12264-016-0081-2",
      "categories": [
        "safety"
      ],
      "citedIn": []
    },
    {
      "id": "zimmermann_2023",
      "fullText": "Zimmermann, J., Zölch, N., Coray, R., Bavato, F., Friedli, N., Baumgartner, M. R., Steuer, A. E., Opitz, A., Werner, A., Oeltzschner, G., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., & Quednow, B. B. (2023). Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex. The International Journal of Neuropsychopharmacology, 26(6), 438–450. https://doi.org/10.1093/ijnp/pyad023",
      "authors": "Zimmermann, J., Zölch, N., Coray, R., Bavato, F., Friedli, N., Baumgartner, M. R., Steuer, A. E., Opitz, A., Werner, A., Oeltzschner, G., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., & Quednow, B. B.",
      "year": "2023",
      "title": "",
      "journal": "",
      "doi": "10.1093/ijnp/pyad023",
      "url": "https://doi.org/10.1093/ijnp/pyad023",
      "categories": [
        "pharmacology"
      ],
      "citedIn": []
    }
  ]
}